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In its strictest sense electromyography (EMG) refers to methods of studying the 
electrical activity of striated muscles. Modern electrodiagnostic techniques involve 
both EMG and motor and sensory-nerve conduction studies. In a clinical context, EMG 
and nerve-conduction studies together are commonly denoted as (clinical) EMG. The 
present thesis deals with EMG in the strict sense. High-density surface EMG (HD-
sEMG) is a non-invasive technique to measure electrical muscle activity with multiple 
(more than two) closely spaced electrodes overlying a restricted area of the skin. The 
two-dimensional grids used in studies described in this thesis were developed in our 
department and allow the recording of EMG activity over time and place. 
High-density surface EMG: A novel technique 
The development of the novel technique of HD-sEMG started in 1996 under 
supervision of Dick Stegeman, Head of the Physics group of the Department of Clinical 
Neurophysiology in the Radboud University Nijmegen Medical Centre, who in that year 
was awarded a research grant by the Technology Foundation (STW, Utrecht) to develop 
and examine the applications of the technique in neurological and neuromuscular 
patients in a broad sense. The project was founded on the groundbreaking PhD work of 
Karin Roeleveld.37 She showed the possibilities of extracting information from surface 
EMG at the level of the motor unit (MU), the building block of the EMG signal, based on 
the use of multiple, closely spaced electrodes in a two dimensional grid. For a technique 
to be clinically relevant one needs to be able to access MUs since in clinical EMG 
information at that level is crucial. HD-sEMG had to meet the performance of needle 
EMG, the usual way to come ‘close to’ MUs. In general terms, the disadvantage of HD-
sEMG not being close to the active MUs, was thought to be compensated for by the 
addition of the spatial information it provided. One of the great practical advantages 
of HD-sEMG is that it is painless, making it potentially useful especially in children. 
Moreover, and more principally, the EMG signal is fundamentally spatiotemporal in 
nature. Neglecting the spatial aspect of electrical muscle activity can be regarded 
as neglecting ‘half the information’. Blok et al. concluded the STW project with the 
presentation of an early HD-sEMG system4 which has since undergone considerable 
enhancement, including the development of different grids26, 39 and upgrading of 
its software.25 The further fine-tuning of the system and exploration of its clinical 
applications is an ongoing process. 
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Figure 1. Overview of the successive HD-sEMG grids developed at the Radboud University 
Nijmegen Medical Centre, Department of Clinical Neurophysiology, Institute of Neurology, in 
Nijmegen, The Netherlands. The top three photographs show the first prototypes. The two grids 
depicted below were used in the research described in this thesis. 
This introductory chapter is divided into four sections. To place this thesis in its 
historical perspective, some influential early research that provided substantial new 
insights into the electrical activity of muscles is summarized. 
Second, to understand EMG activity, it is important to not only appreciate the 
anatomical but also the physiological basis of such activity, which is why the second 
section discusses relevant physiological principles on muscle function. Special 
attention will be paid to the muscle membrane function because this is the source of 
the electrical activity in striated muscles and therefore the source of the EMG activity 
being measured. 
The third section concerns various aspects of EMG, among which the different 
electrodes used and pathological EMG characteristics of neurogenic and myopathic 
changes of MUs. 
In the fourth and final section of the introduction the aim of the thesis is expounded. 
14 Chapter 1  General introduction 15
Historical perspective
With the reawakening of science during the Renaissance, the interest in the human body, 
not in the least place in muscles, was evident. Leonardo da Vinci, for example, devoted 
much of his thoughts to the analysis of muscles and their functions, as did the Flemish 
anatomist Andreas Vesalius, whose influence through his monumental book, ‘De humani 
corporis fabrica’ (The structure of the human body), extends down to this day. In one 
sense, this was unfortunate because it stressed the appearance and the geography of 
dead muscles rather than their dynamics.3 Conducting anatomical dissection on executed 
criminals, he demonstrated that there were no signs of the ‘animal spirit’ in the human 
brain.17 Before the Age of Enlightenment, philosophers linked the mind and human 
movement to mythical ‘humors’ that controlled the human body.
Van Swammerdam and Galvani: Animal electricity
With his reference to muscular ‘irritation’ Luigi Galvani is considered the oldest source 
of observations on animal electricity.9 In his famous experiment conducted in 1791 he 
demonstrated that electrical pulses applied to a nerve trunk induced a contraction 
of a frog’s skeletal muscle. Yet, it was the Dutchman Jan Swammerdam who as early 
as in 1658 showed the Duke of Tuscany how he was able to contract a muscle simply 
by irritation of a nerve. Hence, 133 years before Galvani, Swammerdam initiated the 
science of movement with these very first steps in the study of neuromuscular control.9 
Although he performed numerous experiments, he did not publish any findings. 
Fortunately, the notations he kept, all written in Old Dutch, were saved. Some 80 years 
later, his experiments were assembled, ordered and published by others, under the 
supervision of Herman Boerhaave.5 
As Swammerdam’s clear demonstration of other mechanisms remained hidden to the 
world for another eight decades, the originally Greek notion of ‘animal spirits’ still had 
a long life ahead of it. A few years after Swammerdam, Giovanni Borelli (1608-1680), a 
pupil of Galileo’s who was Professor of Mathematics at Pisa and Messina before being 
appointed to the court of Queen Christina of Sweden, began his work on the nature 
of animal movement, focusing on a mathematical interpretation of muscle function. 
Borelli unknowingly confirmed Swammerdam’s insights by arguing that what moved 
down the nerve was a ‘commotion’ or ‘oscillation’, but he maintained that there was 
a fluid within the nerves — a ‘succus nerveus spirituosus’ — that contributed to the 
inflation of muscles on contraction (1680-81). The belief in animal spirits travelling along 
the nerves remained current up to the end of the eighteenth century, when Galvani 
verified the electrical nature of nerve conduction. 
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Figure 2. Representation of Jan van Swammerdam’s isolated nerve-muscle preparation: “Another 
very delicate and useful experiment maybe made, if one of the largest muscles be separated 
from the thigh of a frog, and, together with its adherent nerve, prepared in such a manner as to 
remain unhurt.” The initial demonstration simply involved holding the muscle and subsequently 
stimulating the nerve: “if [...] you take hold, of each tendon with your hand (a a), and then irritate 
the propending nerve with scissors (b), or any other instrument, the muscle will recover its former 
motion, which it had lost. You will see that it is immediately contracted, and draws together, as it 
were, both the hands, which hold the tendons.”5
Galvani’s muscle-nerve experiment is seen as the beginning of neurophysiology and the 
study of dynamics of muscular contraction. For more than two centuries after Galvani, 
biologists have known and acted on the revelation that skeletal muscles will contract 
when stimulated electrically and, conversely, that they produce a detectable current or 
voltage when they contract by any cause. 
Duchenne: The father of medical electrotherapy
Guillaume Benjamin Amand Duchenne de Boulogne (1806-1875) turned his back 
on family tradition when he chose to become a doctor rather than a seafarer. After 
his wife’s death, for which he was blamed, he devoted his life to an odd fascination: 
electricity. He observed that by applying electrical current to a patient’s skin he could 
cause muscles to contract. Lacking a formal appointment, he visited hospitals in Paris, 
seeking out intriguing cases of nerve and muscle disorders and continuing his use 
of ‘faradism’, the application of electricity to the skin for diagnostic or therapeutic 
purposes. In the 1840s he began his study of muscles and paralysis using an induction 
coil. Among other discoveries, he deduced that if a paralyzed muscle contracted due 
to localized faradizations, the cause of the paralysis had to lie in the brain. In other 
words, as the muscle was fine, it had to be the control mechanism that was damaged. 
Conversely, if the muscle did not contract in response to localized faradizations, then it 
2
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was the muscle or nerve that was damaged. With his induction coil studies Duchenne 
laid the groundwork for the field of neurology. Some Paris colleagues initially held the 
eccentric doctor up for ridicule. Eventually, though, his work mapping the muscles of 
the face, the ‘Duchenne smile’, became hugely famous. In his book he describes, among 
other observations, his finding that genuine smiles showing real happiness and delight 
not only utilize the muscles of the mouth but also those of the eyes. He was eventually 
considered one of the greatest clinicians of the 19th century and will be remembered for 
his neurological examinations to which he added electrical stimulation as a diagnostic 
test in localization. He also first identified Pseudohypertrophic Muscle Dystrophy as a 
primary muscle disease, nowadays known as Duchenne’s muscular dystrophy.
Sherrington: The motor unit
In the 19th century, the literature on ‘electrology’ and ‘electrotherapy’ witnessed 
a sudden and important boost, changing the contemporary (neuro)physiological 
understanding of fundamental mechanisms such as nerve conduction and muscle 
contraction mechanisms tremendously.9 During well over a century, numerous 
investigators dedicated themselves to the study of the innervation, function and control 
of skeletal muscle but it was the neurophysiologist Sir Charles Scott Sherrington (1857-
1952) who first recognized that the control of muscles through motor neurons within 
the central nervous system (CNS) required an anatomical substrate (Fig. 3). Accordingly, 
he proposed that each motoneuron innervates a group of individual muscle fibres in 
the sense that each muscle fibre receives innervation from one motoneuron. In 1925, 
Sherrington introduced the term ‘motor unit’ for the combination of a motoneuron 
and the muscle fibres innervated by it. In Section 2 we will discuss the activity of these 
motor units (MUs) as the basis of EMG activity during voluntary contractions.
Adrian, Bronk, and Denny-Brown: Electromyography
The second aspect of Galvani’s discovery, i.e., that muscles produce electricity, largely 
remained a scientific curiosity until the 20th century when improved methods of 
detecting and recording minute electrical discharges became available. It is known, for 
instance, that in 1849 Du Bois Raymond measured electrical activity during a voluntary 
muscle contraction.9 
Hermann Piper is considered to be the first scientist to study surface EMG signals by 
using a string galvanometer in 1912.35 Because of the surface electrodes or inadequate 
amplification, the characteristics of the contribution of single MUs could, however, not 
be determined. 
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It was not until 1929, when Edgar Douglas Adrian and Detlev Wulf Bronk developed the 
concentric needle electrode (see Fig. 4), that EMG became more widely used. 
Figure 3. Sir Charles Sherrington is often seen as the founder of Clinical Neurophysiology. 
Sherrington’s work highlighted a number of properties of reflex arches at the spinal level and 
how they are influenced and modulated by brain structures at a higher level, e.g. the cerebellum 
and the brainstem. His work was immortalized in one of the most classical texts of modern 
neurophysiology, the biography entitled ‘The Integrative Action of the Nervous System’, first 
published in 1906.
Figure 4. Schematic presentation of a concentric needle electrode as used by Adrian and Bronk 
in their motor unit investigations (1929).
3
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They succeeded in obtaining clear intramuscular recordings of myo-electric activity 
from their own triceps brachii muscles during voluntary contractions.1 Subjects in their 
studies were able to increase the force of their muscle contractions by raising the firing 
frequency of the already active MUs and by increasing their number (recruitment). This 
important study on ‘The Discharge of Impulses in Motor Nerve Fibres’ provided a brand 
new way of thinking about the regulation of human movement. Although Adrian is said 
to have doubted whether his simple electrode would have any clinical applications, it 
proved to be one of the most successful tools in EMG studies and is still used in clinical 
neurophysiology worldwide well over a million times a year. When inserted directly into 
a muscle, the electrode proved to be sufficiently sensitive to record electrical events 
accompanying the activation of muscle fibres and single MUs in healthy and diseased 
muscles. The pattern of electrical activity in normal muscle thus became characterized, 
and this permitted departures from normal activity to be recognized and correlated 
with the presence of disorders of MUs.6 Together with Sherrington, Lord Edgar Douglas 
Adrian was awarded the Nobel Prize in Medicine in 1932 for their joint discoveries of the 
function of neurons. 
In 1938, in conjunction with Pennybacker, Derek Denny-Brown published the first 
EMG study of single MUs in patients with neurological disorders. Denny-Brown was 
interested in the pathophysiology of neuromuscular disorders and sought to correlate 
the clinical features with the electrophysiology and pathology. Through EMG he was 
able to separate neurogenic from myopathic diseases. Since then, the application of 
EMG in neuromuscular diseases has greatly expanded, providing greater diagnostic 
capability and therapeutic success.33 
Hodgkin and Huxley: A breakthrough in membrane dynamics
Alan Hodgkin and Andrew Huxley made major contributions to the understanding 
of the time-course and the generation of the nerve-fibre action potential. In 1952, 
they published five reports describing a series of experiments and a model of an 
action potential in a squid’s giant axon.19-23 It had been known for over a century that 
a difference in electrical potential existed between the inside of a cell and its fluid 
environment. Hodgkin and Huxley made a model for membrane dynamics based on 
Ohm’s law (V=IxR). In this equation of three unknown quantities, one needs to know 
two quantities to calculate the third. To this end, Hodgkin and Huxley introduced two 
electrodes into the giant nerve fibre of the squid. They used these squids because they 
had axons large enough to manipulate and use their specially built glass electrodes 
on. With their experimentations on the squid’s axon, they succeeded in creating a 
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circuit model, which is depicted in Figure 5. One electrode served to clamp the voltage 
in predetermined steps, the other to measure the current produced during activity. 
Calculations yielded the third quantity, i.e., the resistance of the membrane, whose 
inverse value, its permeability or conductance, was the variable the experiments 
were designed to measure. Their model, developed before the practical, widespread 
application of electron microscopes and well before computer simulations, allowed 
a basic understanding of the time course of the action potential generation without 
having a detailed understanding of what the membrane of a nerve cell looked like. 
Hodgkin and Huxley studied the changes in membrane resistance as a function of 
time and applied transmembrane voltage. Using constant voltage differences across 
the membrane, they were able to measure changes in the transmembrane currents. 
They concluded that these changes could only be explained by changes in membrane 
resistance and therefore the concept of opening and closing voltage-gated ion channels 
was proposed. By analyzing the estimated sodium (Na) and potassium (K) conductance 
(GNa and GK, respectively) from voltage-clamp pulses of different amplitudes and 
durations, Hodgkin and Huxley succeeded to obtain a complete set of empirical 
equations that described the time-course of the action potential generation (also see 
Section 2). 
Figure 5. The diagram depicted in the Hodgkin and Huxley papers illustrating an electrical circuit 
as assessed in the squid’s giant axon’s membrane, with RNa and RK reflecting transmembrane 
voltage-dependent ion channels; the other components are constant. The ‘leakage’ current (Il) 
may, for example, be caused by chloride. 
5
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On the basis of their experiments they proposed that ion channels were present in 
membranes and that their model predicted how they worked. Their pioneering work 
laid the basis for the concept of resting and action potentials and encouraged ideas on 
how ion channels in membranes might open and close, ideas that at that time could not 
be tested. The behaviour of ion channels will be discussed in more detail later on.
The thesis’ historical context 
The studies reported in the current thesis should be seen as part of a long line of 
research that commenced in the late 19th century when neurophysiological studies 
of muscles and their functions were first performed on patients with neuromuscular 
disorders. With his eagerness to combine pathophysiology of neuromuscular disorders, 
correlating clinical features with the electrophysiology and pathology, Denny-Brown 
subsequently inspired countless researchers. 
Knowledge of the structural and functional MUs in striated muscles, obtained in his 
and expanded in later studies, led to new knowledge and new techniques, as is the case 
with the tool presented in this thesis. Apart from our accumulated (neuro)physiological 
and clinical knowledge, it is especially our recent technological advances that have 
made the development of innovative instruments like HD-sEMG possible. Technical 
progress in amplifiers, analog-to-digital converters and personal computers allowed the 
development of up to a 130-channel sEMG apparatus. 
In the Journal of Neurological Sciences, Mayer also wrote about Denny-Brown: “he 
was concerned about the well being of his patients under study and not keen on using 
painful invasive procedures.”33 The search for and the development of a non-invasive 
instrument to study muscle characteristics to gather new pathophysiological insights 
and eventually for use in clinical practice is fully in line with his concerns and research 
tradition. 
Muscles alive
This section provides a basis for the physiological understanding of the EMG signal. 
Different aspects of motor units (MUs) and membrane physiology will be explained. 
During voluntary contractions, the EMG signal is the sum of electric potentials of all 
simultaneously active MUs, the so-called motor-unit action potentials or MUAPs. The 
sarcolemma or muscle fibre membrane forms the basic source of the EMG signal.
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The motor unit
To generate a movement, the CNS activates alpha-motoneurons in the brainstem or 
spinal cord.38 Each motoneuron subsequently innervates a group of individual muscle 
fibres such that each muscle fibre receives innervation mostly from one motor neuron. 
This motor neuron, and the muscle fibres innervated by it, is called an MU (for a 
schematic representation, see Fig. 6). 
Figure 6. A schematic representation of three motor units (MUs). The MU encompasses the 
cell body of the lower motor neuron in the spinal cord; its axon, which emerges from the cord 
to become a constituent fibre of a nerve root and, ultimately of a peripheral nerve; its terminal 
arborizations and the neuromuscular junctions with which they are associated; and all the 
muscle fibres that are innervated by it. Each skeletal muscle fibre is innervated by at least one 
motoneuron and its axon. The same axon may also innervate other muscle fibres.  
6
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A functional unit
As the axons approach the muscle, they split, with each branch dividing further, so 
that eventually a single parent axon may contact several hundred muscle fibres. The 
contact region between an axonal twig and a muscle fibre is termed a synapse or 
neuromuscular junction. From the neuromuscular junction the excitation spreads along 
the muscle fibre. The region with neuromuscular junctions is called the motor endplate 
zone. The zones are distributed along distinct and scattered regions.31 Since insufficient 
current flows from the axon twig to stimulate the muscle fibre directly, the nerve 
ending releases the chemical transmitter acetylcholine to bring about the necessary 
amplification of the axonal signal. From the motor endplate zone, action potentials 
propagate along the muscle fibres and into the T-transverse tubular system, i.e., the 
membrane region that projects deep into the cell to ensure an even distribution of 
the impulse (see Fig. 7). Via the so-called excitation-contraction coupling, the electrical 
activity of the muscle fibres is finally coupled to the interaction of actin and myosin 
molecules in the muscle, which ultimately generate contractile force. Hence, the MU 
is the functional unit of striated muscle, since an impulse descending the nerve axon 
causes all the muscle fibres in one MU to contract almost simultaneously. The number of 
muscle fibres that are served by one axon, i.e. the number in a single MU, varies widely. 
MUs may contain 20 to 50 fibres,7 even up to 2000 in larger limb muscles.15
Firing frequency and recruitment
Adrian and Bronk (see page 17) found their subjects to be able to increase the force 
of their muscle contractions by two principles: 1. by raising the firing frequency of 
the motoneurons and 2. by calling additional MUs into action (recruitment). These 
principles are still important for a proper interpretation of the EMG signals generated 
by today’s EMG techniques.
In 1965, Henneman and colleagues published five papers that provided a detailed account 
of MU or motoneuron recruitment properties that can be summarized in terms of a 
unifying tenet they called the ‘size principle’.18 It states that the smaller motoneurons in 
the ventral horn are likely to correspond to the smallest MUs. This seemed reasonable, 
because the metabolic activity of a motoneuron is probably proportional to the number 
of muscle fibres and nerve endings it is required to maintain. Others have subsequently 
modified Henneman’s theory.8, 42 
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Figure 7. Schematic representation of muscle tissue in which the electrical impulse (black arrows) 
travels along the sarcolemma.
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Membrane physiology
Electrical ‘information’ along the muscle fibre propagates in two directions: from the 
motor endplate zones towards each tendon.32, 34, 40 It is important to note that electrical 
processes in the body are spatiotemporal processes: over time there is a change 
in membrane potential (see below), and in space there is a propagation of action 
potentials over the muscle fibre membrane. The sarcolemma or surface membrane 
of muscle fibres consists of two closely adjoining lipid leaflets in which proteins are 
embedded, creating semi-permeability. In contrast to the myelinated nerve conduction 
velocity, which is about 40 to 50 m/s, muscle fibre conduction velocity (MFCV) is rather 
slow, about 4-5 m/s.43, 24 
Resting membrane potential in skeletal muscle
Inside a muscle cell, the electric potential is negative with respect to its exterior. 
This so-called resting membrane potential, which is in the order of –70 to –90 mV, is 
developed across the thin barrier of the sarcolemma and reflects differences in ionic 
concentration that exist across the cell membrane and the selective permeability of the 
cell membrane. The intracellular concentration of potassium (K+) is relatively high, and 
the concentration of sodium (Na+) and chloride (Cl-) is relatively low compared to the 
outside of the cell. These inequalities in ionic concentration are created and maintained 
by a transport mechanism requiring the expenditure of energy by the cell, and are also 
related to the varying degrees of permeability the cell membrane has for different ions. 
As was already discussed in the Hodgkin and Huxley models, two forces affect a passive 
movement of ions. First, particles unequally distributed in a solution will tend to move 
by diffusion, moving down their concentration gradients until these are abolished. 
Second, the movement of ions is driven by voltage gradients. The factual movement of 
ions is regulated by the membrane permeability.
Excitable cells have the property to change that permeability for certain ion species 
very rapidly. This leads to a depolarization of the cell membrane and the generation of 
an action potential, which we will elaborate on page 27.
Ion channels
Ions may cross the membrane through so-called ion channels, the most important 
of which, in the present context, are Na, K and Cl channels. Each Na channel has an 
activation and an inactivation gate, while potassium channels have only one gate. The 
potential difference across the membrane in rest is mainly due to the differences in 
K+ concentration on either side of the membrane. With the membrane in rest, the 
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Na activation gates are closed, Na inactivation gates are open and K gates are closed, 
together prohibiting ionic current from nullifying the transmembrane potential 
difference. To ensure that the distributions of ions are maintained across the 
membrane, the ions are pumped against their respective concentration gradients by 
special proteins in the membrane (the ATPase). 
Particularly during the last few decades great advances have been made in 
understanding the structure and molecular mechanisms of the ion channels, pumps, 
and binding proteins. 
In 1991, Roderick MacKinnon – a medical doctor who gave up his profession and 
started doing physiological research because ‘he just had to solve’ the problem of 
ion channels – and his group stunned the scientific community by determining the 
three dimensional structure of a protein that controlled the potassium ion channels 
12, 30 (see Fig. 8), something many other researchers before him had failed to achieve. 
They determined the first high-resolution image of an ion channel from the bacterium 
Streptomyces lavidens.
Figure 8. Cartoons of ion channels. Cartoon A depicts an ion channel in a lipid bilayer membrane. 
The membrane (lipid bilayer) is impenetrable to water-soluble molecules and ions. Ion channels 
were thought to be simple openings or ‘channels’ in the membrane that could open and close (see 
Hodgkin and Huxley). In 1998 MacKinnon’s group determined the first high-resolution structure 
of a potassium ion channel. He was thus the first to reveal how an ion channel functions at the 
atomic level: it uses an ion filter that admits potassium ions and stops sodium ions. The cell may 
also control the channel’s opening and closure. Cartoon B shows the latest simulation of the 
voltage gated K-channel based on McKinnon’s work.
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Muscle fibre action potential
Like nerve cells, muscle cells are excitable, i.e., they produce action potentials after the 
application of a suitable stimulus. As the ionic basis of these events is very complex and 
a full account goes beyond the scope of this introductory chapter, we will make do with 
a simplified representation. 
The action potential is a transient reversal of the membrane potential caused by an 
alteration in membrane permeability. The voltage-sensitive activation gates of the 
Na channels open, allowing Na+ ions to enter the cell, which causes a sudden further 
depolarization of the membrane. The opening of the Na channels at successive points 
along the membrane allows an electrical signal, the action potential, to be transmitted 
from one region of the fibre to another, without decrement. At the original site in the 
mean time, the Na inactivation gates close and the K gates open. The K channels have 
the opposite effect, in that they reduce membrane depolarization, hence terminating 
the action potential whilst ensuring that the membrane does not become electrically 
unstable and spontaneously starts generating action potentials. The membranes of 
excitable cells also comprise Cl channels that have the same effect as K channels. 
Shortly after, the Na activation and K gates close and the Na-K pumps begin to re-
establish the resting membrane potential. In conclusion, a proper functioning of all ion 
channels is essential for adequate action potential propagation.
Figure 9. Copy of the original figure as published in the first of five papers of Hodgkin and Huxley 
showing the changes in sodium (Na) and potassium (K) conductance (continuous lines) during a 
propagated action potential. The membrane potential change is indicated by the dotted line.
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If the sarcolemma fails to generate an action potential in response to endplate 
depolarization, contraction will not take place in spite of normal functioning at the 
neuromuscular junction and normal properties of the contractile apparatus. Unexcitable 
sarcolemma results in muscle paralysis.2 Conversely, if the surface membrane generates 
multiple, uncontrolled action potentials in response to a normal stimulus at the 
neuromuscular junction, sustained contractions can result where only a brief twitch 
was intended. We will be expanding on these principles in Part 1 of this thesis. 
In skeletal muscle, the major energy-requiring membrane transport protein is the 
Na+/K+ ATPase. The primary function of these Na-K pumps is to counterbalance the 
passive leakage of Na and K, thereby allowing the maintenance of transmembrane Na, K 
gradients, excitability and contractility.10 Because of the size of the action potential and 
its sudden onset, the action potential transport events constitute the major challenge 
for the Na+-K+ pumps. The Na+/K+ transport protein actively transports Na+ against 
its concentration gradient from the inside of the cell to the extracellular space while 
simultaneously moving K+ in the opposite direction. When the Na+-K+ pumps cannot 
readily restore the Na+-K+ gradients, working muscle cells often undergo an inside net 
loss of K+ and gain of Na+. This leads to loss of excitability and force, in particular when 
excitation-induced passive Na+-K+ fluxes are large. Thus, excitability depends on the leak/
pump ratio for Na+ and K+. When this ratio is increased by inhibition or downregulation 
of the Na+-K+ pumps, the force decline seen during continued stimulation is accelerated. 
This effect already manifests itself explicitly within the first few seconds of electrical 
stimulation. Fortunately, electrical membrane disbalance also increases the Na+-K+ 
pumping rate within seconds. Thus, the maximum increase (20 times the in-rest 
level) may be reached in 10 seconds, with utilization of all available Na+-K+ pumps.11 
The intracellular action potentials cause extracellular potential changes, which can be 
recorded with extracellular electrodes, as will be discussed in the next section. 
Electromyography
Electric muscle activity
As was described previously, the source of EMG activity is the transmembrane current 
at the sarcolemma level. However, the description of the action potential on page 27 is 
based on data obtained by recordings with an electrode placed inside the cell. With such a 
direct approach – not used in clinical EMG – the electrical activity of muscles is recorded 
extracellularly and in situ, with the muscle fibres lying in a medium that, because it contains 
electrolytes, is able to conduct electric current and is therefore called a volume conductor. 
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Due to this ‘volume conduction’, transient voltage changes are set up in the whole 
surrounding volume, including voltage changes at its surface. EMG examination allows these 
changes to be measured by electrodes distant from the fibre. During voluntary contraction, 
potentials from MUs can be recorded: the motor unit action potentials (MUAPs). MUAP 
characteristics provide clues as to several MU aspects and EMG recordings can thus yield 
information about the functioning and structure of single MUs. 
However, not only the single MUAP is important and may help detect and explain 
neurogenic or myopathic changes (see Fig. 13). The ‘central neural components’ are crucial 
as well, among which the amount of MUs and their recruitment and firing patterns. 
During voluntary contraction multiple MUs are active and the electrical activity measured 
by EMG is caused by multiple MUAPs. In the clinical practice single MUAPs are assessed 
during low-force contractions. During voluntary contraction and increasing force towards 
maximal voluntary contraction in healthy individuals both the firing frequency and the 
number (recruitment) of MUAPs increase. This may change in pathology (see page 33).
Recording principles
Different electrodes can be used to measure the electrical activity of muscle. Needle 
electrodes measure electrical activity within a circumscribed region of the muscle, and 
electrodes on the skin surface measure electrical activity of a larger part of the muscle. 
The various EMG techniques have different scopes (see Fig. 10) as will be discussed in 
the following subsections.
Figure 10. Overview of the various EMG techniques used to record electrical activity in muscle. 
Conventional bipolar sEMG, with one electrode pair over each muscle, yields information about 
a large section of the muscle, useful in movement studies to obtain information from different 
muscles with multiple, concurrent bipolar recordings. With HD-sEMG, involving multiple 
electrodes on one muscle, it is possible to also obtain information at the single motor unit 
(MU) level. The data on muscle fibre conduction velocity can be used to supplement the specific 
information at the muscle fibre and fibre membrane level as obtained with needle EMG or even 
with microscopical techniques like patch clamp. 
10
�������� ������ ���������� ������������ �������
��������
�����������������
�������
����������
30 Chapter 1  General introduction 31
Needle EMG
By inserting the needle electrode directly into a muscle, electrical activity within 
circumscribed regions of that muscle, and, in particular, the electrical events 
accompanying the activation of muscle fibres or groups of muscle fibres can be 
recorded. A relaxed, healthy muscle shows a brief burst of activity when the needle 
penetrates the muscle. This insertion activity is caused by mechanical stimulation of the 
muscle fibres and ceases almost immediately after the electrode stops moving or within 
the next few seconds. Spontaneous muscle-fibre activity refers to the electrical activity 
that may be recorded from a fully relaxed muscle after cessation of the insertion activity 
and when the needle is not being moved. In healthy subjects (normal) spontaneous 
activity is to be found at the endplate zone and is called endplate noise. Other 
spontaneous activity in a relaxed muscle includes fibrillations, positive waves, myotonic 
discharges, complex repetitive discharges and fasciculation potentials.14 These various 
potentials or combinations can be recorded in diverse diseases. However, fasciculation 
potentials may also occur in healthy subjects and, in contrast to the other potentials, 
fasciculation potentials are not single-fibre potentials. Chapter 8 of this thesis will show 
that these fasciculation potentials can also be recorded with HD-sEMG in amyotrophic 
lateral sclerosis (ALS). Abnormal spontaneous (single) muscle-fibre activity can only be 
recorded with needle EMG (see Fig. 10). 
Needle EMG has the advantage that the influence of the volume conduction is less 
obvious compared to a skin-surface measurement. Because the distance between the 
active muscle fibres and the electrode is relatively small, the MUAPs are of relatively 
short duration and can be fairly easily recorded. During voluntary contraction, single 
MUAPs can therefore easily be evaluated with needle EMG. However, its usefulness 
and reproducibility are limited by the fact that the amplitude and morphology of the 
MUAPs are largely determined by the few muscle fibres that lie close to the needle 
tip. Because in pathology not all the muscle fibres and/or MUs are equally affected, 
this can cause sample errors. This also means that needle EMG tends to have poor 
reproducibility. Furthermore, needles cause pain to patients and specifically hamper the 
assessment of recruitment patterns at higher force levels. In the clinical practice, these 
latter drawbacks especially limit the use of needle EMG in children.
Bipolar surface EMG
It is difficult to obtain intuitive insight into the properties of the skin layer and the 
subcutaneous layers as volume conductors. The interaction of volume conduction with 
the basic source characteristics can only be valued by using biophysical modeling.40 And 
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yet, volume conduction greatly affects the recorded potentials: it changes the MUAP 
waveform morphology, decreases the measured amplitudes and changes the frequency 
content of the signals.16, 41 
Chapter 2 of this thesis provides an overview of the different techniques to measure and 
analyze sEMG. With two electrodes placed on the skin, sEMG has several disadvantages 
compared to needle EMG. In their technology assessment study of clinical applications 
of sEMG comprising a computerized literature search covering the period between 
1964 and 1994 issued by the American Association of Electrodiagnostic Medicine 
(AAEM), Haig et al. concluded that “There is in fact almost no literature to support the 
use of sEMG in the clinical diagnosis and management of nerve or muscle disease.” 36 
Bipolar sEMG proved insufficiently equipped to provide adequate information at single 
MU level and was thus unsuitable for use as a diagnostic tool in clinical applications. 
Kinesiology and fatigue studies is almost exclusively the domain of sEMG with a single 
bipolar electrode pair per muscle.27- 29, 44 
High-density surface EMG
To extend and enhance the information generated by bipolar sEMG, high-density 
surface EMG or HD-sEMG was developed, a non-invasive technique to measure 
electrical muscle activity with multiple (more than two) closely spaced electrodes 
overlying a restricted area of the skin.13 
Comparing sEMG content with needle EMG information as a golden standard will 
by definition degrade the former. Instead, one should focus on what HD-sEMG can 
add to needle EMG measures and vice versa. What makes HD-sEMG superior is that 
the technique not only provides temporal information about electrical events, it 
also addresses the ‘other half’ of the information, namely the spatial features of the 
electrical activity over the muscle.34, 40, 45 It allows new characteristics like muscle fibre 
action-potential propagation to be recorded, which, as will be shown in Chapter 3, 
could lead to new pathophysiological insights in neuromuscular disorders. Figure 11, 
for instance, shows the bipolar signals in which a motor endplate zone can be detected 
because of the inversion of signal polarity and the low amplitude. From there, MUAPs 
propagate in two directions along the muscle fibre towards the tendons.
Figure 12 depicts both needle and HD-sEMG recordings of the biceps muscle of a 
healthy subject during a low-force contraction (A,C) and during maximal voluntary 
contraction (B,D). One column of our 126-channel sEMG grid is shown. 
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Figure 11. This figure shows motor unit action potentials (MUAPs) in one column of the HD-sEMG 
grid on a large time base. In the bipolar derivation shown, the motor endplate zone can easily be 
detected by the low amplitude and the reversal of signal polarity. From the motor endplate zone 
the MUAPs propagate along the fibre towards the tendon.
Figure 12. Four EMG recordings of the biceps muscle of a healthy subject. The top two recordings 
were obtained with needle EMG during low-force contraction (A), and during maximal voluntary 
contraction (B). The bottom two are bipolar HD-sEMG recordings during low-force contraction 
(C), and maximal voluntary contraction (D). In both the motor endplate zone can be detected 
allowing the conduction of the MUAPs along the fibre to be estimated. 
11
Fi
br
e 
di
re
ct
io
n
100 �V
20 ms
12
4 mV
0.2 mV
100 ms
2 mV
A
B
C
D
32 Chapter 1  General introduction 33
EMG changes in pathology
Disorders of the human neuromuscular system are quite common. Depending on the 
precise definition of a neuromuscular disease, estimates range from 160,000 to 500,000 
patients in the Netherlands. Although there are about 600 known neuromuscular 
disorders, they are often hard to diagnose. One of the reasons is that there are many 
different diseases and only a few symptoms and signs. Supplementary, more detailed 
examination techniques, among other methods EMG, can assist in classifying these 
disorders. Patients with muscle-function disorders may exhibit negative symptoms like 
muscle weakness or positive symptoms like muscle cramps or myotonia, or both. In 
most neuromuscular disorders muscles weaken and waste away over time, making it 
difficult to speak, breathe, or move. It is therefore essential that to adequately evaluate 
muscle function in neuromuscular disorders both the force and the electrical activity 
of the muscles involved are measured simultaneously. This thesis aims to illustrate the 
added value that combining mechanical muscle activity with a sophisticated sEMG 
technique may have. 
One way to classify neuromuscular disorders is to order them according to their 
anatomical substrate. In case of weakness, for example, EMG can help to differentiate 
between a neurogenic origin (in the motoneuron or motor nerve) and a myopathic 
origin (in the muscle itself). Figure 13 is a schematic representation of MU pathology and 
the related changes in EMG patterns. In Part 3 of this thesis it is investigated whether 
neurogenic and myopathic changes can be observed using HD-sEMG.
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Figure 13. Image A shows a structure of normal motor units (MUs), each consisting of a single 
motor nerve together with the muscle fibres it innervates. The innervation area or motor endplate 
is located approximately halfway along the muscle fibres. From there, action potentials propagate 
in two directions towards the tendons. In a muscle, the anatomical areas of multiple MUs overlap. 
Image B depicts characteristic pathological changes in neurogenic disorders: reduced number 
of MUs and increased MU size. Image C displays typical pathological changes in myopathic 
disorders: normal number of MUs but reduced MU size. 
Aim of the thesis
The series of studies presented in this thesis address various aspects of HD-sEMG in 
diverse neuromuscular and neurological disorders. The research project was initiated 
both to obtain pathophysiological insights and to explore the clinical applicability of 
HD-sEMG as a diagnostic tool. 
To help explain abnormal force production in specific patients, in Part 1 we first tried to 
unravel pathophysiological mechanisms. The spatiotemporal information of HD-sEMG 
recordings specifically allows the distinction of mechanisms that underlie bioelectric 
signal propagation. Based on our expectations that the underlying mechanism 
of weakness was incomplete or abnormal action potential propagation along the 
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sarcolemma, we launched an extensive series of studies in generalized myotonia 
patients. 
As stated earlier, although sEMG does not yield information about spontaneous single-
muscle-fibre activity, it does allow an accurate measurement of spontaneous motor-
unit activity such as fasciculation potentials and muscle cramps or spasms. In order to 
shed more light on likely pathophysiological mechanisms and to further refine the use 
of the HD-sEMG technique in the examination of spontaneous MU activity or muscle 
activity in general, we performed the two studies that are reported in Chapter 6 and 7.
Besides our search for new pathophysiological insights, we also wished to explore the 
clinical applicability of HD-sEMG. To test whether our technique could indeed serve 
as a non-invasive, easy-to-use diagnostic tool, and to identify optimal ways to detect 
neurogenic changes, in Chapter 9 we report the study that we conducted in patients 
with pronounced neurogenic disorders. We aimed to identify those variables that 
would most clearly discriminate between patients and healthy individuals. 
Because the use of HD-sEMG grids and relevant software in clinical settings is rapidly 
gaining ground, we finally reviewed the literature as to the state of affairs vis-à-vis the 
use of HD-sEMG in patients.
 
In conclusion, the present thesis evaluates the applicability of high-density surface 
EMG, a new EMG technique that affords information about spatio-temporal muscle 
function that used to be inaccessible with needle EMG. We expected the technique 
to provide us with new pathophysiological insights and that its spatial information 
would help us identify single MU characteristics allowing us to discriminate between 
pathological and healthy muscles and MUs. 
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Summary
The different techniques to measure and analyse surface EMG are summarized with an 
emphasis on the clinician’s point of view. The application of surface EMG in neurological 
disease is hampered by many inherent problems, especially the difficulties in extracting 
features of single motor units (MUs). However, the evolution of surface EMG from 
single bipolar recordings via a linear array of multiple electrodes to densely packed, 
multi-channel electrode arrays could in principle solve this problem. The added value of 
using multiple channels (up to 128) with an interelectrode distance of few millimetres 
to obtain more spatial information is emphasized. At least for some muscles it is now 
possible to extract information from the surface EMG, conventionally thought to 
belong to the domain of needle EMG (for example the ‘electrical size’ of MUs). The 
use of analysis techniques such as the estimation of muscle fibre conduction velocity 
has already proven to be of diagnostic value in several myopathies characterised by 
a disturbed membrane function and in metabolic myopathies with abnormal fatigue 
profiles. Future research should be directed at the development of analysis techniques 
enabling the extraction of more relevant MU variables from surface EMG signals. 
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Introduction
In a recent technology assessment study of Haig et al. issued by the American 
Association of Electrodiagnostic Medicine (AAEM) after a computer literature search 
from 1964 to 1994 and the analysis of 2600 manuscripts regarding clinical applications 
of surface EMG (sEMG) the following was concluded: “There is in fact almost no 
literature to support the use of sEMG in the clinical diagnosis and management of 
nerve or muscle disease”.4 Of course, such a disappointing conclusion challenges 
workers in the field of sEMG to develop better, more useful techniques in the diagnosis 
and follow-up of neuromuscular disease. Furthermore, since this assessment study 
deliberately excluded the estimation of muscle fibre conduction velocity (MFCV) and 
applications during fatigue it can be argued if the above conclusion is fully justified. 
The electrophysiological determinants of (pathological) muscle fatigue have already 
shown to be the exclusive domain of sEMG.8-10, 17 Comparing sEMG with needle EMG 
information content, as a golden standard will degrade the former. More important 
seems to be the issue of what sEMG can add to needle EMG information and vice versa. 
A major obstacle in applying sEMG is the impossibility of measuring the spontaneous 
activity of denervated muscle fibres, which is so important in conventional needle EMG. 
Non-invasive measurement of MU activity with sEMG is used now both in the central 
and peripheral nervous system (see Table I). Although it can only be used on a small 
set of suitable muscles, the study of propagation and other topographical aspects of 
voluntary activated MU potentials (MUAPs) along an array of electrodes potentially 
uncovers otherwise inaccessible physiological information.1, 11, 13
Table 1. SEMG applications in neurology
Central nervous system Peripheral nervous system
Timing Evoked activity
Movement patterns CMAP (amplitude/area)
Amount of activity/ central drive Voluntary activity
Involuntary movements Amplitude/frequency
Central fatigue Fatigue
Tremor Endplate localisation
Muscle fibre conduction velocity
MUAP variables: amplitude and duration
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Applications
Central nervous system
Due to the high (theoretically unlimited) temporal resolution of electrophysiological 
measurements, sEMG has long been used in the assessment of central nervous system 
activation of muscles. Applications are the measurement of timing and duration of CNS 
output, for example, in movement disorders such as dystonia and tremor. The same 
kind of analysis can be applied on complicated movement patterns such as gait and gait 
disorders. The combination of multiple sEMG derivations combined with for example 
an accelerometer gives a good visual representation of difficult movement disorders. In 
orthostatic tremor, for example, this kind of measurement is essential for diagnosis.14 
Due to the high tremor frequency (around 16 Hz) the mechanical output of the muscle 
is almost fused, which makes it virtually impossible for the clinician to recognise the 
tremor component. With sEMG measurements this specific tremor is easy to diagnose.
Peripheral nervous system
Initially, for the peripheral nervous system, clinical applications of sEMG have been 
cumbersome. However, there has been an evolution in electrode design, which has 
made it possible to derive increasingly basic information from the sEMG (see Fig. 
1). Using a mono- or bipolar EMG derivation it is possible to measure amplitude 
and frequency content of voluntary contractions. Examples of extreme neurogenic 
conditions measured with bipolar sEMG are given by Hermens et al.5 However, in 
general this is only of very limited value from a clinical point of view. Adding a second 
electrode pair and aligning these parallel to the muscle fibres made it possible to 
measure the MFCV with a surface technique. 
Abnormal fibre conduction velocity
In two myopathies characterized by membrane disturbances, hypokalemic periodic 
paralysis (HOPP) and generalized myotonia (GM) severe disturbances of MFCV were 
found, enabling the detection of asymptomatic carriers in the HOPP family (Fig. 2).15, 16 
The conventional needle EMG findings in these patients were not of diagnostic value. 
Coupled to the MFCV, a significantly lowered median frequency (Fmed) was also found in 
these patients (Fig. 3). However, the variability of the frequency parameters was clearly 
larger than that of MFCV estimation and the latter was obviously superior in detecting 
affected relatives. 
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Figure 1. The development of increasingly complex electrode arrays for surface EMG is shown 
from bottom to top. For each electrode configuration the added physiological information is 
summarized in the right column (From Refs. 13, 18, 5, respectively, with permission).
In amyotrophic lateral sclerosis (ALS) we found an increased MFCV (4.9 m/s versus 
4.2 for controls). However, the Fmed was lowered in this ALS group (72 versus 80 Hz 
for controls). These results were compared with an invasive technique for measuring 
the MFCV of single muscle fibres. The invasive MFCV results were clearly lower in 
the ALS group as compared with the sEMG results.6 The differences between these 
techniques are probably due to the fact that with sEMG only MUAPs of surviving 
MUs are measured. These MUs try to compensate for the force loss and part of this 
adaptation is an increased muscle fibre diameter with higher conduction velocities as 
a consequence. The invasive technique also measures the conduction of denervated 
muscle fibres. It is interesting to note in connection with the introductory remarks that 
in that study invasive EMG and sEMG give complementary information: the invasive 
EMG shows the drop out of fibres while the sEMG shows the physiological adaptation 
of surviving MUs. 
44 Chapter 2  Evolution of surface EMG 45
Figure 2. Examples of the normal (a) and reduced (b) MFCV in a family with hypokalemic periodic 
paralysis. The calculated MFCV values are 4.4 and 2.8 m.s-1; the cross-correlation coefficients are 
0.95 and 0.97, respectively. The vertical calibration is 0.24 mV/div. Note the much lower frequency 
content of the signals from the patient (adapted Ref.15).
Figure 3. The power spectra of the same measurements as in Figure 2. The median frequency of 
spectrum (a) corresponding to Figure 2a is 86 Hz, the Fmed of spectrum b is 44 Hz. The horizontal 
calibration is 24.4 Hz, the vertical calibration is in arbitrary units (adapted from Ref.15).
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Pathological fatigue
Abnormal behaviour of MFCV during fatigue tests in McArdle’s disease and type I 
fibre dominance was shown by Linssen et al.8, 9 In a patient with carnitine deficiency, 
an abnormal increase in Fmed of sEMG of the vastus lateralis muscle was shown.
2 In GM 
patients an abnormal lowering of MFCV, Fmed and amplitude of sEMG accompanied a fast 
decline in force.16
Topographical changes
The last step in the development of electrode design (Fig. 1) is the multi-channel 
high- density electrode. With such arrays it is possible to obtain information from the 
sEMG with regard to the topography of MUAPs. Masuda and Sadoyama have shown 
that endplate detection is possible in this way.11 More elaborate analysis with a multi-
electrode grid has shown the possibility of estimating the position, and direction 
of the MUAP, endplate zone and muscle-tendon transition. The amplitude decline 
perpendicular to the MUAP indicates the depth of the MU.3, 12, 13
Methodology
As is also true for a conventional electrodiagnostic study in neuromuscular diseases, 
application of a standard sEMG protocol is in general not useful. The measurements and 
especially the protocol of muscle activation should be chosen in relation to the clinical 
differential diagnosis and questions posed. 
Until now, non-invasive measurement of MFCV has proven to be the most valuable 
tool in sEMG.1 The method is especially useful in a limited number of myopathies 
characterised by a disturbed membrane function. It is interesting to note that profound 
and global reduction in conduction velocities of the muscle membrane are not detected 
with standard needle examinations but that sEMG measurements resulted in clear 
abnormalities.15 
The MFCV is usually measured by calculating the time delay between two or more bipolar 
electrodes in a linear array (Fig. 1). Due to the small time differences between the two 
signals a high sample rate is necessary (in combination with linear interpolation) for 
a reliable estimate. Alternatively, the MFCV can be calculated by phase shifting in the 
frequency domain, this makes the time resolution as high as necessary, independent of 
the sampling rate.8-10
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A limitation of this technique is the fact that, until now, only a small number of muscles 
permit these measurements. The muscle must have a clearly delineated endplate zone 
and a parallel course of muscle fibres. Mostly, the biceps brachii, brachioradialis, vasti 
and distal parts of tibialis anterior have been used. 
An especially useful application with good prospects for the future is the 
electrophysiological study of pathological fatigue in myopathies. SEMG changes in 
normal fatigue are extensively described.17-19 Abnormal changes in MFCV induced 
by fatigue are an important tool, especially due to the possibility to measure MFCV 
during all kinds of voluntary contraction and at all levels of effort. It is important to 
choose the protocol according to the clinical situation. For example, in GM an abnormal 
decline in force (and EMG amplitude and MFCV) is only demonstrated after a period 
of rest and within the first seconds of the contraction.16 After repeated contraction 
these abnormalities subside. By the same token, it is necessary to apply prolonged, 
submaximal exercise in patients with carnitine deficiency to show an abnormal increase 
in median power frequency of sEMG of the vastus lateralis.2 During this kind of exercise, 
the muscle depends on lipid oxidation, which is disturbed in carnitine deficiency.
Recent developments in the analysis of MUAP variables with sEMG using a multi-
electrode grid and the application of volume conduction theory promise new 
possibilities. Several properties of MUAPs, until now assumed to belong to the domain 
of needle EMG, can be measured with sEMG.3, 12, 13 Most importantly, the amplitude of 
MUAPs as detected with a multichannel grid show high correlations with amplitude 
measurements of macro EMG recordings of the same MUAPs.12 This indicates that 
important parameters of the MUAP can also be deduced from sEMG. In addition, 
with this technique, sEMG provides details concerning MU location, direction of 
fibres, endplate position and fibre-tendon transition, which are not accessible with 
conventional needle EMG. 
A comparison between needle and sEMG limitations and benefits is provided in Table 
2. As can be seen, needle EMG is versatile, quick and gives a unique opportunity to 
measure membrane instability. SEMG, on the other hand, provides unique spatial 
information besides conventional MUAP variables such as amplitude. Being non-
invasive and patient friendly, the application of sEMG in neurology certainly deserves 
further research.
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Table 2. Comparison between surface and needle EMG.
Needle EMG Surface EMG
General
Number of muscles Many Limited
Analysis time Short Moderate
Quantitative data Usually not, although possible Generally
Patient acceptance Limited due to pain Good
Motor unit variables
MUAP amplitude + +
Recruitment pattern + ±
Spontaneous activity + -
Muscle fibre conduction - +
Spatial variables
Endplate position, fibre - +
length
MUAP position Depth Depth/direction
4.  Conclusion
The high temporal resolution of sEMG makes it an ideal tool to measure the motor 
output of the central nervous system in a variety of disorders and facilitates the analysis 
of complicated movement patterns. With respect to the peripheral nervous system, 
promising results have been obtained by the measurement of MFCV in myopathies 
characterised by membrane abnormalities and the changes of sEMG in pathological 
muscle fatigue. 
The last decade has shown a development of increasingly complex sEMG array designs. 
The first results indicate that with these (two-dimensional) electrode configurations it 
is now possible to obtain information from the sEMG regarding MUAP variables, which 
originally was thought to belong to the domain of needle EMG. 
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Summary
Patients with autosomal recessive generalized myotonia, or Becker’s disease, often suffer 
from a peculiar transient paresis (TP). As yet, the relationship between this TP and the 
defect in the gene encoding for a voltage gated chloride channel protein in the muscle 
membrane of these patients is unclear. In order to gain a better understanding of the 
electrophysiological properties of the muscle fibre membrane in these generalized 
myotonia patients, we have studied TP with a novel high-density surface EMG (HD-
sEMG) technique. We conclude that the TP is explained by a deteriorating muscle 
membrane function, ending in conduction block and paresis. HD-sEMG during the period 
of force decline in TP shows a decrease in peak-peak amplitude of the motor unit action 
potentials (MUAPs) from endplate towards tendon. This disturbance increases with 
time and place, indicating a deteriorating membrane function, and ends in a complete 
blocking of propagation within seconds. Spatiotemporally, this leads to a V-shaped HD-
sEMG pattern. In a more general sense, this contribution shows how spatiotemporal 
information, available through non-invasive HD-sEMG, may provide novel insights into 
electrophysiological aspects of membrane dysfunction. 
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Introduction
Autosomal recessive generalized myotonia (GM) is a nondystrophic disorder of skeletal 
muscles. This disease was separated from the autosomal dominant myotonia congenita 
(Thomson’s disease) by Becker.3 Additional to myotonia, GM patients often suffer from 
a peculiar transient weakness of the muscles after a period of rest. Following an initial 
normal or near-normal strength, a rapid but temporary decline in muscle force occurs. 
This transient paresis (TP) diminishes with repetitive contractions: the ‘warm-up’ 
phenomenon.25 
The myotonia has its basis in an electrical instability of the muscle fibre membrane.24 
Bryant was the first to recognise that a similar instability is produced in normal muscle 
fibre membranes when the chloride conductance is experimentally reduced.6 Consistent 
with this hypothesis, it has now been established that both GM and Thomsen’s disease 
are caused by mutations in the gene encoding for a voltage-gated skeletal muscle 
chloride channel protein.14, 16, 21 The causal relationship between this disorder of the 
chloride channel and the TP is unknown.
Electrophysiological changes measured during TP in GM patients were mainly studied 
through electrically elicited compound muscle action potentials (CMAPs). Most of 
these studies, using repetitive nerve stimulation, found a decremental response of the 
CMAP.2, 5, 9, 22 Using a three-channel surface EMG technique, Zwarts and van Weerden 
described a decline in muscle fibre conduction velocity (MFCV) during periods of 
TP in voluntary contractions in these patients, illustrating membrane dysfunction.33 
A satisfactory explanation of the TP within the framework of these accompanying 
electrophysiological phenomena has not been given yet.
We have studied the electrophysiological properties of the muscle fibre membrane in 
GM patients with a novel 126-channel high-density surface EMG (HD-sEMG) technique, 
in order to gain a better understanding of the relation between this peculiar paresis and 
membrane dysfunction. With this technique, recently developed at our department,27 it 
is possible to obtain detailed spatiotemporal information on the electrophysiological 
properties of individual motor units (MUs) non-invasively.15, 23 
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Subjects and methods
Patients and normal subjects
We have studied seven patients with GM, diagnosed according to established criteria17: 
two brothers, a brother and a sister of another family and three sporadic cases (one 
female and two males). The mode of inheritance was compatible with an autosomal 
recessive trait and first symptoms were present in the first decade of childhood. All 
patients had muscle stiffness, myotonic runs on needle EMG, TP, warm-up phenomena 
and muscle hypertrophy (more pronounced in male patients). The patients were drug-
free for more than one month before and during the experiments. The disease was 
stable for more than 5 years. Mean age of the GM patients was 38 years (range 22-
57 years). We compared our results with data from five normal subjects, one female 
and four males, with a mean age of 39 years (range 22-64 years). The UMC Nijmegen 
Medical Ethical Committee approved the study. All patients and normal subjects gave 
their informed consent.
Recording of force and HD-sEMG
The left arm was fixed in a horizontal position in an arm flexor dynamometer supplied 
with strain gauges, with the elbow in a 90-degree abduction. The hand was in a middle 
position. Force was recorded isometrically and was visually fed back to the subject on 
a PC monitor. Simultaneously with the force, HD-sEMG was measured with a two-
dimensional electrode grid developed at our department. One-hundred-and-thirty 
commercially available printed circuit board testing probes (Farnell Inc., type ‘serrated 
contact’) were stripped of their spring and used as gold-coated electrodes. These probes, 
with 1.5 mm diameter, were mounted directly on a specially designed flexible printed 
circuit board (Fig. 1). The print was wrapped around a foam base to ensure flexibility and 
adequate contact with the skin for each electrode. Electrodes were arranged in a 10x13 
rectangular matrix with an interelectrode distance of 5 mm in both directions. Signals 
were recorded monopolarly with a reference electrode on the olecranon. The electrode 
grid was carefully placed over the biceps muscle with the 10 columns parallel to the 
muscle fibres (Fig. 2). To avoid short-circuiting between electrodes, no electrode paste 
was applied. The serrated contact structure of the electrodes ensured a sufficiently 
low contact impedance between electrodes and skin.4 A total of 126 monopolar signals 
were amplified (corner electrodes were not connected), bandpass filtered (3-400 Hz) 
and simultaneously AD-converted (16 bits with a resolution of 0.5 µV/bit at a rate of 
2000 samples/s/channel) using a multi-channel amplifier system (Mark 6, Biosemi Inc., 
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Amsterdam, The Netherlands). Data were stored on the hard disk of a 180 MHz Pentium 
PC for off-line analysis. During the measurement, the signals of any one of the columns 
could be selected for on-line visualization, both in monopolar and higher order (e.g. 
bipolar) montages.
Figure 1. The electrode grid consists of 130 gold-coated electrodes, with an interelectrode 
distance of 5 mm. No contact gel was used before application (electrode diameter 1.5 mm). Corner 
electrodes were not connected (126 channels of EMG).
Figure 2. Schematic illustration showing the surface electrodes (solid circles) placed on the 
biceps brachii muscle. The small rectangle illustrates a possible subset of electrodes (column) 
used for analysis. This column is selected on the basis of signal quality and presence of a maximal 
number of isolated single MUAP firings.
4,5 cm 
6,0cm 
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Experimental protocol
The patients’ and subjects’ maximal voluntary contractions (MVC) were taken as the 
peak force of three short performances. Next, isometric contractions were performed 
at different percentages of the MVC: 5%, 20%, 40%, 60% and 100% MVC, each sustained 
for 30 seconds. After each measurement, a period of 10 minutes of rest was taken. For 
illustrative purposes, a single measurement was performed in which a normal subject 
imitated the irregular force pattern as in TP, starting from a 60% MVC force level.
Data analysis
The HD-sEMG signals were analysed off-line. For optimal detection of single motor 
unit action potentials (MUAPs), a bipolar montage was constructed by subtracting the 
signals from electrodes in consecutive positions along the columns (fibre direction). For 
all our GM patients, the paresis was most pronounced at the 60% MVC level. Therefore, 
in this paper, the HD-sEMG data during the first period of monotonic force decline after 
exercise onset will be described for this force level. One column of the grid was selected 
for analysis (e.g. the rectangular strip in Fig. 2), on the basis of good signal quality and 
the presence of many isolated single MUAP firings. 
Amplitude measurement
To determine the topography of the HD-sEMG amplitude in the direction of the muscle 
fibres, we visually isolated MUAPs in the signal from an electrode pair adjacent to the 
endplate zone. When the available spatiotemporal information indicated that this MUAP 
remained isolated (no interference from other MUAPs) during its propagation towards 
the tendon, it was included in the analysis. For each electrode position where the peak 
was visible, the peak peak amplitude (PPA) of the bipolar signal was determined. This 
process ended either when the last electrode in the column was reached, or when the 
signal became so small that it disappeared in the background activity (smaller than 50 
µV). The procedure was repeated for each isolated peak that could be detected during 
the selected period of monotonic force decline. 
Muscle fibre conduction velocity (MFCV)
MFCV estimates were made using a standard cross-correlation technique after signal 
interpolation.20 MFCV was estimated during TP by dividing the period of TP in segments 
of 250 ms, over which the cross-correlation was determined. A sliding window of 100 ms 
was used to step through the signals. This was done for the same column that was used 
in the amplitude analysis. Signal pairs with a cross-correlation coefficient of less than 
0.7 were not accepted for MFCV determination.
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Results
Force
At a low force (5% MVC, not shown) level, force profiles in GM patients were not 
different from those in normal subjects, who smoothly reached and maintained the 
desired force level. At higher force levels, a specific pattern emerged in GM patients. 
In the 20% MVC measurements, the force-profiles remained almost normal in four 
patients (e.g. Fig. 3A, upper panel). In three patients we observed a small initial force 
“dip” just after reaching the desired level (e.g. Fig. 3B, upper panel). At 40% MVC 
and 60% MVC, all seven patients showed an irregular force pattern with intermittent 
decline in force (Fig. 3, middle and lower panels). 
As stated before, since TP was most pronounced and uniform during the 60% MVC 
experiment, we analysed HD-sEMG data before and during the first period of TP in the 
60% MVC experiment. Mean MVC in the seven patients was 202 Newton (range 125 
- 298 N) and in normal subjects 330 N (range 133 - 430 N). Normal subjects were able to 
maintain force without any problem during the first 10 seconds of 60% MVC, in which 
the TP in patients occurred. Initially, GM patients were able to reach the desired force 
level (mean 59% MVC, range 43 - 73% MVC). However, immediately thereafter, force 
declined despite our call to continue the contraction. On average, the force dropped to 
29% (range 4 - 45%) of the initial – nearly 60% MVC - force level. Mean duration of the 
first period of monotonic force decline over which we analysed the HD-sEMG pattern, 
was 3.3 seconds (range 1.9 - 6.8 s).
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Figure 3. Force profiles of two GM patients (A and B), at three different intended levels (20% MVC 
in upper panels, 40% MVC in middle panels, and 60% MVC in lower panels) as a function of time. 
The y-axes denote percentages of MVC. The 20% MVC could be reached by all patients, though with 
an initial dip in force in some patients (B). The patient depicted in A showed a normal isometric 
contraction at 20% MVC. At the start of 40% MVC, periods of paresis appear in both patients, which 
are more prominent at 60% MVC. The warm-up effect is illustrated notably for the 40% MVC level 
(beyond 40 s and 30 s in A and B, respectively) and for the 60% MVC (beyond 30 s in B). 
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HD-sEMG
During the phase of the first TP of the 60% MVC measurement, the HD-sEMG 
recordings of the seven patients basically showed the same aberrant pattern.
Amplitude
In normal subjects, we found a HD-sEMG pattern in which MUAPs can be seen to 
propagate from the motor endplates in both directions along the muscle fibres. 
Motor endplate zones can easily be detected in the bipolar signals of an array using 
low amplitude and inversion of the signal polarity as main indicators.19, 32 Our results 
are consistent with results from other investigators who used electrode arrays in the 
examination of normal subjects.18, 19, 32 The MUAPs in normal subjects are conducted 
undisturbed along the muscle fibres from the motor endplate zone towards the tendon 
(Fig. 4B, lower panel and Fig 5D.). 
Before the TP, the HD-sEMG recordings of the GM patients show a nearly normal 
EMG pattern (Fig. 4A lower panel, and Fig. 5A, at 6.4 - 6.6 s). With the involuntary force 
decline in GM patients, the pattern along the membrane changes in a peculiar way. In 
Figure 4A and in its time-zoomed version in Figure 5A, an example of such behaviour in 
one of our patients is shown. 
At first, MUAP amplitudes drop at the fibre ends. Then, more and more electrodes 
show a strong decline in MUAP amplitude, with a later onset of this decline when the 
electrode is closer to the motor endplate (Fig. 4A, lower panel, Fig. 5A and 5C). The 
activity around the endplate never completely vanishes. This results in a ‘V’-shaped (or 
rather a ‘>’-shaped) appearance of the signals in the bipolar montage. In the monopolar 
montage, this drop of MUAP amplitude can also be observed (Fig. 5E). 
In healthy muscles, we have never observed such an EMG pattern. Normally, during 
decrease in voluntary effort, the EMG is characterized by a physiological decrease in 
MU recruitment in all channels simultaneously (Fig. 4B, Fig. 5B and 5D), with no or only 
a marginal decrease in signal amplitude along the fibre.
Figure 6 shows peak peak amplitudes (PPAs) of all isolated MUAPs that were detected 
during the first phase of paresis after force onset. MUAP propagation was followed from 
one electrode to the next, thus yielding an amplitude profile from the endplate to the 
tendon. All amplitudes are scaled to the PPA of the MUAPs in the bipolar trace just 
adjacent to the endplate (e.g. trace 32 in Fig. 5A).
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Figure 4. Examples of HD-sEMG patterns in one patient (A) and a normal subject (B). Top panels 
show the 60% MVC force curves; Lower panels show the HD-sEMG data over the period specified 
between bars in the top panel. HD-sEMG of the selected column of the grid (12 bipolar montages 
from 13 monopolar electrodes in a column (Fig. 2) in fibre direction) is displayed. A ‘V-shape’ 
(actually a ‘>-shape’) in the HD-sEMG data of the GM patient appears, with activity only around 
the endplate zone (trace 32-34) at the end of force decline. The normal subject (B) imitates the 
force decline, starting at 60% MVC. The HD-sEMG data of the normal subject show unchanged 
propagation of MUAPs from the endplate zone (trace 32) along the fibre. As expected, the force 
decline is realized by de-recruitment of motor units. 
 
0 5 10 15 20
20
40
60
B
Fo
rc
e 
[%
M
V
C
]
3.2 3.4 3.6 3.8 4 4.2 4.4
37
36
35
34
33
32
31
30
29
28
27
26
Time [s]
Tr
ac
e
0 5 10 15 20 25 30
20
40
60
80
Fo
rc
e 
[%
M
V
C
]
A
6.5 7 7.5 8 8.5 9 9.5
37
36
35
34
33
32
31
30
29
28
27
26
Time [s]
Tr
ac
e
64 Chapter 3  Propagation disturbance of motor unit action potentials during transient paresis in generalized myotonia 65
3 3.2 3.4 3.6 3.8 4
37
36
35
34
33
32
31
30
29
28
27
26
B
1 mV
6.4 6.6 6.8 7 7.2 7.4
37
36
35
34
33
32
31
30
29
28
27
26
Tr
ac
e
A
0.5 mV
3.3 3.35 3.4 3.45 3.5
37
36
35
34
33
32
31
30
29
28
27
26
Time [s]
D
6.8 6.85 6.9 6.95 7
37
36
35
34
33
32
31
30
29
28
27
26
Tr
ac
e
C
6.8 6.85 6.9 6.95 7
38
37
36
35
34
33
32
31
30
29
28
27
26
Time [s]
Tr
ac
e
E
0.5 mV
64 Chapter 3  Propagation disturbance of motor unit action potentials during transient paresis in generalized myotonia 65
Figure 5. To illustrate changes in conduction during the TP, parts of the HD-sEMG curves in the 
lower panels of figure 4 are shown at an intermediate (A and B) and high time resolution (C and 
D), respectively. A and C represent the data of the same GM patient as in Figure 4A, and B and D 
represent the data from the normal subject imitating force decline. In the GM patient’s data, the 
position of the motor-endplate zone is at trace 33. The propagating activity of single MUAPs can 
be observed. At the start of force decline (around 6.5 s, A), there is little change in MUAP wave 
shape away from the motor endplate. Later (beyond 6.6 s), activity still starts at the endplate zone, 
the MUAPs start to propagate but rapidly change wave shape on their way and finally completely 
disappear (see C). In the monopolar montage, this drop of MUAP amplitude can also be observed 
(E). HD-sEMG signals of the normal subject in the period of force decline are illustrated in B and 
D. The MUAPs starting at the motor endplate zone are conducted unaltered along the muscle 
fibres. They show an almost unaltered shape and amplitude.
This trace is indicated as ‘1’ on the x-axis of Figure 6. When the signal becomes so small 
that it is indistinguishable from noise, PPA is set to zero. Figures 6A and 6B give examples 
of the PPAs of one GM patient and of one normal subject, respectively (patient and 
normal subject as in Fig. 4 and Fig. 5). Figure 6C shows the results of the mean amplitude 
behaviour in the five male patients (solid lines) compared to the five normal subjects 
(dotted lines) including the subject imitating the force decline (S1) and the patient of 
Figures 4 and 5 (Pt4). The data of the female patients did not allow the selection of a 
sufficient number of isolated peaks (>20) to yield a reliable estimate of the amplitude 
topography. The PPA in GM patients is halved at a distance of only 1 cm from the endplate 
(at electrode ‘3’ in Figure 6C), while in the normal subjects, this amplitude remains 
constant, shows a very slight decrease or even increases over the muscle (Fig. 6C, dotted 
lines). As may be deduced from Figure 4A and Figure 5A, the action potentials early in the 
paresis are rather undisturbed (‘+’-symbols in Fig. 6A, for the earliest 50% of all MUAPs). 
They keep a relatively large PPA along the fibre. The later peaks, marked with the ‘ο’-
symbol, show a rapid decline (below-average PPA). This systematic behaviour of the early 
50% (+) and the late 50% (o) of the firings is in contrast with the mixed pattern (Fig. 6B) 
shown by the healthy subject (Fig. 4B), which is not correlated with time. 
Muscle fibre conduction velocity
From visual inspection a decline of the MFCV along the muscle fibres seemed to be 
present, but it appeared that the MFCV could not reliably be estimated in the phase of 
transient paresis in GM patients. In general, a reliable quantification is impossible without 
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a high resemblance between the consecutive wave shapes (the correlation coefficients 
between subsequent traces should be > 0.7). During TP, this condition is not met because 
of the changing signal wave shapes of the MUAPs from one trace to the next (see Fig. 5C). 
Figure 6. Decrease of PPA with distance from the motor endplate. The numbers on the x-axis 
represent the electrodes away from the endplate. The y-axis shows the relative PPA of all isolated 
peaks that are detected during the transient paresis (TP). All PPAs are scaled to the signal 
measured at the electrode pair nearest to the endplate (position 1). A and B show PPAs from one 
of the GM patients and from one of the normal subjects, respectively (both the same as in Figs. 4 
and 5). The ‘+’-symbols represent the 50% of the peaks, earliest in time, the open circles the latest 
50% of the peaks. The solid lines connect the average PPA values. (C) The course of the average 
PPAs of the five male GM patients (solid lines) and the five healthy subjects (dotted lines). The 
inset shows the normal subjects (S1-S5, S1 is the subject imitating force decline) and the five 
patients analysed (Pt1-Pt5, Pt4 is the patient of which data are shown in Figs. 4 and 5) and the 
number of MUAP firings on which the mean profiles are based.
1 2 3 4 5 6 7
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
A
m
pl
itu
de
 in
 n
or
m
al
iz
ed
 u
ni
ts
Electrode position from endplate
B
1 2 3 4 5 6 7
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
A
m
pl
itu
de
 in
 n
or
m
al
iz
ed
 u
ni
ts
Electrode position from endplate
A
1 2 3 4 5 6 7 8 9
0
0.2
0.4
0.6
0.8
1
1.2
1.4
A
m
pl
itu
de
 in
 n
or
m
al
iz
ed
 u
ni
ts
Electrode from endplate to tendon
C
S 1, n=34 
S 2, n=58 
S 3, n=57 
S 4, n=66 
S 5, n=54 
Pt 1, n=23
Pt 2, n=28
Pt 3, n=25
Pt 4, n=36
Pt 5, n=52
66 Chapter 3  Propagation disturbance of motor unit action potentials during transient paresis in generalized myotonia 67
Discussion
The occurrence of TP is force dependent. At 5% MVC force levels, GM patients had no 
problem maintaining an isometric contraction for a period of at least thirty seconds. This 
can be considered an unexpected finding. When stimulating a nerve supramaximally 
with 5 or 10 Hz, patients already show a decline in force and EMG amplitude after 5 
seconds.2, 9 Frequency of voluntary drive to MUs is in this order of magnitude (exceeds 6-
8 firings /s),12 so a rapid decline could be anticipated for all voluntary force levels as well. 
The lack of TP at the lowest levels can be explained by a rapid and smooth switchover 
to other, not yet recruited MUs (MU rotation). Preliminary analysis of the HD-sEMG 
data of the 20% MVC force in the GM patients indeed shows an alternating recruitment 
of MUs. The central nervous motor drive can cope with the functional limitation of the 
not fully activated muscles. The typical electrical phenomenon, i.e. the typical V-shaped 
decay of activity, was observed in individual MUs after some seconds. However, this was 
always followed by the immediate recruitment of new MUs, as determined by a varying 
position of endplate zones. Patient dependent coping mechanisms also determine the 
way in which restoration of force after TP occurs ‘electrophysiologically’. They point to 
the existence of interindividual differences in the way by which the central nervous 
motor drive overcomes the functional limitation. So a study of both low force and 
the restoration phase will need the incorporation of central drive mechanism in the 
explanation of the observations.
At the highest force levels, when a large fraction of the available MUs or all MUs have 
to be recruited (at 50% MVC, 90% of the MUs in hand muscles is active),13 MU rotation 
or other coping mechanisms can hardly compensate for the peripheral neuromuscular 
problem. In between high and low force levels, there is a transition of behaviour. In the 
upper panel of Figure 3A, the force pattern still is ‘like normal’ (successful rotation at 
20% MVC), whereas in the upper panel of Figure 3B, the insufficiency of this rotation 
turns up already. From supramaximal electrical nerve stimulation experiments,9, 28, 30 it 
is known that MU force drops stronger in patients when stimulus (i.e. firing) frequency 
increases. This explains the further deterioration of the TP with still higher force levels 
(60%-100% MVC; not shown), also documented by Zwarts and van Weerden.33 
Recording surface EMG with a large number of densely packed electrodes offers a novel 
view on electrophysiologal phenomena of the sarcolemma as observed in this study. In 
the electrophysiological changes of the MUAPs of GM patients during the force decline 
a temporal and a spatial aspect can be distinguished.
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Initially, GM patients show a normal interference pattern of the HD-sEMG and a normal 
force rise. In the course of time, our results basically show the same characteristics as 
reported by nerve stimulation studies: an unusual lowering of amplitudes, indicating 
disturbed membrane function.2, 5, 9, 28
With respect to spatial characteristics, we confirmed the general observations of other 
investigators who used an sEMG array in normal subjects, i.e. the determination of the 
motor endplate zone in the bipolar lead and the undisturbed propagation of MUAPs 
over the muscle fibre from endplate towards tendon.18, 19, 32 
Our most important and unique finding is that there are peculiar spatial changes in 
the MUAPs during TP. The topographical aspects of the measurements with the 10 x 13 
electrode grid clearly indicate increasing abnormalities in the propagation of the action 
potentials from motor endplate zone towards tendon. It is shown that during TP, the 
amplitude of a MUAP declines when it propagates along the fibres. Eventually MUAPs 
even vanish. The further away from the endplate zone, the sooner this becomes visible. 
A V-shape emerges in the spatiotemporal presentation of the EMG, indicating a gradual 
deterioration of action potential propagation from the endplate towards the tendon in 
time. The resulting decrease in PPA along the fibre is dramatic: while in normal subjects 
the PPA remains more or less constant, the PPA is halved over a distance of only 1 cm 
in GM patients. Abnormal morphological features, like focal necrosis, cannot explain 
the spatially distributed character of membrane dysfunction during TP, because initially 
normal activity is seen along the whole fibre length. Therefore, it must be a physiological 
phenomenon. One can think of three underlying mechanisms bringing about the 
MUAP wave shape and amplitude changes: i) dispersion between action potentials 
of fibres of a single MU, ii) amplitude decline of single fibre action potentials (SFAPs) 
because of MFCV decrease and, iii) decline and eventually blocking of intracellular 
action potentials (IAPs). As can be deduced from simulation studies (e.g. using the 
SiMyo simulation model)10 dispersion alone is insufficient by far as an explanation 
for the amplitude decline observed. The second possibility (a decrease of MFCV and 
an associated reduction of the spatial extension of the IAP), would affect bipolarly 
recorded signals much more than monopolar signals (also confirmed by simulations 
with the SiMyo model). From the example in Figure 5E, this possibility can also be ruled 
out as a sufficient explanation. The previous arguments are further supported by single 
fibre EMG studies in GM patients 26 that showed a dramatic drop in signal amplitude 
without an obvious relation to a MFCV decrease. Therefore, amplitude decline of IAPs 
and a subsequent propagation blocking of SFAPs seem to be required as an explanatory 
mechanism at a single-fibre level for the electrophysiological response during TP. 
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At a more basic physiological level, the phenomenon can be explained by a disturbed 
repolarisation capacity of the fibre membrane.14 The reduced chloride conductance 
in GM patients is thought to build up a membrane depolarisation, caused by an only 
partial repolarisation after each action potential. This results in hyperexcitability, 
causing myotonia and, when severe, in hypoexcitability because of K+ accumulation in 
the T-tubules.8, 31 The diminution and eventual blocking of MUAP peaks is consistent 
with such a mechanism. Focal block of conduction was already observed by Trontelj 
and Stalberg29 with stimulated single fibre EMG in GM patients. Last but not least, 
SFAP blocking offers a persuasive explanation for the observed decrease in force 
during TP. Failing membrane propagation prevents the activation of a growing part of 
the contractile mechanism. The nature of the improvement after some time could be 
explained by the induction of a strongly increased Na+-K+ pump activity, which develops 
within seconds.11 
The particular spatial distribution of the observations can, at the level of the 
sarcolemmal structure, be interpreted in two ways. One possible interpretation is 
that ion channels are inhomogeneously distributed along the sarcolemma. For sodium 
channels this indeed has been shown in some animal muscles. A high Na-channel 
concentration was found near the endplate zone with a strong, gradual decline towards 
the tendon.1, 7 The shape of this curve is similar to our V-shaped HD-sEMG pattern. The 
low Na-channel concentrations near the tendon give rise to a lower safety factor for 
action potential generation. In combination with the disturbed sarcolemma function 
of GM patients, this could easily give rise to a more pronounced expression of the 
disturbance further away from the endplate. Another possibility is that the excitation 
of the generated action potentials gradually deteriorates due to the abnormal, but as 
such homogeneously, distributed chloride conductivity. This leads to single fibre action 
potential amplitude decrease, MFCV decrease and eventually propagation blocking. 
As yet, detailed information concerning these topographical aspects of ion channels 
in human muscle fibres is lacking, and the pathophysiological mechanism therefore 
remains partly speculative. 
In conclusion, HD-sEMG provides basic and unique information about electrophysiological 
and topographical aspects of the sarcolemma. Surprising as it may seem, recording at 
some distance from the muscle thus provides a more precise view of the electrical activity 
of the muscle fibre membrane. 
This research is supported by the Technology Foundation (STW, Utrecht, The Netherlands), 
grant NGN.3818.
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Summary
At medium and high force levels, patients with generalized myotonia (GM) cannot 
produce normal force because of a peculiar transient paresis. The authors have 
previously demonstrated that, during transient paresis, there is a disturbed propagation 
of muscle fibre action potentials along the sarcolemma, resulting in conduction block 
and paresis. At low force levels, however, these patients can produce a constant force. It 
is as yet unknown how GM patients, despite these muscle membrane abnormalities, are 
able to produce constant force during isometric voluntary low force contractions.
Using high-density surface EMG (HD-sEMG), we tested the hypothesis that in GM 
patients, muscle membrane function is already disturbed at low force levels despite 
constant force, and that abnormal motor unit (MU) recruitment acts as a compensatory 
mechanism to obtain normal force stability.
HD-sEMG was measured on the biceps brachii at 20% of the maximal voluntary 
contraction (MVC) in seven GM patients previously shown to have transient paresis 
at higher force levels. HD-sEMG provides spatial and temporal information that is 
used to analyze propagation disturbances and recruitment strategies. In addition, we 
performed needle EMG in two patients simultaneously.
The HD-sEMG abnormalities included disturbed propagation of motor unit action 
potentials (MUAPs) over the muscle fibre membrane and abnormal MU recruitment 
patterns, pointing to central adaptation mechanisms. Prolonged periods of low 
HD-sEMG amplitudes were sometimes present, despite constant force, indicating 
that mechanisms other than MU recruitment also contribute to force preservation. 
During the periods of low HD-sEMG, the density of myotonic discharges, recorded 
simultaneously with needle EMG, was not increased. 
In conclusion, GM patients can show, despite muscle membrane dysfunction, normal 
force stability. Abnormal MU recruitment as a compensatory mechanism occurs in GM 
patients, but cannot fully explain constant force.
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Introduction
Patients with recessive generalized myotonia (GM) often experience a transient 
weakness of their muscles.1, 4, 11, 14, 19, 21 For many of these patients, this transient paresis 
can be even more disabling than the myotonia itself.11, 18 In an earlier study, we had shown 
that transient paresis is most likely due to a deteriorating muscle membrane function, 
ending in a conduction block of MU action potentials (MUAPs).6 With repetitive muscle 
contractions the conduction abnormalities are reduced, and consequently, the paresis 
diminishes. This is known as the ‘warm-up’ phenomenon.19 
Transient paresis is a force-dependent phenomenon. In the earlier study, we reported 
absence of transient paresis at low force levels.6 The ability of GM patients to maintain 
constant force without any sign of transient paresis is remarkable in the light of 
electrophysiological findings. Electrical repetitive nerve stimulation studies found a 
decremental response of electrically elicited compound muscle action potentials after a 
few seconds, already at 5 Hz stimulation frequency.1, 4, 15, 17 This decremental response was 
more pronounced at higher stimulus frequencies, and varied between GM patients.1, 4 
In voluntary contractions, the minimum firing frequency of MUs is 6-8 Hz.7 Combining 
these data, one would expect transient paresis to occur also at low force levels. 
The aim of the present study was to test the hypothesis that at low force levels, muscle 
membrane function is already disturbed, and that stable force production is maintained 
with a central compensatory mechanism. The 126-channel high-density sEMG 
(HD-sEMG) technique that was used enables us to analyze the variability in MUAP 
amplitudes in fibre direction, as well as over time. These data were expected to give 
information about both the propagation disturbances of the muscle fibre membranes 
and the recruitment patterns. 
Methods
Patients and healthy subjects
We studied seven patients with generalized myotonia, diagnosed according to 
established criteria11: two brothers (#2 and #6), a brother and a sister of another 
family (#5 and #7) and three sporadic cases (#1, #3, and #4). The mode of inheritance 
was compatible with an autosomal recessive trait, and first symptoms were present 
in the first decade of childhood. All patients showed muscle stiffness; myotonic runs 
on needle EMG, transient paresis, warm-up phenomena and muscle hypertrophy. The 
76 Chapter 4  Maintaining constant voluntary force in generalized myotonia despite muscle membrane disturbances 77
patients were drug free for over a month before and also during the experiments. The 
disease had been stable for more than 5 years. Mean age of the patients was 38 years 
(range, 22 to 57 years). We compared our results with data from seven healthy subjects, 
two women and five males with a mean age of 38 years (range, 26 to 64 years). The 
Ethical Committee approved the study. All patients and healthy subjects gave their 
informed consent.
Measurement of force and HD-sEMG
The subject’s left arm was fixed in a horizontal position in an arm flexor dynamometer 
supplied with strain gauges, with the elbow in a 90-degree abduction. The hand was in 
a middle position. Force was visually fed back to the subject on a PC monitor and stored 
digitally (100 samples/s). Simultaneously with the force, HD-sEMG was measured 
with a two-dimensional electrode grid in which electrodes were arranged in a 10 x 13 
rectangular matrix with an inter-electrode distance of 5 mm in both directions.2 Signals 
were recorded monopolarly, with a common reference electrode on the olecranon. 
The electrode grid was carefully placed over the biceps brachii muscle with the 10 
columns parallel to the muscle fibres. The serrated contact structure of the electrodes 
assured sufficiently low contact impedance between electrodes and skin.2 A total of 126 
monopolar signals were amplified (corner electrodes were not connected), band pass 
filtered (3.2 - 400 Hz) and simultaneously analogue-to-digital converted (16 bits with 
a resolution of 0.5 µV/bit at a rate of 2000 samples/s/channel) using a multi-channel 
amplifier system (Mark 6, Biosemi Inc., Amsterdam, The Netherlands). Data were stored 
on the hard disk of a Pentium PC for off-line analysis. During the measurements, the 
signals of any one of the columns could be selected for online visualization, both in ‘raw’ 
monopolar and in bipolar montages.
Experimental protocol
The subject’s maximal voluntary contraction (MVC) out of three short performances 
was taken as the peak force. Next, isometric contractions were performed at different 
percentages of the MVC, each sustained for at least 25 seconds. Ten minutes of rest 
preceded each measurement. Because we were interested in force levels where 
transient paresis is absent, contractions of 5% MVC, 20% MVC and 40% MVC were 
performed in this order. In two patients who had the longest periods of low or almost 
zero HD-sEMG amplitude (#3 and # 4), needle EMG was performed simultaneously with 
HD-sEMG in a second experimental round. The needlepoint was placed superficially in 
the m. biceps brachii muscle just below the most proximal HD-sEMG electrodes.
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Data analysis
Force
Force profiles were analyzed off-line. At 20% MVC, the force level was stable in five 
of seven patients. This force level was chosen for further analysis, because it was the 
highest force level at which most GM patients were able to maintain stable force. 
Statistical analysis was used to examine differences in the variability of the force 
profiles between patients and healthy subjects over 25 seconds. Standard deviations 
over time of force profiles were compared using a Wilcoxon test.
HD-SEMG
The HD-sEMG measurements at the 20% MVC force levels of patients and healthy 
subjects were analyzed off-line. For detection of the endplate zone and MUAP firings, 
a bipolar montage was used by subtracting the monopolar signals from electrodes in 
consecutive positions in fibre direction. The column with the highest mean root mean 
square amplitude value (RMS) of the bipolar signals in the first two seconds of the 
recording was selected for further analysis.
Amplitude analysis
The starting point of our analysis was the variability in MUAP amplitudes, expressed as 
RMS values. During 25 seconds, using a (halfway overlapping) sliding window of 50 ms, 
shifted in steps of 25 ms, a total of 1000 amplitudes (1000 = 25s / 25ms) were calculated 
for each of the 12 bipolar traces of the selected column. This resulted in a matrix of 12 
x 1000 values. These 1000 amplitude values were used for analysis in fibre direction (I) 
and over time (II). As a measure of the variability of amplitudes we used coefficients 
of variation (CV= (standard deviation/mean) x100%). Mean and standard deviation of 
these CV values were calculated. For the variability over electrodes in fibre direction 
(I), one mean and one standard deviation of the amplitudes over the selected electrode 
column were calculated from the 12 bipolar signals, resulting in 1000 CV values, one 
for each segment of 25 ms. Large CV values over electrodes are expected to indicate 
MUAP propagation disturbances. To summarize the variability over time (II), one mean 
and one standard deviation value were calculated over the 1000 amplitudes from every 
bipolar trace, resulting in 12 CV values, one for each trace. Large CV values over time are 
expected to indicate erratic MU recruitment patterns.
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Visual evaluation
Because of our experience that quantitative analysis of abnormal HD-sEMG patterns 
only provides a part of the insight into the phenomena at hand, the data were also 
visually evaluated. We focused on abnormalities in: endplate positions, MUAP 
propagation over the muscle fibre membrane, and recruitment patterns. The position 
of the endplate zone can easily be detected in the bipolar signals from the combination 
of a low amplitude channel and the inversion of the signal polarity.13, 20 Propagation of 
MUAPs over the muscle fibre membrane was visually evaluated at a time base of 500 
ms. Recruitment patterns of MUs were visually evaluated by presenting the data at a 
time-base of 3000 ms. Typical examples of HD-sEMG data will be shown. 
Results
Force
The mean maximal force in GM patients was 214 N (range, 141 to 360) and 307 N (range, 
133 to 422) in healthy subjects. As indicated, two patients (#6 and #7) showed marked 
transient paresis at 20% MVC (Fig. 1A). They were excluded from further analysis, 
because the hypothesis presupposes stable force. Figure 1B shows all 20% MVC force 
profiles of the seven healthy subjects and the other five GM patients (#1, #2, #3, #4, 
and #5) without transient paresis at this force level. Standard deviation of mean force 
in healthy subjects was 0.42% MVC and in patients 0.68% MVC. Although the force 
profiles of the GM patients appeared slightly more irregular, and the standard deviation 
of the mean force was higher in patients, the difference did not become significant (P= 
0.62).
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Figure 1. (A) Force profiles of the two patients with transient paresis at 20% MVC. Both patients 
were asked to maintain constant force at the 20% MVC level. The X-axis shows time in ms., and 
the Y-axis denotes the percentage of voluntary maximal contraction. (B) Similar force profiles of 
5 other GM patients and 7 healthy subjects at 20% MVC are shown.
HD-sEMG
Amplitude analysis
Figure 2A shows the mean and standard deviation of the CV of the amplitudes in fibre 
direction (I) over the 25-second time period for the selected column. In one patient (#5) 
the mean CV is much higher than in healthy subjects. Overall, the standard deviation 
of the CV (vertical bars) appears to be smaller in healthy subjects. Figure 2B shows the 
CV over time (II) of the five patients and the seven healthy subjects. In two patients (# 3 
and, #4) the mean and the standard deviation of this CV over time is much higher than 
in healthy subjects. The specific HD-sEMG patterns behind this amplitude behaviour in 
patients #3, #4, and #5 will be dealt with in detail below. Patients #1 and #2 show healthy 
CV characteristics both in the spatial (Fig. 2A) and the temporal (Fig. 2B) domain. 
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Figure 2. The mean and standard deviation (bars) of the coefficient of variation (CV) of the RMS 
amplitude of bipolar HD-sEMG, both along the fibre (in space) (A) and over time (B) are shown. 
Data of GM patients (stars) and healthy subjects (squares) are represented. (A) Patient #5 had a 
higher mean CV and standard deviation of the amplitude along the muscle fibre compared to 
the values of healthy subjects and the other patients. This high mean CV indicates that there is 
a considerable variability in amplitude over the different electrodes in the selected column. (B) 
CV characteristics of HD-sEMG amplitudes in time (over 25 seconds) in one column are shown. 
A higher mean and standard deviation is present in patients #3 and #4, indicating that there is a 
larger variability in electrical activity in time (e.g. irregular MU firings). 
Visual evaluation
Endplate region and propagation of MUAPs
All healthy subjects showed one invariable endplate zone position and normal MUAP 
propagation. In healthy subjects, MUAPs propagate from the motor endplate zone in 
both directions along the muscle fibres. Form and amplitude of the MUAPs hardly 
changed between the endplate and the tendon. An example is shown in Figure 3A. The 
values in Figure 2A for patients #1 and #2 indeed reflect normal MUAP propagation. 
These patients also had an invariable endplate zone position as in healthy subjects. 
Patients #3, #4, and #5 expressed disturbance in propagation as an amplitude decline of 
MUAPs from one trace to the next (example in Fig. 3B, patient #3). Such abnormalities in 
propagation, but also variability in motor endplate zone positions were present in these 
patients (example in Fig. 3D, patient #4).
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Figure 3. Examples of parts of the HD-sEMG curves of a healthy subject (A) and GM patients 
(B, C, and D) during constant force at 20% MVC. HD-sEMG data of the selected column are 
shown at a total time base of 500 ms. (A) represents the HD-sEMG data of a healthy subject. 
As in all healthy subjects, a constant shape and amplitude of MUAPs from motor endplate zone 
(characterised by a phase reversal between traces 19-20) toward the tendon can be observed. (B) 
shows HD-sEMG data of patient #3. Clearly abnormal propagation of MUAPs, with activity around 
the endplate zone (trace 14) only, along with less short lasting, but still not normal propagation of 
MUAPs (around 370 and 460 ms) is present. HD-sEMG data of patient #5 (C) shows striking broad 
potentials at several electrodes. There is likely a motor endplate zone position at electrode 33. (D) 
shows an example of different motor endplate zone positions during constant force production 
in patient #4.
Visual inspection of the HD-sEMG data of patient #5, who showed a high mean of the 
CV over electrodes (Fig. 2A), also revealed disturbed propagation. However, the HD-
sEMG data of this patient showed other phenomena that were in large part responsible 
for the high CV of amplitudes over electrodes. Figure 3C shows HD-sEMG data of 
this patient. The motor endplate regions can be detected at trace numbers 30 and 33, 
from where MUAPs propagate in two directions. In the traces more distal from these 
endplate zones (lower traces 34-37 in Fig. 3C), broad bipolar signals become visible. 
Such abnormally formed signals were never seen in healthy subjects, or in the data of 
the other patients. Although the CV in fibre direction was not increased in the other 
patients, visual evaluation of the data of both in patient #3 (Fig. 3B) and patient #4 
did show abnormal propagation. In the latter patient, a propagation disturbance once 
showed the same typical ‘V-shaped’ profile (Fig. 4B1) that was observed during transient 
paresis described in our previous study,6 but now occurring without any sign of transient 
paresis (Fig. 4A). Although force remained constant, the duration of the propagation 
disturbances lasted over 5 to 10 seconds. The strongly variable motor endplate zone 
positions were remarkable in patients #3, #4, and #5. MUAPs showing different motor 
endplate zones simultaneously became visible as illustrated in Figure 3D, which is never 
observed in healthy subjects.
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Figure 4. Top panel (A) shows the 20%MVC force curve; the lower panels show the HD-sEMG data 
over the periods (B1, B2) specified between bars in panel (A). To illustrate abnormal conduction 
of MUAPs and erratic MU firing, parts of the HD-sEMG curve of patient 4 are shown in parts B1 
and B2. A ‘V’ shape (actually a >) in the HD-sEMG data appears (B1), followed by a burst of MU 
activity (B2, second half).
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Figure 5. The top panels in each part show the 20% MVC force curves; the lower panels show the 
HD-sEMG data over the period specified between bars in the top panels. To illustrate different 
firing patterns during constant force, parts of the HD-sEMG are shown at a time base of 3 seconds 
(A, B) and 6 seconds (C). (A) Data of a healthy subject showing a regular pattern of MUAP firings 
with a clearly visible endplate zone (trace 85). (B) and (C) represent sEMG data of two patients 
(#4 and #3 respectively) showing irregular firings of MUs. Different endplate zones are visible and 
therefore hard to identify.
Recruitment patterns
In all healthy subjects, a regular HD-sEMG pattern was found during constant force (Fig. 
5A). Visual evaluation of the data of patients #3 and #4 with a higher mean and standard 
deviation of the CVs over time (Fig. 2B), showed indeed an abnormally varying MUAP 
firing pattern (Figs. 5B, 5C, and 4B). Bursts of MUAPs were seen at different intervals. 
These bursts alternated with prolonged periods of very low HD-sEMG amplitudes (Figs. 
5B and 5C), all this during constant force (see upper panels of the Figs.). Despite normal 
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values in Figure 2B, patient #5 also showed abnormalities in firing pattern, although less 
pronounced than patients #3 and #4. In the three patients (#3, #4, and #5) with changing 
motor endplate zone positions and abnormalities in MUAP propagation, also abnormal 
firing patterns were observed. In contrast, patients #1 and #2, without such disturbances 
at the MU level, both showed regular firing patterns. 
Figure 6. Panel (A) shows the 20% MVC force curve of patient #4. Panel (B) shows a needle EMG 
registration and panel (C) shows one column of HD-sEMG traces. Between 2.75 s. and 3.5 s. dense 
myotonic discharges are present in the needle EMG registration while they are absent in the HD-
sEMG registration. 
HD-sEMG and needle EMG
In two patients who had the longest periods of low HD-sEMG amplitudes (#3 and 
#4), we simultaneously performed needle EMG. Needle EMG in both patients showed 
myotonic discharges. In the HD-sEMG recordings, these abundant discharges were not 
detected. During the periods of low HD-sEMG amplitude, the level of the myotonic 
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discharges was not increased. An irregular MU firing pattern was found in both needle 
EMG and HD-sEMG (Fig. 6), although the HD-sEMG recordings better reflected the 
(abnormal) recruitment patterns.
Discussion
In this study we tested the hypothesis that at low force levels muscle membrane 
function is already disturbed, and that GM patients are able to maintain constant force 
due to MU recruitment as a compensatory mechanism. The results reveal that the force 
level at which transient paresis occurs varies between GM patients. At 20% MVC, two 
patients (#1 and #2) showed stable force and normal HD-sEMG characteristics, three 
patients showed stable force curves but abnormal HD-sEMG characteristics (#3, #4, 
and #5), and two patients (#6 and #7) showed transient paresis. At higher force levels 
all patients (including patient #1 and #2) showed transient paresis and abnormal MUAP 
propagation. Because we already studied transient paresis earlier,6 and since the warm-
up phenomenon was beyond the scope of our study, the data of the patients #6 and #7 
were not further analyzed. 
Patients #1 and #2 showed that normal MUAP propagation is possible in GM patients 
at low force levels. This can be explained in two different ways. When stimulating a 
nerve supramaximally with 5 or 10 Hz, all MUs are activated. Voluntary drive of MUs 
leads to a minimum firing frequency of 6-8 Hz during isometric voluntary contractions.7 
During these low force contractions, type I muscle fibres are activated first.9 The lesser 
vulnerability of the muscle membrane of type I muscles to propagation disturbances 
could therefore offer a first explanation. No evidence was found in literature to 
support this hypothesis. Second, the normal MUAP propagation can be a result of the 
warm-up phenomenon. Although we took a period of 10 minutes of rest between the 
different measurements and instructed patients to relax as much as possible, minimal 
contractions in between measurements cannot be fully excluded, because it is a regular 
compensatory mechanisms in daily life in GM patients. 
The varying endplate positions, as found in patients #3, #4, and 5, were never described 
before in these patients. The best explanation for this observation is that the endplate 
regions of different MUs are clustered less uniformly than in healthy subjects.12 Whether 
this peculiar phenomenon is functionally relevant has to be determined.
The remarkable combination of membrane dysfunction and stable force was present 
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in three of the five GM patients (#3, #4, and #5). Abnormalities in the propagation of 
MUAPs are manifested by an amplitude decline from motor endplate towards the 
tendon. The MUAPs in healthy subjects show an undisturbed conduction, with almost 
the same amplitude along the muscle fibres from the motor endplate zone towards the 
tendon.6, 13 
To quantify spatial and temporal abnormalities of MUAP amplitudes in patients, we used 
the CV over time and in fibre direction. Although apart from temporal variability (Fig. 
2B) we observed abnormal conduction of action potentials in patients #3 and #4, they 
revealed only a marginally higher CV value along the fibre. Patients #3 and #4 showed 
high CV values over time that reflect the irregular pattern of HD-sEMG, while patient #5 
had a more or less regular pattern, although not as regular as in healthy subjects. Hence, 
we were only partly successful in our attempt to quantify the abnormalities, which are 
visually evident. An abnormal variation over time indeed barely seems to be correlated 
to an abnormal change over recording positions, and vice versa. Theoretically this is 
possible, although we did expect a stronger correlation between these abnormalities. 
The level of recruitment of MUs in time seems more or less independent of the grade 
of propagation disturbances as far as we have seen in our recordings. This needs further 
investigation.
In our previous study, MUAP propagation disturbances and conduction block explained 
declining force (transient paresis) at higher force levels in GM patients.6 The appearance 
of these marked propagation disturbances, despite constant force output, indicates 
involvement of compensatory mechanisms. Obviously, at higher force levels, when the 
majority of all MUs has been recruited, these compensatory mechanisms fail, resulting 
in transient paresis. 
The results of our study did partly support our hypothesis. Compensatory recruitment 
mechanisms are manifested in the HD-sEMG as bursts of MUAP activity in the three 
GM patients who had MUAP propagation disturbances (#3, #4, and #5). In this context, 
the varying endplate zone position does confirm the supposition that other MUs are 
activated. MUAP propagation disturbances were sometimes followed by a burst of MU 
activity, but not at each occasion. Regardless of MUAP propagation disturbance and 
sometimes the absence of (new) MU recruitment, patients were still able to continue 
normal force generation. Stable force production during prolonged periods of low EMG 
amplitude and disturbed MUAP propagation can be explained by three underlying 
mechanisms. 
First, it can be hypothesized that only deep MUs are active. HD-sEMG is less sensitive 
on deeper located MUs.16 However, it is unlikely that only deeply located MUs are 
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responsible for force production during these low HD-sEMG periods. Moreover, 
the monopolar raw signals with a much larger take up area also showed these low 
HD-sEMG amplitude periods. Second, myotonic discharges at muscle fibre level can 
contribute. However, during force production in two patients there was no increase in 
myotonic discharges in needle EMG recordings during these periods of low HD-sEMG 
amplitude. This is in contrast with the findings of Ricker and Meinck, who first found 
a decrease of MUAP activity and subsequently an increase of myotonic discharges.15 
In the HD-sEMG recording, we did not detect myotonic discharges. This is in contrast 
to what was observed by Landau, who claimed he observed myotonic discharges with 
sEMG electrodes.10 Both inconsistencies require further research. Third, processes 
downstream the excitation-contraction coupling, such as prolonged actin-myosin 
interaction, may result in a sustained constant force generation. 
Because the MUs that have ‘dropped out’ cannot be measured anymore, there is no easy 
answer to the question of what happens to them. An experimental model is offered by 
Gandevia et al., in which nerve conduction is blocked acutely and completely.8 The results 
of this study establish that subjects can recruit and grade the motor drive to a muscle in 
the absence of feedback from that muscle. Also, knowledge from the activation strategy 
of the central nervous system (CNS) indicates that the voluntary command activating 
the spinal motor pool is likely very global and aimed at patterns of motor execution.3 
Both arguments favour the assumption that the CNS keeps activating α-motoneuron 
despite the failure of the muscle membrane to follow the central command.
The question arises how the CNS can cope with muscle fibres as unreliable partners 
in generating a steady force. In general, strategies of the CNS to overcome peripheral 
(neuromuscular) disorders have been studied very little. A well-known example is 
the early recruitment of MUs in myopathic disorders.5 Thereby, the diminished force-
generating capacity of individual MUs induces the CNS to recruit MUs more and 
earlier than normal. The complicating factor in GM patients is evidently the variable 
way in which the MUs diminish in force and eventually drop out. The normal stability 
of the force with different types of abnormal HD-sEMG characteristics, even in the 
same patients over time, indicates that no fixed strategy exists to overcome this 
peripheral problem. Small force transients and possibly also small changes in muscle 
length, apparently detected by muscle spindles and Golgi tendon organs conveying 
this information by group Ia and II afferents, are sufficient information for the CNS to 
recruitment extra MUs.
In conclusion, this study is the first to both investigate the central and peripheral 
electrophysiological aspects in GM patients and the ability to generate constant force 
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despite muscle membrane abnormalities. We found that GM patients, despite abnormal 
HD-sEMG characteristics, can produce stable force curves. Both MUAP propagation 
disturbances over the muscle fibre membrane and abnormal central recruitment 
patterns are present. From the periods with low HD-sEMG amplitude it is clear that, 
apart from these two, other mechanisms may also play a role in maintaining constant 
force. It is intriguing that, within a certain range, the central nervous system is able to 
cope with the very unreliable muscle function in these patients. 
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Summary
The initial temporary weakness that occurs in autosomal recessive generalized 
myotonia diminishes with repetitive contractions. Physiological understanding of this 
phenomenon is incomplete. The underlying hypothesis of our study was that the ‘warm-
up phenomenon’ relates to the exercise-related activation of Na+-K+-ATPase. Three 
patients performed isometric exercise of the brachioradialis muscle on two separate 
days. Randomly, on one of these days the contraction was preceded by a 30-minute 
infusion of the Na+-K+-ATPase inhibitor ouabain into the brachial artery of the exercising 
arm (0.4 µg·min-1·dl-1). Force was measured simultaneously with electrical muscle activity 
using high-density surface electromyography (HD-sEMG). A transient rapid decline in 
force occurred after initiation of exercise, accompanied by electrophysiological changes 
indicating sarcolemmal conduction block. Ouabain infusion did not affect the recovery 
from transient paresis or the accompanying electromyographic changes, indicating that 
the warm-up phenomenon in generalized myotonia is not mediated by Na+-K+-ATPase.
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Introduction
Myotonia congenita was first described in 1876 by Thomsen,31 who suffered the disease 
himself. He described the myotonic stiffness, the nonprogressive character, and the 
dominant inheritance of the disease. In the late 1950s, Becker recognized a recessive 
form of myotonia congenita, with a more generalized myotonia (GM) than in the 
dominant form.3 It was subsequently shown that membrane resistance of myotonic 
goat muscle fibre was considerably increased at rest,6 which was later found to be due 
to a strongly reduced chloride conductance.7 Shortly thereafter, the same phenomenon 
was demonstrated in humans.23 Adrian and Bryant1 pointed out that the discharge of 
a myotonic muscle fibre arises from a cumulative after-depolarization, large enough 
to initiate a self-maintaining activity, and that after-depolarization depends on the 
integrity of the transverse tubular system. The actual defect was later confirmed as an 
abnormal gene on chromosome 7 encoding for the skeletal-muscle chloride channel.17 
Since then, more than 30 different mutations (missense, nonsense, deletions, insertion, 
splice) have been identified.19 However, mutations have not been identified in all 
patients, and thus more mutations can be expected.2
 Although the genetic defect responsible for the disease has been clarified, the 
pathophysiological processes that link genotype to the typical phenotype are still not 
fully understood. In generalized myotonia (GM), for instance, muscle stiffness and 
weakness may occur intermittently within a short interval. Both myotonia (muscle 
stiffness) and transient paresis (muscle weakness) occur, particularly after a period 
of rest, and improve with continuing exercise.14, 20 Warm-up is mostly associated 
with a decrease of muscle stiffness. It should be noted that in this paper, the ‘warm-
up’ phenomenon is merely associated with the force recovery phase after an initial 
paresis.
 The impaired chloride conductance in skeletal muscle only partially explains the process 
of myotonia and transient paresis (TP). Skeletal muscle chloride channels play an 
important role in regulating muscle excitability, as the chloride conductance supports 
the repolarization phase of the muscle membrane after propagation of the action 
potential. Slower repolarization consequently results in a partial depolarization leading, 
on the one hand, to hyperexcitability and thus to spontaneous firings (myotonia) and 
on the other, to hypoexcitability and thus a depolarization block19 most likely due to 
potassium accumulation in the T-tubules.12, 32 However, this model does not explain how 
continuous exercise prevents an ongoing paresis.
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Electrophysiological measurements with a newly developed high-density surface EMG 
system (HD-sEMG)5, 34 have shown that changes in sarcolemma function are closely 
related, although indirectly, to the underlying ion channel defect as described by Drost 
et al.14, 15 Using HD-sEMG in GM patients, it was found that the initial normal sarcolemma 
conduction was quickly followed by a fast conduction block along the sarcolemma, both 
in time and place.14 Nevertheless, the underlying mechanism of the subsequent ‘warm-
up’ remained unclear. If instructed to produce as much force as possible at any given 
time during a contraction period, patients are able to overcome weakness and to regain 
force within 10 to 20 s after the initial drop in force during the TP. Thus, although central 
activation is maintained throughout the contraction period, and propagation is blocked 
during TP, the state of the membrane can be restored within seconds, enabling renewed 
action potential propagation along the muscle fibre. Consequently, the potassium 
accumulation in the T-tubules, already mentioned as an underlying cause of the TP, must 
have cleared within this time-frame and, been prevented from recurring.
Because improvement of force and action potential propagation develops within 
seconds, the transient character of the paresis was attributed to the enhanced activity 
of Na+-K+-ATPase.14 Na+-K+-ATPase activity is induced by exercise and facilitates K+ 
ion clearance from the T-tubules within seconds. If this hypothesis is correct and the 
enhanced activity of Na+-K+-ATPase is indeed involved in recovery from the TP, its 
inhibition should prevent the occurrence of this warm-up phenomenon in GM. Specific 
inhibition of Na+-K+-ATPase can be attained by ouabain, a steroid that is normally used to 
reduce atrio-ventricular conduction in the heart and to increase cardiac contractility in 
patients with heart disease. By infusing ouabain locally into the brachial artery, only low 
concentrations are needed to establish a local effect.26, 27 The concentration of drugs in 
the forearm mainly depends on local blood flow and infusion rate, whereas the systemic 
concentration of an infused drug depends on its volume of distribution, local extraction 
or metabolism in the forearm, and the elimination half-life.28 With this knowledge, the 
dose can be calculated at which an effective local concentration is achieved without 
inducing systemic actions. Local inhibition of the exercise-induced enhanced activity 
of Na+-K+-ATPase was recently reported by us by the infusion of ouabain in a perfused 
forearm model in combination with HD-sEMG.28
The aim of this study, therefore, was to test the hypothesis that the transient character 
of the paresis in GM can be ascribed to the exercise-related enhanced activation of Na+-
K+-ATPase. The in vivo role of Na+-K+-ATPase activation was investigated by evaluating 
the effects of ouabain on the recovery of TP in GM patients.
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Subjects and methods
Subjects
Three male patients with GM (Becker’s type) from different families participated in 
this study. The clinical diagnosis, according to established criteria,20 was genetically 
confirmed in two of them. These two patients (patients 1 and 2) were compound 
heterozygous for mutations associated with the recessive form of myotonia. Patient 
3 had one known splice site mutation and a family history compatible with a recessive 
mode of inheritance, making the diagnosis of GM most probable. The patients were 
aged 32, 40, and 48 years, respectively. The age of onset was in the first decade of 
childhood, and the disease had been stable for at least 5 years. The clinical symptoms 
of muscle stiffness, myotonic runs on needle EMG, TP, warm-up phenomena, and 
muscle hypertrophy were present in all three patients. The patients were medication-
free for at least 1 week prior to the experiments. Nine control subjects (5 men, 4 
woman; aged 23-55 years) were used as reference for force values of the brachioradialis 
muscle, and three control subjects (all men; aged 23-39 years) provided reference for 
normal brachioradialis HD-sEMG tracings. The study was approved by the local ethics 
committee and all patients gave their written informed consent.
HD-sEMG and force measurement
All measurements were performed on the left brachioradialis muscle using an arm flexor 
ergometer to quantify force production. The subject sat in a chair with the upper arm 
in 90 degrees abduction, the elbow in 120 degrees flexion, and the wrist pronated. The 
arm was supported at the elbow and the wrist. HD-sEMG signals were obtained with an 
electrode grid containing 32 gold-coated electrodes (1.53-mm diameter) in two columns 
of 16 electrodes and with an interelectrode distance of 3 mm (centre-to-centre). Before 
placing the electrode grid, the skin was carefully scrubbed and rubbed in with electrode 
gel to decrease skin impedance. The double array of electrodes was placed parallel to the 
fibre direction on the distal part of the brachioradialis muscle and a reference electrode 
was placed on the olecranon. A total of 32 monopolar signals were recorded with respect 
to the reference, amplified, bandpass-filtered (3-800 Hz), and simultaneously AD-
converted (16 bits, 0.5 µV·bit-1) using a 64-channel amplifier system (Mark 6, Biosemi Inc., 
Amsterdam, the Netherlands). Data were sampled at 4000 Hz, displayed in real time, and 
stored on disk for offline analysis. Isometric forearm force was simultaneously measured 
with a 100-Hz sampling rate, displayed in real-time for visual feedback, and stored on disk 
for offline synchronization with the HD-sEMG data by means of a generated time code.
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Reference values for maximum voluntary brachioradialis force in this arrangement 
were obtained from nine healthy control subjects. Normal force and HD-sEMG patterns 
during the contraction period were obtained from three healthy control subjects.
Experimental protocol
A schematic representation of the protocol is shown in Figure 1. All subjects performed 
two identical tests on two different days separated by at least one week. Each test 
consisted of two periods of sustained isometric exercise of brachioradialis at 60% of 
the individual maximum voluntary contraction (MVC) force to ensure the occurrence of 
TP.14 The duration of the contraction period was 2 minutes in order to enable recovery 
from TP during exercise. The first contraction was performed after at least 30 minutes 
of rest. The interval between the two contractions was 60 minutes to ensure recovery 
to baseline. Randomly, on one of the test days and 30 minutes prior to the second 
contraction period, an infusion of ouabain into the brachial artery of the exercising 
arm was started, and continued throughout the exercise. Ouabain was infused at a rate 
of 0.4 µg·min-1·dl-1 forearm volume in order to block the exercise-induced enhanced 
activity of Na+-K+-ATPase as previously demonstrated.28, 33 For this purpose, the brachial 
artery was cannulated with a 20-gauge catheter (Angiocath; Deseret Medical, Becton 
Dickinson Sandy, Utah) and ouabain was infused with an automatic syringe infusion 
pump (type STC-521; Terumo, Tokyo, Japan). The order of the contraction periods (with 
and without ouabain infusion) was not randomly chosen, so as to prevent a crossover 
effect of the drug. Instead, a time-control experiment was performed to investigate the 
possible carryover effect of the first contraction on the second.
Day 1 MVC 30 min rest
2 min
60% MVC
30 min recovery 30 min recovery
2 min
60% MVC
end
ouabain infusion
Day 2 30 min rest
2 min
60% MVC
30 min recovery 30 min recovery
2 min
60% MVC
end
Figure 1. Schematic representation of the protocol. Two tests on two separate days were 
performed by each patient. The effect of ouabain infusion on the temporary muscle weakness in 
GM was tested in one test. The other test (without infusion) served as a time-control experiment. 
Both tests were performed in random order. MVC, maximum voluntary contraction force.
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Data analysis
The analyses of force and HD-sEMG signals were performed offline. To enable 
quantitative comparison of the TP recovery phase between the different conditions 
(with and without ouabain for the ouabain test and contraction 1 and 2 for the time-
control test), the force signal was divided in 20 consecutive periods of 5 seconds, 
starting at the time of minimum force during the TP. For each of these 20 periods the 
area under the curve was calculated and expressed in N×s.
Several variables were calculated from the bipolar HD-sEMG signals. Bipolar signals 
were calculated by subtraction of the signals from electrodes in consecutive positions 
along the columns (fibre direction). The Root Mean Square (RMS) of all the HD-sEMG 
signals was calculated as a measure of amplitude. The column with the highest overall 
RMS, after omitting signal artefacts, was selected for further analysis of the sEMG 
variables.
Muscle fibre conduction velocity (MFCV) was calculated for each subsequent period of 
250 ms from the delay of each set of two bipolar signals (skipping one set in between), 
using the phase difference method.22 Only bipolar recordings that were either distal 
or proximal of the innervation zone were used. Signal pairs with a cross-correlation of 
<0.70 were not accepted for calculation of MFCV.
During the 2-minute contraction phase, RMS values were calculated for the subsequent 
periods of 250 ms and averaged over the variable number of bipolar signals in the 
column. In addition, the recovery phase was investigated by calculating the area under 
the curve of RMS values, using the corresponding times derived from the force data, 
thus starting at minimum force during the TP, and up to 100 s of recovery in 20 periods 
of 5 s.
Bipolar median frequency (Fmed) was calculated during each contraction phase from the 
bipolar signals as the 50th percentile of the power density spectrum after fast Fourier 
transform over subsequent periods of 250 ms. Fmed was calculated for the same column 
(highest RMS value) as the RMS. As with force and RMS variables, the area under the 
curve for Fmed was calculated in 20 periods of 5 s to investigate recovery of the TP.
The neuromuscular efficiency (NME), defined as the quotient of force and RMS (in N.µV-1), 
was calculated from the corresponding values of area under the curve for force and RMS. 
Statistical analysis
To enable quantitative comparison of the TP recovery phase between the different 
conditions (i.e. with and without ouabain for the ouabain test and contraction 1 
and 2 for the time-control test), a generalized linear model9 was used to account for 
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the dependent character of the repeated measurements. Summary statistics were 
calculated as the slope derived from regression analysis between the two contraction 
periods of a single test (ouabain or time-control test), and comparison of the summary 
statistics between both tests was examined by means of Student’s paired t-test. Data are 
reported as mean ± SD. The level of statistical significance was set at P ≤ 0.05
Results
The MVC force was 127.5 N in Patient 1, 130.3 N in Patient 2, and 116.0 N in Patient 3. 
Although the MVC values were low, two of the three patients fell within the 95% 
confidence interval (120.9 – 344.8 N) derived from the controls (n=9). 
Force measurement
The work intensity of 60% MVC resulted in a TP in all three patients within 5 seconds 
after the start of exercise (Fig. 2). Although the patients were instructed to maintain as 
close as possible to 60% MVC, force production decreased rapidly within the next 6 s 
to a minimum that was 98%, 64%, and 91% lower (for Patient 1, 2, and 3, respectively) 
than the force at the start of the TP (Table 1). Within 10 s all three patients were able to 
slowly build up force again, although the time needed for half recovery varied among 
the individual patients, as did the force pattern over the remainder of the contraction 
period (Table 1; Fig. 2). Because of the small number of patients studied, we have 
refrained from going into detail concerning the individual differences in force recovery. 
As expected, healthy subjects had no problems maintaining force at 60% MVC for at 
least the first 40 s (n = 3, MVC = 218.1 ± 43.2 N).
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Table 1. Force and time characteristics during transient paresis in three GM patients.
High Low Net Half rec.
Patient 1 Force (%MVC) 66.6 1.6 -65.0 (98%) 34.1
Time (s) 1.1 5.1 4.0 23.2
Patient 2 Force (%MVC) 68.4 25.0 -43.5 (64%) 46.7
Time (s) 0.7 6.5 5.8 4.7
Patient 3 Force (%MVC) 44.7 4.1 -40.6 (91%) 24.4
Time (s) 5.1 7.4 2.3 3.5
Transient paresis (TP) was provoked by sustained isometric brachioradialis exercise at 60% of 
the patient’s maximum voluntary contraction (MVC) force. Data were derived from the first 
contraction period of the ouabain test (no ouabain infusion). High, peak force level prior to the 
occurrence of TP; Low, minimum force during TP; Net, net force decrease in % MVC and duration 
(in s); Half rec., force level and duration for half recovery of the force from TP, relative to the force 
and time at the start of the TP (i.e., at minimum force during the TP).
Figure 2. Force production of the patients during the first contraction period (without ouabain 
infusion). In all patients the work intensity of 60% MVC resulted in a transient paresis within 
seconds, which was, (in part) overcome in the remainder of the contraction period.
Figure 2 
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HD-sEMG recordings
At the start of exercise, before the occurrence of the TP, HD-sEMG recordings of 
the patients showed a normal pattern with increasing activity when force was rising 
and an undisturbed bi-directional propagation of the action potentials from motor 
endplate zone towards the tendon. During the involuntary force decline, a gradual 
loss of electrical activity of the sarcolemma was seen in all three patients as a function 
both of time and place, i.e. from tendon towards endplate (Fig. 3A). This deteriorating 
sarcolemma function, which ended in a complete block of propagation, led to the 
characteristic V-shaped pattern in the HD-sEMG recordings, which has been described 
previously.14 At the moment when force production was at its minimum, the amplitude 
of the HD-sEMG signal was almost nil, although activity never completely disappeared 
around the endplate zone. At the point of half recovery, when force level had returned 
to halfway between peak and minimum force, propagation was still impaired for all 
three patients. In all cases (3 x 4 contraction periods), undisturbed propagation for 
one or more motor units was not seen before 40 s of recovery had passed (apart from 
a few occasional bursts with subsequent TP), and some motor units had still not fully 
recovered during the last 15 s of the contraction (Fig 3C). 
Calculation of MFCV did not appear possible. As can be seen in Figure 3A, propagation 
from endplate towards tendon became blocked during TP and remained disturbed for 
a long period during the recovery phase (Fig. 3C). This propagation block precluded a 
reliable estimation of MFCV since less than 20% (11% for Patients 1 and 2 and 32% for 
Patient 3) of the values from endplate towards tendon could be calculated during the TP 
(from peak force to half recovery) according to our quality constraints. Moreover, due to 
the deteriorating peak values towards the tendon, the estimated MFCV values showed 
large variability. Figure 3C shows clearly that even in the last part of the contraction 
period, when force production had more or less recovered, a progressive disturbance 
of action potential propagation was still present and obscured the calculation of MFCV. 
Based on the aforementioned reasons, it is our opinion that calculation of MFCV was 
not reliable enough and we therefore excluded it from further analysis. 
In two of the three patients, bipolar RMS followed a similar pattern as the force data with 
a rapid increase at the initial start of exercise, a fast decline during the TP, and more or 
less recovery from the TP in the remainder of the time. The third patient showed hardly 
any amplitude increase during the initial force increase, but reached, compared to the 
other two patients, the highest RMS values during the remainder of the time.
A fast shift to lower Fmed frequencies was detected in all patients during the occurrence 
of the TP. With some small individual variations, Fmed remained constant around 40 Hz 
during the second half of the contraction period.
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Figure 3 
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Figure 3. Force and HD-sEMG signals during various parts of the contraction period in an individual 
patient. (A) Characteristic V-shaped pattern in HD-sEMG signals indicating the occurrence of TP; 
initial normal activity pattern, followed by loss of electrical activity as a function of time and 
place from tendon to endplate, finally resulting in conduction block. (B) Normal propagation from 
endplate (channel 9) towards tendon (proximal and distal) after initiation of exercise. (C) Impaired 
propagation after the TP. Although force production is more or less recovered, progressive 
disturbance of action potential propagation was still present in the last 10 s.
Effect of Na+-K+-ATPase blockade on transient paresis
Force
The expected lack of recovery from the TP in GM after blocking Na+-K+-ATPase by 
ouabain infusion did not occur, as is shown in Figure 4. No significant differences 
between the two periods (with and without ouabain infusion) were found in the force 
characteristics of the TP itself, i.e. the time to rise to peak force (P = 0.72), the time for 
peak force decline (P = 0.50), and the area under the peak (P = 0.50). Although the force 
during recovery tended to be lower after ouabain infusion, a similar trend was seen in 
the second contraction period of the time-control experiment. Statistical analysis of the 
recovery phase (100 s in 20 periods) showed no significant differences either between 
the ouabain test and the time-control test (Table 2). 
Table 2. Mean slope of recovery of TP (n=3) derived from linear regression analysis between both 
contraction periods of each test.
Ouabain test Time-control test P-value
Force 0.87 (0.4) 0.77 (0.5) 0.73
RMS 1.13 (0.4) 1.00 (0.3) 0.76
Fmed 1.30 (1.3) 0.80 (0.7) 0.63
NME 1.03 (0.5) 1.40 (0.5) 0.52
RMS, EMG amplitude (root mean square); Fmed, median frequency; NME, neuromuscular 
efficiency. Bipolar montage. Values are means ± SD.
106 Chapter 5  Na+-K+-ATPase is not involved in the warm-up phenomenon in generalized myotonia 107
Figure 4. Force production of the patients during all four contraction periods. In black, force 
production after 30 minutes of ouabain infusion. In grey, force production of the control periods, 
of the ouabain test as well as both contraction periods of the time-control test. Although there 
are some minor differences, the overall conclusion is that ouabain infusion did not prevent 
recovery from TP in these GM patients.
HD-sEMG
As expected from the lack of effect by ouabain infusion on the force data, no major 
changes were noticed in the HD-sEMG signals either. Propagation of the action potential 
remained disturbed for a long period, whereas force production slowly recovered, but 
no further deterioration was noticed during ouabain infusion. Quantitative values for 
RMS, Fmed and NME during the recovery phase of the TP showed no significant changes 
between the ouabain contraction period and its control period (Table 2), as shown for 
RMS in Figure 5.
Figure 4 
Patient 1
0 20 40 60 80 100 120
Fo
rc
e 
(%
 M
VC
)
0
20
40
60
80
Patient 2
0 20 40 60 80 100 120
Fo
rc
e 
(%
 M
VC
)
0
20
40
60
80
Patient 3
Time (s)
0 20 40 60 80 100 120
Fo
rc
e 
(%
 M
V
C
)
0
20
40
60
80
106 Chapter 5  Na+-K+-ATPase is not involved in the warm-up phenomenon in generalized myotonia 107
Figure 5. Comparison of recovery in root mean square (RMS) between the ouabain test and the 
time-control test. (A) Area under the curve for RMS during the recovery phase (20 periods of 5 s) 
of both contraction periods in the ouabain test. In black, contraction period 1; in grey, contraction 
period 2 (with ouabain). (B) Area under the curve for RMS during the recovery phase in the time-
control test. In black, contraction period 1; in grey, contraction period 2; both without ouabain 
infusion. (C) Regression plot of the values derived from the ouabain test (plot A), with period 1 
versus period 2. Regression line in black, line of identity in grey. Equation, P-value, and correlation 
coefficient are shown in the upper left corner of the plot. (D) Regression plot of the values derived 
from the time-control test (plot B). 
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Discussion
We found that inhibition of the exercise-induced enhanced activity of Na+-K+-ATPase 
with ouabain does not affect recovery from TP in three patients with GM. This 
observation invalidates our hypothesis that exercise-induced activation of Na+-K+-
ATPase mediates the warm-up phenomenon in these patients.
In normal muscle, Na+-K+-ATPase is thought to become activated during exercise, as a 
necessary mechanism to restore sarcolemmal Na+-K+ gradients, thus preventing reduced 
excitability of the sarcolemma.25 Sarcolemma excitation rapidly activates Na+-K+-ATPase 
in rat muscle, allowing the pump to increase the Na+ efflux approximately 20-fold within 
10 seconds.25 A similar activation within seconds is thought to apply to for human skeletal 
muscle (see Clausen11 for review). Because the Na+-K+-pump is the only active transport 
system to counterbalance the passive movements of Na+ and K+, and because its time 
frame of enhanced activity matches the beginning of recovery after TP, it was certainly 
plausible to ascribe a role for Na+-K+-ATPase in the recovery of TP in GM.
 The exercise protocol used in this study was sufficient to produce a marked TP in our 
patients. All three patients were subsequently able to slowly build up force again (within 
10 s), confirming the presence of a ‘warm-up’ phenomenon. Against our prediction, 
inhibition of Na+-K+-ATPase by ouabain did not prevent the patients from warm up. 
Both force and HD-sEMG variables recovered after the TP, despite 30 minutes of local 
ouabain infusion prior and during exercise. When considered with respect to force 
alone, the results still might be interpreted as a task shift during the warm-up phase 
from brachioradialis to biceps brachii and brachialis muscles. These muscles are not 
located in the compartment infused with ouabain, but participate in elbow flexion. 
However, based on the HD-sEMG data, which showed no effect at all between sessions, 
this possibility seems unlikely.
The lack of a negative effect of ouabain indicates that recovery of TP in GM is not 
mediated by Na+-K+-ATPase, assuming that ouabain indeed blocks the exercise-induced 
enhanced activity of Na+-K+-ATPase. The major advantage of the perfused forearm 
model combined with intra-arterial infusion of drugs is the possibility of increasing local 
plasma concentrations without inducing systemic actions. Cerebral effects of ouabain 
that could potentially affect HD-sEMG measurements are thus avoided, and peripheral 
phenomena in the muscle can be distinguished from changes in central drive. We have 
previously found that intra-arterial ouabain completely prevents the increase in MFCV 
during recovery, indicating that ouabain can indeed inhibit local forearm Na+-K+-ATPase 
in the sarcolemma as well as in the T-tubules.28 
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Moreover, ouabain is a well known inhibitor of Na+-K+-ATPase11, 21 and has been successfully 
used in the forearm model even at doses that are lower than used in the present study.13, 
28, 30 Although it is impossible to block all local Na+-K+-ATPase, complete blocking was not 
our goal. We intended to block at least the exercise-induced enhanced activity of Na+-
K+-ATPase, as it was our hypothesis that this enhanced activity mediates the warm-up 
phenomenon in these patients. In our patients we cannot completely exclude insufficient 
blocking of Na+-K+-ATPase activity, based on a possible adaptation in the expression of 
Na+-K+-ATPase due to long-term K+ accumulation.8, 16 However, since we used a dose that 
was twice as high as in our previous study,28 the lack of effect on recovery of TP seems 
unlikely to be due to an insufficient inhibition of Na+-K+-ATPase in the sarcolemma and 
the T-tubules. Therefore, we concluded that the normal recovery of TP in GM is most 
likely not mediated by Na+-K+-ATPase. This, however, raises the question as to what other 
possible mechanisms play a role in the recovery of TP in GM.
Due to the relatively slow time-constant of recovery, it is unlikely that passive diffusion 
of potassium from the T-tubules is a potential mechanism. A possible alternative 
pathway for removal of excess potassium from the T-tubules, the most probable cause 
of the TP given the lack of functional chloride channels, is via the inward rectifier 
potassium channels. Using a mathematical model, Wallinga et al.32 showed that the role 
of the inward rectifier in maintaining excitability during repeated action potential firing 
is almost as effective as the Na+-K+-pump. The inward rectifier only conducts inward 
current for tubular potassium clearing, if the membrane potential is more negative than 
the potassium equilibrium potential.29, 32 Due to the small volume within the T-tubule 
in combination with its large surface, potassium concentration rapidly increases with 
every subsequent action potential. According to the Nernst equation, this results locally 
in an increased potassium equilibrium potential, which might hypothetically rise above 
the membrane potential. This was illustrated in the model of Wallinga et al.,32 where an 
accumulated T-tubular potassium rise of 0.4 mM per action potential (to a maximum of 
6.8 mM) raised the potassium equilibrium potential just above the membrane potential 
while this inwardly directed potassium component was absent for the sarcolemma, 
since the rise in potassium concentration was not as high as in the T-tubules. However, 
as postulated from this mathematical model, this condition is warranted not only by 
the effect of increased tubular potassium concentration on the potassium equilibrium 
potential, but also by the high resting conductance to the chloride equilibrium 
potential.32 Since this high chloride conductance is lacking in GM, this is most likely 
not the pathway for recovery of TP. Moreover, potassium influx through the inward 
rectifiers is only possible as long as the membrane potential is more negative than the 
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potassium equilibrium potential and this is a self-limiting process. It therefore, cannot 
fully compensate for the potassium accumulation. Finally, the TP only occurs after a 
period of rest and can be overcome by repeated contractions. 
 Another alternative explanation might be the decrease of the activation level of 
the sarcolemma, induced by the propagation block during paresis. Initially, muscle 
fibres will be excited at a high frequency with a relatively large excess of extracellular 
potassium. When propagation is blocked, potassium accumulation decreases, and part 
of the action potentials arriving at the endplates may actually start to propagate along 
the sarcolemma again, resulting in excitation at a lower frequency. A similar effect 
was described by Cairns et al.,10 who found that force increased when the stimulation 
frequency was lowered in muscles with deficient action potential propagation. The 
‘poorer’ EMG pattern when comparing Figure 3C and Figure 3B could support this 
hypothesis.15 Less and slower action potentials are observed. The lower frequency of 
arriving action potentials must still be high enough to sustain (almost) normal force, 
possibly due to a delayed mechanical relaxation such as found during prolonged 
activation or fatigue.24 
 Finally, it might be considered whether the frequency of successful action potential 
propagation along the length of the muscle could also be influenced by the possible re-
emergence of action potentials out of the tubular system when the chloride conductance 
is low, as recently proposed by Lamb.18 This could lead to very complex patterns of 
action potential re-activation and failure. In addition, the concept that the lowering of 
intracellular pH plays a role in the warm-up phenomenon4 may need to be reconsidered.
In conclusion, the hypothesis that Na+-K+-ATPase was involved in the recovery from TP 
in GM patients has formed the basis of our study. However, although this hypothesis 
was based on good grounds and we are as yet unable to support one of the alternative 
explanations, we found no evidence for such a causal link.
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Summary
Fasciculation potentials (FPs) are observed in healthy individuals, but also in patients 
with neurogenic disorders. The exact site of origin and the clinical relevance in 
distinguishing for example ALS from other neurogenic diseases based on specific 
characteristics of the FPs is still a matter of debate and needs further exploration.
This report describes the use of high-density surface EMG (HD-sEMG), with multiple 
electrodes in a compact grid to non-invasively record FPs. The technique provides both 
temporal and spatial information of fasciculations. Examples of the FPs of a patient 
diagnosed with definite ALS are presented. FPs are shown in different electrode 
montages and the unique spatial characteristics of different FPs are presented. During 
30-second recordings, 137 FPs were detected. Via a decomposition algorithm these FPs 
could be assigned to 11 different underlying sources. 
It is concluded that HD-sEMG, both because of its non-invasive character and the unique 
spatiotemporal information, is very suitable to examine fasciculations. It allows long 
stable recording times and provides quantitative information. This electrophysiological 
tool is expected to expand the existing knowledge of FP properties. 
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Introduction
In various neuromuscular disorders abnormal ‘spontaneous’ activity of (groups of) 
muscle fibres can be observed. Concentric or monopolar needle electromyography 
can show positive sharp waves, fibrillation potentials, complex repetitive discharges, 
myotonic discharges and fasciculation potentials (FPs). A fasciculation potential is 
an action potential, which is often associated with a visible fasciculation. It has the 
configuration of a motor unit action potential (MUAP) but occurs spontaneously.1 If FPs 
are generated in superficial muscle layers they cause the visible twitches. In the present 
study we will elaborate on FPs.
The physiological mechanism of fasciculations and their site(s) of origin have been 
controversial topics and to date neither has been well established yet.6 Thus far, in most 
peripheral neuromuscular disorders the evidence points towards a distal site in the 
axon as their source.3, 15 In amyotrophic lateral sclerosis (ALS), besides this site also a 
proximal and even a supraspinal origin for various FPs have been postulated.20, 22, 31
The occurrence of FPs does not always indicate pathology as it is also observed in healthy 
individuals.21, 30 Their clinical significance to differentiate between health and disease 
should hence be interpreted in the light of the company they keep, i.e., fibrillations, 
positive sharp waves or enlarged MUAPs.7
In ALS FPs are hallmarks of the widespread involvement of motor neurons. Here, their 
clinical importance is stressed by the fact that neurologists do not feel confident in 
diagnosing the condition in patients lacking fasciculations.16 Various attempts have 
been made to distinguish ALS from other neurogenic disorders based on the diverse 
characteristics of FPs.5, 12, 22, 31 Although closer analyses of the morphology of the separate 
FPs appeared not to facilitate the diagnosis of ALS, two consecutive FPs, defined as two 
consecutive differently shaped FPs lacking a baseline between them, were claimed to 
be pathognomonic findings in ALS.25 In sum, an accurate delineation of FPs requires 
sophisticated techniques and intricate analyses while the diagnostic value of their 
properties is still ambiguous.6 
Although a quantitative evaluation of FPs seems relevant to improve their diagnostic 
value, standard needle examinations may not provide optimal information. The 
small sampling volume limits the recordings from a single concentric or monopolar 
electrode whereas the use of a multi-needle electrode or multiple-needle insertions is 
not an acceptable alternative. Previous studies using surface EMG (sEMG) recordings 
demonstrated that bipolar sEMG is a highly sensitive method to determine the 
frequency of fasciculations in different parts of the body.10, 11, 30 More advanced (multi-
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channel) sEMG techniques are exploited to study the spatiotemporal aspects of motor 
units (MUs) and whole muscle activity.18, 19, 28 To our knowledge, multi-channel techniques 
have not been used to explore the distinguishing qualities of FPs.
 We present the results of a study of FPs for which we used the high-density sEMG 
technique (HD-sEMG). Via a 2-dimensional array of recording electrodes, HD-sEMG 
allows the simultaneous measurement of electric potential fields evoked by active MUs 
through the intact skin, providing simultaneous information about their temporal and 
spatial dynamics.2, 28, 32 In a previous study with postpolio patients we demonstrated that 
the technique proved sufficiently sensitive to detect the increase of MU size resulting 
from reinnervation.8 In the present short report, we describe the application of HD-
sEMG to record fasciculations in an ALS patient, present various unique FP features 
inaccessible with other techniques and will illustrate the potential of HD-sEMG in the 
examination of FPs. 
Methods
The participant in our study was a male patient with sporadic ALS who at the time of 
testing was diagnosed as definite ALS according to the El Escorial Criteria.4 The patient 
was selected for the study because clinically he had abundant fasciculations in almost 
all skeletal muscles in both arms and legs, including the left brachial biceps muscle. All 
measurements were performed on the latter muscle. The patient was seated in a chair 
with the arm supported at the elbow and the wrist. The upper arm was kept in 90-degree 
abduction, the elbow in 120-degree flexion and the wrist in a zero position. The patient 
was asked to keep his arm as relaxed as possible in aid of which he was presented with 
visual EMG feedback. The data were obtained during a 30-second recording.
The Medical Ethics Committee of the Radboud University Nijmegen Medical Centre 
approved the study and the participant gave his informed consent prior to the study.
HD-sEMG acquisition
Measurements with HD-sEMG were performed with a 2-dimensional electrode grid.2 The 
130 gold-coated electrodes, of 1.5 mm diameter, were mounted directly onto a specially 
designed flexible printed circuit board. Electrodes were arranged in a 10 x 13 rectangular 
matrix with a 5-mm interelectrode distance in both directions. Signals were recorded 
monopolarly with a reference electrode on the olecranon. The electrode grid was carefully 
placed over the biceps brachii muscle with the 10 columns parallel to the muscle fibres. 
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The monopolar signals were amplified, bandpass filtered (3-400 Hz) and simultaneously 
A/D converted, at a rate of 2000 samples/s/channel with 16-bits resolution at 0.5 µV/bit. 
The data were stored on a PC for offline analysis. 
Both monopolar and bipolar montages can be displayed. A monopolar montage has 
a substantial larger field of view mainly caused by the non-propagating elements of 
deeper lying MUAPs.27 As will be shown, a column or a row of channels can be selected 
for online (monopolar or bipolar) visualization. Bipolar montages are obtained by 
subtracting the monopolar signals measured at two adjacent electrodes in fibre 
direction along the same column, which reduces the number of channels in the column 
by one. Differences in the FPs’ spatial properties (e.g. in size and position) result in 
spatial differences in surface FPs. Consequently, each FP is assumed to have its own 
specific spatiotemporal pattern at the skin. 
For the detailed analysis of the FPs’ spatial distribution, we used a sEMG decomposition 
algorithm as described by Kleine et al.13 The result of decomposition is a classification 
of MUAP or FP waveform and all their firing moments.26 The difference between 
surface- and needle-EMG decomposition is the use of spatial information represented 
in multiple channels in HD-sEMG.13, 14 By definition, FPs fire irregularly and their 
classification has to rely solely on waveform morphology, whereas in MU decomposition 
also known constraints with respect to firing patterns can be used. In short, we applied 
the following steps. First, a selection of bipolar signals was made and the detection 
threshold was arbitrarily set at 0.03 mV. The peak detection was performed on all 
channels, but only the highest peak was accepted. Effectively, this aligns all FPs to 
the highest peak and removes double detection. Subsequently, 10-ms signal segments 
around the highest peak were submitted to a cluster analysis. An arbitrary number of 
fifteen clusters were formed. After visualization of the superimposed signal segments, 
the clusters were merged or split until the within-cluster variation was lower than the 
between-clusters variation. To obtain the position of the MU that generates a FP, the 
distance-amplitude relationship was used. According to Roeleveld the peak-to-peak 
amplitude of a bipolar action potential decreases with a power of two with distance.24 A 
numeric evaluation of this relation was used. A grid with a resolution of 0.5 mm was put 
over the cross-section given in Figure 5C. For each grid point the predicted potential 
distribution on the 10 pairs of surface electrodes was calculated from the distance to 
the electrodes. The position that minimized the sum of squared residuals is assumed to 
represent the likeliest position of the MU centre. 
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Results
The HD-sEMG affords an easy recording of the patient’s FPs. The visual feedback the 
patient received to promote relaxation of the arm helped avoid potential interference 
of continuously discharging MUs. Although the FPs consistently had configurations 
similar to those of the MUAPs, they could easily be distinguished based on their 
irregular firing patterns that contrasted the MUAPs’ regular firing patterns. The typical 
recording illustrated in Figure 1 shows the spatiotemporal dynamics of four different 
FPs. The two montages display different spatiotemporal properties. The monopolar 
montage (Figure 1 panel A) shows five FPs recorded from all 13 electrode positions. The 
morphology of the waveform is slightly different in each channel.
Figure 1. Examples of HD-sEMG data in a monopolar montage (panel A) and the same data 
in a bipolar montage (panel B). The inset schematically shows the electrode grid with its 130 
electrodes. The column on the grid from which the FPs were recorded is indicated by the dark 
rectangle. In the monopolar montage five FPs are displayed (FP4 was recorded twice). In the 
bipolar montage only the propagating elements of the signal are left over. The black dots indicate 
the motor endplate zones of the FPs from where the FPs propagate toward the tendon. Using 
the time delay (dt) and the distance between the electrodes, a muscle fibre conduction velocity 
can be estimated. In the bipolar montage FP3 with almost the same waveform in all monopolar 
channels disappears. 
FP1 FP2 FP3 FP4 FP4
0.4mV
50 msdt
FP1 FP2 FP4 FP4
B. BipolarA. Monopolar 
Fibre direction
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Due to their higher spatial selectivity, the 12 (13 – 1) bipolar signals (Figure 1 panel B) are 
used first for FP separation. The FP waveforms become shorter. The phase reversal of 
the FPs indicates endplate zone positions (black dots). The FPs travel from the motor 
endplate zone towards the tendon and the time delay (dt) can be used to estimate 
the mean muscle-fibre conduction velocity of the MU. The different FPs also vary in 
amplitude (peak-to-peak amplitudes up to 1.2 mV). Based on the dissimilar waveforms 
and spatial properties, such as the different endplate zones, the FPs can already be 
separated fairly well. Note that the FPs with almost the same waveform in all monopolar 
channels will disappear in a bipolar montage (FP3).
Figure 2 presents a configuration perpendicular to the fibre direction (“row” direction, 
see inset). The bipolar subtraction of FPs was performed in the fibre direction. The FPs 
can be differentiated more robustly because their position, size and depth affected the 
amplitude distribution especially in this direction (Fig. 2). Three different FPs can be 
discerned and FP4 was recorded twice.
Figure 2. The bipolar FPs (panel 1B) now displayed in a montage perpendicular to the fibre 
direction. The inset shows two columns because the bipolar montage is always a subtraction of 
FPs in fibre direction. Note that with this montage the FPs can be easily differentiated due to 
their amplitude distribution.
0.4 mV
FP1 FP2 FP4 FP4
50 ms
Fibre direction
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Using the EMG information from all electrodes of the grid, a unique two-dimensional 
spatial pattern of each FP is obtained as a function of time, examples of which are 
depicted in Figure 3. Panel A shows the superposition of the spatiotemporal pattern of 
two FPs both indicated with FP4 in Figures 1 and 2. These FPs show exactly the same 
spatial distribution of the potential, and therefore they must arise from the same group 
of muscle fibres. Another spatial pattern of two superimposed FPs is given in Figure 3 
panel B. In the column indicated with the arrow, the FPs have almost identical waveforms. 
From the FPs’ spatiotemporal differences across the grid as a whole (panel B) it is evident 
that we are dealing with two different FPs. This illustrates that electrodes perpendicular 
to the muscle fibre direction have to be included in order to differentiate of FPs.
Figure 3. Both panel A and B represent the superposition of two FPs across the entire electrode 
grid. They illustrate the unique two-dimensional spatial pattern of the bipolar FPs. Panel A 
shows that the two displayed FPs are identical. The inset depicts an enlarged detail of the FPs of 
electrodes perpendicular to the fibre direction. The arrow in panel B indicates the column in which 
the FP signals are almost identical. The magnification indicates that the montage perpendicular 
to the fibre direction clearly shows differences and thus two different FPs.
A B
0.4 mV
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Consecutive FPs, according to the definition of Shiga et al., must also have different 
spatiotemporal characteristics.25 Figure 4 shows an example of such a complex 
waveform (panel A) in the fourth column of the grid. Examination of the same potential 
in an other column (panel B) and a view perpendicular (panel C) to the muscle fibres 
clearly reveals that these are indeed two consecutive FPs with two different spatial 
distributions. Figure 5A and 5B show a schematic cross-section through the upper arm 
with the electrodes indicated as dots. The two FPs of Figure 4C have been superimposed 
onto this simple anatomical model. Note the clear spatial separation of the distribution. 
Given the known relationship between MUAP amplitude and distance24 the centre of 
the MU can be estimated as given in Figure 5C. Note the clear spatial separation of the 
electrical sources.
Figure 4. Example of a consecutive FP pair at three different electrode configurations. Panel A 
shows a complex waveform from the fourth column. In panel B the same data are displayed in 
another column. Here two propagating FPs are visible with the endplate zone position between 
both the fourth and the fifth electrode. However, the perpendicular montage demonstrates (C) 
clear spatial differences illustrating that this consecutive FP configuration originates from two 
different FPs. 
0.4 mV 0.2 mV 0.4 mV
50 ms
A B C
Fibre direction Fibre direction
Fibre direction
126 Chapter 6  Fasciculation potentials in high-density surface EMG 127
Figure 5. Anatomical properties of the two (consecutive) fasciculation potentials shown in 
Figure 4C. The circle with a diameter of 8 cm symbolizes a cross-section through the upper arm. 
The 10 electrode positions with 5 mm interelectrode distance in the medial to lateral direction 
are marked by a dot. In part A and B the bipolar fasciculation potential is superimposed on the 
corresponding electrode position. In C the estimated midpoint of the underlying MU is indicated 
along with a circle that symbolizes a MU territory with a diameter of 1 cm. Note that the MU 
territories do not overlap, i.e. the FPs can not be explained by parts of the same MU that are 
activated in succession. 
A
40 ms
0.2 mV
B
1 cm
1 cm
C
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The result of semi-automatic peak detection and semi-automatic clustering is shown 
in Figure 6. One row perpendicular to the fibre direction has been selected by visual 
inspection (row 8). In total 137 peaks exceeded a threshold of 0.03 mV. Clustering 
resulted in 11 different FP waveforms. These different FP morphologies reoccurred 
between 2 and 32 times (numbers below the column, Figure 6) within 30 seconds. In 
two clusters consecutive FPs were recorded (indicated grey). The potentials in the 7th 
column were also shown in Figure 4.
Figure 6. Result of the cluster analysis of all 137 FPs grouped into 11 different clusters. The FPs in 
each group are superimposed. The number of superimposed FPs is given at the bottom. The grey 
columns show the consecutive FPs (in column 7 and in column 11). 
2 16 10 22 332 9 1910 12 2
Fibre direction
128 Chapter 6  Fasciculation potentials in high-density surface EMG 129
Discussion
The current study shows that FPs can easily be obtained and analyzed using HD-sEMG. 
An advantage of HD-sEMG is that not only temporal, but also spatial information of FPs 
can be acquired. The FP’s spatial information shows its distribution over the muscle. 
Like voluntarily activated MUAPs, FPs conduct along the muscle fibres, from the motor 
endplate zone towards the tendon (Fig. 1B). In HD-sEMG recordings, the FPs’ spatial 
profiles have the same configuration as the MUAPs profiles. 
The technique additionally allows montage changes. Compared to a bipolar montage, 
more FPs can be identified with a monopolar montage since it affords a deeper “look” 
into the muscle. Because these FPs not always have a clear propagation characteristic 
at the skin surface across the various channels, they can easily be missed in a bipolar 
montage (FP3 in Fig. 1). However, because of their spatial features and the shortening of 
the waveforms, FPs can more easily be differentiated in a bipolar montage. The montage 
perpendicular to the muscle fibres reveals amplitude-distribution information about 
the FPs’ position, their size and depth of the activity. In MUAPs these properties were 
previously revealed by Roeleveld et al.23 
The unique spatiotemporal characteristics of FPs across all channels, as illustrated in 
Figure 3, yield extensive FP characterization. On one channel, the FP configuration of 
different FPs can be identical, moreover this may even occur in one column (panel 3B, 
4B). Along the medial to lateral direction of the electrode grid, the potential amplitude 
is defined by the distance of the MU relative to the recording electrode. From this 
relationship we have estimated the position of the MUs as shown in Figure 5. It is 
important to note that all muscle fibres belonging to a MU are usually within a territory 
of 1 cm in diameter. Even in neurogenic diseases the MU territory, as assessed with 
scanning EMG, is within normal limits.9 This maximum MU diameter of 1 cm is plotted 
in Figure 5C in order to demonstrate that the two MU territories do not overlap. Thus, 
the two consecutive FPs (Fig. 4B) must have different MUs as their origin. Not only the 
depth of the MU but also the size of a MU determines the amplitude. The depth of both 
MUs in Figure 5C is about 7 mm in both cases, so the amplitude difference between 
Figure 5A and Figure 5B points to a size difference of factor two. 
The 137 FPs identified in this study could be assigned to 11 different electrical sources. 
Besides their number, the characteristics of individual FPs become available. Potentially, 
HD-sEMG also offers non-invasive access to the FPs’ firing statistics. As mentioned 
before, HD-sEMG can add new information about FPs for example in ALS. Especially 
because FPs are responsive to medication, e.g. cholinergic drugs can induce FPs,17 and 
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spinal anaesthesia can abolish 50 to 60% of fasciculations in ALS,29 HD-sEMG may be 
useful in medication studies in ALS. 
As mentioned above, Shiga et al. claimed that two consecutive FPs with different MU 
origins are an electromyographically pathognomonic finding in ALS.25 In the ALS patient 
in our study we found consecutive FPs: 2 of the 137 FPs proved consecutive. Statistically, 
however, this still may be explained as a coincidental finding. Before accepting these 
FPs as a diagnostic marker of ALS, it is needed to correct for the statistical chance 
of coincident firing. Such rigid cross-correlation analysis requires huge numbers of 
accurately classified FPs to reach a significance level. The hypothesis of Shiga et al. could 
be tested if long-duration HD-sEMG recordings yield a sufficient number of events. 
Previous studies showed that needle or sEMG recordings revealed considerably 
more fasciculations than mere visual inspection.10 Howard and Murray subsequently 
demonstrated that multi-lead surface recordings of different muscles simultaneously 
provide a highly sensitive method to determine the frequency and anatomical 
distribution of fasciculations11. The recording of fasciculations with needle examination 
is limited by the spatial information obtained, and recordings typically sample a volume 
of only a few mm3. Evidently, HD-sEMG is a more sensitive technique that will detect 
and delineate more FPs. 
Yet, compared to needle EMG, sEMG has principle disadvantages resulting from the 
electrodes’ greater distance to the muscle fibres. Surface EMG, for instance, cannot 
provide information about spontaneous activity at the muscle-fibre level such as 
fibrillation potentials and positive spikes. On the other hand, HD-sEMG has the benefit 
of being non-invasive thus affording longer stable registrations. This is of special 
significance for FPs because the discharge intervals of individual units are known to 
vary from a few milliseconds to more than a minute.11
 
In conclusion, HD-sEMG allows an easy recording of FPs and provides both spatial 
and temporal information about these involuntary contractions of (parts of) the MU. 
Moreover, the non-invasive character of the technique permits longer recording times, 
which yields quantitative information that can further our understanding of FPs. 
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Summary
We report a child with Satoyoshi syndrome manifested by involuntary painful muscle 
contractions and alopecia. Although an autoimmune origin of Satoyoshi syndrome seems 
likely, its exact aetiology remains as yet unknown, as is the origin of the involuntary 
contractions. To gain a better understanding of the electrophysiological characteristics 
of the involuntary contractions, we performed a surface electromyographic (EMG) study. 
We investigated muscle contractions in the legs using two noninvasive techniques: 
high-density surface EMG (HD-sEMG) recordings on one muscle, and polymyographic 
surface EMG (sEMG) recordings on various muscles. 
During the involuntary contractions, HD-sEMG showed a fourfold increase in 
amplitude compared to maximal voluntary contractions. These high potentials were 
widely distributed across the whole muscle and showed a pronounced oscillatory 
behaviour with a frequency around 45 Hz. Polymyographic sEMG revealed that the 
involuntary contractions often occur simultaneously in various muscles or showed a 
switch of activity from one muscle to another. These findings point to hyperactivity 
or a desinhibition at the alpha-motorneuron level, originating probably at that level, 
although a central origin cannot be excluded. 
138 Chapter 7  Involuntary painful muscle contractions in Satoyoshi syndrome: A surface electromyographic study 139
Introduction
Satoyoshi syndrome is a childhood-onset progressive multisystem disorder characterised 
by intermittent painful muscle contractions, malabsorption, diarrhoea, endocrinopathy, 
alopecia and secondary skeletal abnormalities.10 Its aetiology is unknown, although an 
autoimmune basis is likely through association with other autoimmune conditions, 
the presence of antibodies,3 and the improvement of symptoms with corticosteroid 
treatment and intravenous immunoglobulin.4 The painful contractions usually begin in 
the legs during childhood, and progress slowly with increasing severity and intensity, 
also involving limbs, trunk, neck, and masticatory muscles. Muscle contractions 
generally last for a few minutes and usually recur after an interval of less than a minute. 
These contractions are so intense that they induce abnormal posturing of affected 
limbs. Satoyoshi reported that the more severe the muscle contractions are and the 
earlier the disease onset in these patients is, the more severe the growth disturbance 
and the joint deformity are.11
The relation between the presumed autoimmune origin and the involuntary muscle 
contractions currently is still unclear. The answer to the question whether the painful 
muscle contractions in Satoyoshi syndrome have a peripheral (like muscle cramps) or 
central origin (like muscle spasms) would provide a clue to the pathophysiology and the 
cause of this rare syndrome.
Muscle cramp is a clinical diagnosis. It is characterized by a sudden, uncomfortable 
squeezing or contraction, lasting for seconds to minutes, often with a palpable hard 
knot in the affected muscle. Stretching the muscle or contraction of its antagonist 
muscle speeds relief of the cramp.5 Cramp is limited to a single muscle. The exact site 
of origin of muscle cramp is still a matter of debate. A surface EMG technique, with 
multiple electrodes on one muscle, recently has been applied to gain better insights into 
its pathophysiology. It has been demonstrated that muscle cramps present themselves 
with a characteristic pattern of a slowly moving fraction of contracting muscle fibres in 
a single muscle, indicating that cramp spreads through neighbouring groups of muscle 
fibres.7 A recently developed surface EMG technique, with multiple surface EMG 
electrodes in a single grid, named high-density surface EMG technique (HD-sEMG), 
allows simultaneous recordings from various locations across a muscle, providing both 
temporal and spatial information about motor unit activity.1, 15
Muscle spasms are ill-defined. They form part of a spastic syndrome that also includes 
exaggerated tendon reflexes and muscle tone.13 Zijdewind and Thomas showed that 
motor unit firing rates of the thenar muscles that have been weakened in patients with 
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chronic spinal cord injury were low during both submaximal and maximal voluntary 
contractions.14 During spasms in patients with chronic cervical spinal cord injury, 
motor unit firing rates either increased and then decreased with the spasm intensity 
or were relatively constant. Mean peak spasm firing rates were 18 ± 9 Hz (mean ± SD) 
for the rate-modulated units and 11 ± 10 Hz for units with little or no rate modulation.12 
Because muscle spasms are typically not limited to a single muscle, we also recorded 
polymyographic EMG patterns in various muscles simultaneously with conventional 
sEMG techniques.
Here, we report a child with Satoyoshi syndrome in which HD-sEMG and polymyographic 
sEMG, were performed to gain a better understanding of the pathophysiology of the 
involuntary muscle contractions in Satoyoshi syndrome. 
Case Report
A 6-year-old girl of Turkish origin suffered from exercise-induced, progressive painful 
muscle contractions and thinning hair. Apart from abnormal muscle contractions and a 
short stature (body length below 3 SD), general and neurological examination revealed 
no abnormalities. Laboratory examination revealed a serum creatine kinase of 296 
U/l (normal value < 200 U/L), the presence of anti-nuclear antibodies and a transient 
anaemia. Endocrine investigation (thyroid gland, pituitary function, urine steroid 
profile, serum, and urine glucose) was unremarkable. Radiological investigations 
showed no skeletal deformities. Quadriceps muscle biopsy was normal, as were 
immunohistochemistry (phosphorylase, phosphofructokinase) and mitochondrial 
respiratory chain enzyme activities. Hair root analysis showed a high percentage of 
catagen follicles. Standard nerve conduction and needle EMG (not during involuntary 
contractions) showed normal values. Satoyoshi syndrome was diagnosed, and therapy 
was started with prednisone, 1 mg/kg/day for three months. The painful muscle 
contractions completely disappeared during therapy. Hair growth was not restored. 
Surface EMG methods
EMG measurements were performed on the child’s leg, where the involuntary muscle 
contractions were most pronounced. First, HD-sEMG recordings of the left vastus 
lateralis muscle were recorded during maximal voluntary contraction and during the 
140 Chapter 7  Involuntary painful muscle contractions in Satoyoshi syndrome: A surface electromyographic study 141
painful muscle contractions. HD-sEMG allows multichannel recordings of a single 
muscle and is a non-invasive tool to record the distributions of muscle activation over 
a larger area (6 x 4.5 cm) of a muscle.1, 2, 15 The electrode grid used consisted of 130 gold-
coated (13 x 10) electrodes with an interelectrode distance of 5 mm in both directions. 
The electrode grid was carefully placed over the vastus lateralis muscle with its columns 
of 13 electrodes parallel to the muscle fibres. All signals were amplified, band-pass 
filtered, and simultaneously AD converted (at 2000 samples/s) with a multichannel 
amplifier system.1, 2 The signals were analyzed off-line and displayed in a bipolar 
montage for visual analysis.
In addition, muscle activity of different muscles was recorded simultaneously with bipolar 
polymyographic surface EMG recordings on different muscles of both legs, using Ag/AgCl 
electrode pairs at a 3-cm interelectrode distance. On both legs, the quadriceps muscles, 
the tibialis anterior muscles and the gastrocnemius muscles were investigated.
Results
HD-sEMG recordings of the left vastus lateralis muscle during maximum voluntary 
contractions and during painful involuntary muscle contractions are shown in Figures 
1A and 1B, respectively. During maximal voluntary contractions, the HD-sEMG recording 
showed a normal interference pattern with motor unit action potential amplitudes of 
approximately 50 µV. During the involuntary contractions, bipolar HD-sEMG recordings 
showed a regular pattern, most probably of synchronized motor unit firings with a 
frequency of 40 to 50 Hz, resulting in much higher amplitudes (over 200 µV) than in the 
maximal voluntary contractions. We observed that these high-amplitude EMG signals 
were present with rather constant amplitudes over a substantial part of the vastus 
lateralis muscle. It is important to note that there were no signs of slow spread of local 
EMG activity in the muscle as found with multichannel EMG in muscle cramps.7
Conventional polymyographic sEMG recordings showed simultaneous activity both of 
various muscles of the same leg, and of muscles of both legs during the involuntary 
contractions (Fig. 1C and D, respectively). In the course of the involuntary contractions, 
there was a switch over of EMG activity from one muscle to another, with a ‘waxing and 
waning’ character (Fig. 1C). 
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Figure 1. High-density surface EMG recordings of the left vastus lateralis muscle (A and B) of the 
Satoyoshi patient. One column of the grid (12 bipolar montages from 13 monopolar electrodes in 
a grid column positioned in fibre direction) with the clearest presentation of the phenomenon 
of muscle-wide synchronous oscillatory activity (part B) is displayed. The x-axes indicate time in 
seconds, and the y-axes indicate 12 bipolar recordings derived from 13 electrodes. (A) HD-sEMG 
during maximal voluntary contraction. The sEMG shows a normal motor unit interference pattern. 
(B) Recording from the same area during painful contraction shows widely spread rhythmic 
EMG activity with a much higher amplitude (note the different gain settings) and an oscillatory 
frequency of approximately 45 Hz. Figure C and D show conventional bipolar polymyographic 
sEMG recordings of three different muscles of both legs: the first three traces of the right 
leg and the lower three traces of the left leg. C and D are recordings during the involuntary 
contractions of the Satoyoshi patient at different time points. The polymyographic recordings 
show simultaneous EMG activity in both right and left quadriceps muscles (C), and in different 
muscles (right quadriceps muscle and right tibialis anterior muscle) of the same leg (D).
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Discussion
The EMG findings of this study strongly support the concept that the involuntary 
muscle contractions in Satoyoshi syndrome do not fit into the dichotomy between 
muscle cramps and spasms in a ‘classic sense’. We will give reasons why another 
mechanism seems likely. 
There are several arguments against the mass activity found in this patient being a 
muscle cramp. First, our HD-sEMG recording during the involuntary contractions showed 
an over fourfold increase in amplitudes of the EMG activity compared to the amplitudes 
recorded during maximal voluntary contraction and a regular firing frequency of 40 to 
50 Hz. The synchronous regular firings and the high amplitude during the involuntary 
contractions suggest strictly synchronous repetitive active motor unit discharges, 
which have not been found in cramps.7, 8 Second, the motor unit action potentials in the 
vastus lateralis muscle during the involuntary contractions were present in a large part 
of the muscle, which is in contrast to what has been found in muscle cramps, in which 
only a (slowly shifting) fraction of the muscle is involved.7 Third, the discharge frequency 
of the EMG activity during the involuntary contractions was 40 to 50 Hz. Discharge 
rates in cramps are typically around 150 Hz.5 Last but not least, our polymyographic 
recordings showed that massive electric muscle activity was not limited to one muscle. 
It extended over different leg muscles, even more or less simultaneously in both legs. 
The latter directed us to consider this mass activity as muscle spasms.
As already stated, spasms are ill defined.13 That there were no clinical signs of pyramidal 
tract lesion provides an important argument that the involuntary painful contractions 
in this patient are not ‘conventional’ spasms. In healthy subjects, motor units usually 
fire at 6 to 10 Hz when first recruited and at 15 to 60 Hz during maximal voluntary 
contractions.6 Thomas and Ross showed with needle EMG studies of motor unit activity 
in patients after spinal cord injury that, during spasms, the motor unit firing frequencies 
show mean peak firing rates of 18 ± 9 Hz.12 Rate coding for many motor units appears 
to be similar whether descending motor input is intact or whether it has been reduced 
severely by spinal cord injury.
In 1978, Satoyoshi already described that, during the involuntary contractions in his 
patients, needle EMG recordings revealed synchronized motor unit discharges of 
40 to 50 Hz and of 4 to 10 mV amplitude. He suggested that abnormal discharge 
of anterior horn cells is responsible for the mass activity.11 The HD-sEMG recordings 
showed a stable spatial extension of such synchronized activity throughout the vastus 
lateralis muscle during the contractions. This finding supports and provides additional 
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arguments for this hypothesis of massive hyperactivity or desinhibition at the alpha-
motorneuron level.
In conclusion, although a more proximal origin cannot be excluded, the surface EMG 
findings strongly suggest a deregulation at the alpha-motorneuron level leading to 
involuntary muscle contractions in Satoyoshi syndrome. 
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Satoyoshi syndrome is a childhood-onset multisystem disorder characterized by 
intermittent painful muscle spasms, malabsorption, and alopecia. It has a progressive 
course with an unknown cause, although, mainly because its association with other 
autoimmune conditions, an autoimmune basis is thought to be likely.5 Here, we report 
the novel finding of antibodies against glutamic acid decarboxylase (GAD) in the serum 
of a child with Satoyoshi syndrome, confirming the autoimmune origin of the disease. 
A 6-year-old Turkish girl suffered from progressive painful, mainly exercise-induced, 
muscle contractions and thinning hair, resulting in occipital alopecia. General and 
neurological examination showed no other abnormalities. Laboratory investigations 
showed a serum creatine kinase level of 296 U/l (reference value < 200 U/l), the 
presence of antinuclear antibodies, and a transient anaemia. Endocrine investigation 
(thyroid gland, pituitary function, urine steroid profile, serum and urine glucose) and 
quadriceps muscle biopsy were normal. During muscle spasms, electromyography 
(EMG) with surface electrodes showed highly synchronized motor unit discharges. Hair 
root analysis showed a high percentage of catagen follicles. A diagnosis of Satoyoshi 
syndrome was made, and therapy was started with prednisone, 1 mg/kg/day for 3 
months. Muscle spasms completely disappeared during therapy. 
The abnormal surface EMG findings, and the spasms triggered by voluntary 
contractions in our patient, suggested abnormal excitability of the motor neuron 
pool. Such abnormalities in spinal inhibitory interneuronal circuits are also suggested 
to be the underlying cause in another rare autoimmune disorder, the stiff-person 
syndrome. Symptoms in stiff person syndrome are muscle rigidity and episodic spasms 
involving the axial and limb musculature. Various patterns presentation1 and alopecia4 
have been described in stiff-person syndrome. Sixty five percent of patients with stiff 
person syndrome may have GAD antibodies.3 We therefore decided to check for GAD 
antibodies in serum of our patient, which indeed were present: 1, 3 U/ml (reference 
value < 0.9 U/ml). Low values of anti-GAD antibodies also can be found in patients with 
type I diabetes or in prediabetic patients, however, our patient had normal glucose 
tolerance tests. The different clinical expression of the spinal hyperexcitability in 
Satoyoshi syndrome and stiff-person syndrome could be explained by age-dependent 
differences in maturation of inhibitory circuits.
In conclusion, the finding of GAD antibodies in Satoyoshi syndrome supports the 
presumed autoimmune origin of the disease. Furthermore, this finding shows that 
Satoyoshi syndrome in childhood can be a variant of stiff-person syndrome. We suggest 
that GAD antibodies should be determined in all patients with Satoyoshi syndrome, 
especially because stiff-person syndrome is potentially treatable.2
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Summary
The purpose of this study was to identify optimal ways to detect neurogenic changes 
with high-density surface electromyography (HD-sEMG). For this purpose, we searched 
for the variables that most clearly discriminated between postpoliomyelitis and healthy 
subjects. We obtained HD-sEMG from the quadriceps muscle at different force levels in 
nine subjects with postpoliomyelitis syndrome and in matched healthy controls. Single 
motor unit action potentials (MUAPs), extracted from the HD-sEMG signal and the raw 
signal itself, were analyzed. Areas under the curve of the extracted MUAP waveform, 
indicating motor unit size, perfectly separated both groups. Raw signal analysis showed 
significant differences between groups for the monopolarly recorded amplitude up to 
60% of maximal force and for the level of interference at higher force levels (40 - 100% 
force). We conclude that with HD-sEMG it is possible to detect neurogenic motor 
unit changes noninvasively, both by analysis of the raw signal itself and by analysis of 
extracted single MUAPs. The diagnostic yield of the single MUAP analysis is clearly 
higher. These findings point toward applications for clinical practice and invite further 
studies exploring the diagnostic value of HD-sEMG.
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Introduction
Surface electromyography (sEMG) is still not widely used in the clinical evaluation 
of neuromuscular disorders. Nevertheless, its non-invasiveness is less stressful for 
patients than needle EMG, and a multi-electrode arrangement (high-density surface 
EMG, HD-sEMG) allows investigation of different muscle regions simultaneously.22 
Conventional needle EMG variables such as potential amplitude, duration, area, 
shape, and interference pattern are used to determine whether there is neurogenic 
or myogenic disease.20 Another established electrophysiological method to assess the 
magnitude of anterior horn cell degeneration and compensatory mechanisms is macro 
EMG. Previous studies showed that macro EMG better reflects motor unit (MU) size 
than concentric-needle EMG,17 and, with respect to estimation of MU size, the macro 
EMG technique can be considered a gold standard.19 Comparison of macro EMG with 
multi-electrode sEMG showed that the two techniques have similar results with respect 
to motor unit action potential (MUAP) parameters16 and can therefore be considered 
essentially as equivalent in the detection of enlarged MUs.15
The purpose of the present study was to investigate the possibility of detecting 
neurogenic changes with HD-sEMG. Patients with prior poliomyelitis are suitable to 
investigate the effects of neurogenic MU changes with the HD-sEMG signal, because 
they are known to have markedly enlarged MUs. During recovery after paralytic 
poliomyelitis, large MUs are formed through collateral reinnervation of denervated 
muscle fibres by axonal sprouting of surviving alpha motor neurons. Decades after the 
acute phase, new symptoms may occur (postpoliomyelitis syndrome; PPS).4, 9 
We analyzed both the characteristics of averaged extracted single MUAPs, and the 
signal characteristics obtained from the raw HD-sEMG signal itself.
Subjects and methods
Patients and healthy subjects
We have studied nine ambulatory subjects with PPS, diagnosed according to the criteria 
of Halstead.9 The subjects were part of a larger group of patients who participated in an 
interventional study with pyridostigmine11 and were selected from that group as the 
closest match in age and gender to a group of nine healthy controls. The mean age of 
both the PPS subjects and the healthy controls was 54 years (range, 37 - 68 years and 
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38 - 68 years, respectively). In each group, there were five women. We applied HD-
sEMG on the quadriceps muscle (vastus lateralis), a functionally important muscle 
for locomotion. The most symptomatic limb was investigated. All subjects gave their 
informed consent, and our local Ethics Committee approved the study. 
Recording of force and HD-sEMG
Subjects were seated with hip and knee flexed to 90° on a quadriceps dynamometer. 
Force was recorded isometrically and was fed back visually to the subject on a computer 
monitor. 
Measurements with HD-sEMG were performed with a two-dimensional electrode 
grid.10 The gold-coated electrodes are 1.5 mm in diameter and arranged in a 10 x 13 
rectangular matrix with an interelectrode distance of 5 mm in both directions. Signals 
were recorded monopolarly with a reference electrode on the patella. The electrode 
grid was carefully placed over the vastus lateralis muscle with the 10 columns of 13 
electrodes parallel to the muscle fibres. A total of 126 (the four corner electrodes were 
not connected) monopolar signals were amplified, bandpass filtered (3-400 Hz) and 
AD-converted (16 bits with a resolution of 0.5 µV/bit at a rate of 2000 Hz/channel) using 
a multichannel amplifier system. Data were stored in a computer for offline analysis. A 
software high-pass filter (Butterworth fourth order, 15 Hz) was applied. The signals of 
any of the columns could be selected for online visualization, both in monopolar and 
higher order (e.g., bipolar, double differential) montages. Force data and HD-sEMG data 
were synchronized using a common time code.5
Experimental protocol
The patients’ and subjects’ maximal voluntary contractions (MVC) were recorded as the 
peak force of three short performances with at least 1-minute intervals. Next, isometric 
contractions were performed at force levels between 5 and 20% MVC in which single 
MUAPs could be clearly discerned in the HD-sEMG pattern. Three such measurements 
were performed. Next, different fixed percentages of the MVC were taken: 5%, 20%, 
40%, 60%, and 100% MVC, each of which was sustained by the subjects for 30 s. After 
the 5% and 20% MVC measurement, a 3-minute rest period was mandatory; after the 
other measurements, subjects had a 10-minute rest. 
Mean averaged MUAPs and MU size estimation
The measurements were analyzed offline. Extraction of single averaged MUAPs was 
done according to the method of Kleine and coworkers.13 Because of occasionally 
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occurring electrode contact problems at grid corners, the most distal and the most 
proximal electrode rows were disregarded in this analysis. Extraction of single MUAPs 
was possible from the HD-sEMG only at force levels between 5% and 20% MVC, as 
interference of MUAPs at higher force levels confounded single MUAP extraction. An 
example of an averaged extracted MUAP in both a PPS subject and a healthy control is 
shown in Figure 1. 
Figure 1. Monopolar templates of averaged single MUs, as analyzed from the lateral vastus 
HD-sEMG pattern. (A) The template of a healthy subject, and (B) the template of a PPS subject. 
The templates result from averaging the HD-sEMG interference pattern over all detected firing 
instances. Note the different calibration of the y-axis. The duration of each signal is 50 ms.
The averaged MUAP with the highest area under the curve (AUC) and the highest 
peak-to-peak amplitude was used to estimate the MU size. The AUC was determined 
over a period of 50 ms. Besides AUC and peak-to-peak amplitude, we also analyzed 
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the median muscle fibre conduction velocity (MFCV) and the median frequency of the 
power spectral content of these averaged extracted MUAPs. The MFCV was estimated 
between every consecutive bipolar signal in fibre direction using the phase difference 
method described previously.12 Cross-correlation values between signals lower than 0.7 
and MFCV values above 8 m/s were not accepted. For each subject, the mean value 
for each variable was calculated from all extracted MUAPs. These values were used for 
further analysis.
Raw HD-sEMG pattern analysis
Analysis of HD-sEMG variables was performed in one of the columns of the grid, parallel 
to the muscle fibres. The column with the highest mean signal amplitude (based on the 
root mean squared amplitude, RMS) was selected. Typical examples of such a column of 
HD-sEMG data of a control subject and of a PPS subject are given in Figures 2A and 2B. 
The first 2 seconds of the signal in which the subject maintained a stable force was taken 
for further analysis. To select these segments, the 2-second segment with the smallest 
standard deviation (SD) of force after start was taken, using an algorithm in which an early 
segment was a priori preferred by progressively penalizing the choices of later segments. 
The variables of choice were calculated for all the channels in the target column, excluding 
the leads in which the motor endplate zone was automatically detected. 
We analyzed RMS amplitude and median frequency from monopolar and bipolar 
signal montages and MFCV from bipolar montage, from the raw HD-sEMG signal. 
The increase of MFCV with force increase was tested with linear regression analysis 
using 95% confidence intervals. To assess the interference of MUs in the HD-sEMG 
pattern, a new variable was introduced for the signals in bipolar montage: the ‘level of 
interference’ (LOI). First, all turns in the bipolar signals were detected. A signal segment 
was considered relevant when the absolute difference between two successive turns 
was higher than 30 µV; otherwise, the turn was considered to be noise-related. This 30 
µV level is a threshold based on noise level (determined from measurements at rest) in 
relation to the average amplitude of motor unit activity. Segment amplitude between 
two successive turns was expressed as a fraction of the upper 90th percentile of the 
amplitude distribution of all segments. If the voltage slope (dV/dt) of the segment was 
higher than an experimentally determined threshold, it was considered to be part of the 
electrophysiological activity. LOI is defined as the percentage of total time consisting 
of such segments. This variable is closely related to the so-called turns-and-amplitude 
analysis.6
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Figure 2. Examples of bipolar HD-sEMG patterns in a control subject (A) and in a PPS subject (B). 
The y-axes denote 12 bipolar traces from 13 monopolar electrodes of the selected column of the 
grid. Top panels show the HD-sEMG data of one column parallel to the muscle fibres at 5% MVC. 
Middle and lower panels show HD-sEMG data at, respectively, 60% and 100% MVC. These figures 
show the characteristic differences between control subjects and PPS subjects. 
Statistical analysis
For each group the means and SDs of all the single MUAP variables and the raw HD-
sEMG variables were determined for each subject. A two-tailed unpaired t-test was used 
to determine whether the means were significantly different between PPS subjects 
and control subjects. Statistical significance was defined as P < 0.05. For each subject, 
Pearson’s correlations between the extracted MUAP variables and the raw HD-sEMG 
signal characteristics were determined.
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Results
Force
The mean maximal voluntary force was 409 N (± 160 N) in PPS subjects and 465 N (± 130 
N) in healthy controls; this difference was not significant. 
Mean averaged MUAPs and MU size estimation
The number of averaged MUAPs that could be extracted varied between subjects but 
was not significantly different between PPS subjects and controls. The mean number of 
MUs determined in patients was 9.6 (± 6.8) and in healthy subjects 9.7 (± 7.8). The mean 
value of the median frequency of the power spectrum of MUAP wave shapes was not 
different (P = 0.540) between PPS subjects (50.38 Hz ± 7.40) and healthy subjects (52.24 
Hz ± 4.96). The mean MFCV of the averaged MUAPs in PPS subjects was not different 
from healthy subjects (P = 0.970). In patients the MFCV was 4.49 ± 0.92 m/s and in 
healthy subjects it was 4.50 ± 0.54 m/s. 
The average of the mean MUAP AUC of all PPS subjects was 4.60 ± 1.84 mV.ms (Fig. 
3). In healthy subjects this value was significantly less at 1.37 ± 0.53 mV.ms (P = 0.0001). 
The highest mean AUC of the healthy subjects was smaller than the lowest value in the 
PPS subjects (2.11 vs. 2.23 mV.ms), resulting in a complete discrimination between both 
groups. The mean peak-to-peak amplitude was 0.68 ± 0.31 mV in PPS subjects and 0.18 
± 0.08 mV in healthy subjects. Although this was significantly different between the 
groups (p=0.0002), it was not fully discriminating. 
Figure 3. Mean areas of extracted MUAPs reflecting the electrical motor unit size in healthy 
subjects () and in PPS subjects (); one symbol per subject. Statistical analysis showed a 
significantly higher mean of the AUC in PPS subjects (P = 0.0001). 
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Raw HD-sEMG pattern analysis
The monopolar RMS amplitude was significantly higher in PPS subjects at all force 
levels except at a 100% MVC (Fig. 4A). The bipolar RMS amplitude was significantly 
higher in PPS subjects at 5% MVC (P = 0.02), but there was no significant difference at 
any of the higher force levels (Fig. 4B). The MFCV and median frequency of the signals 
in monopolar and bipolar montages were calculated at all force levels and showed no 
significant differences between PPS and control subjects (Figs. 4C and D). 
In both groups, MFCV increased with higher force levels. This increase was significant 
(P = 0.01) in PPS subjects but not in control subjects (P = 0.06). Mean LOI did not 
significantly differ between PPS and control subjects at lower force levels (Fig. 4E). 
However, from 40% MVC to 100% MVC, the mean LOI was significantly lower in PPS 
than healthy subjects (Fig. 4E).
Correlations of extracted MUAP variables and raw pattern analysis
The MUAP variable AUC was significantly correlated with the monopolar RMS 
amplitude of the raw HD-sEMG signal at 5% MVC, 40% MVC, and 60% MVC. At 20% 
MVC and during 100% MVC this correlation was not significant (P = 0.07 and P = 0.14 
respectively). No significant correlations were found between extracted single MUAP 
variables and the other raw HD-sEMG variables. 
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Figure 4. Variables of the raw HD-sEMG of PPS subjects (black bars ± 1 SD) 
and healthy subjects (white bars ± 1 SD) are shown. * Significance level: P < 0.05. 
(A) Mean monopolar RMS of PPS subjects and healthy subjects. At all force levels the mean 
RMS was higher in PPS subjects. Only at maximal voluntary contraction this difference was 
not significant. (B) Mean bipolar RMS in PPS subjects and control subjects. Only at 5% MVC 
the difference between groups is significantly different. (C) MFCV and (D) monopolar median 
frequency was not significantly different between groups at any force level. (E) The level of 
interference (LOI) was lower in PPS subjects at 40% MVC and higher force levels.
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Discussion
We showed that with HD-sEMG it is possible to differentiate completely between PPS 
and healthy control subjects by analysis of MU size. This supports our premise that HD-
sEMG can be an informative tool in evaluating neurogenic MU changes. In the diagnosis 
of neurogenic disorders, MU size information is particularly useful. The size of the 
averaged MUAPs correlates well with macro EMG findings.16, 21 With its large recording 
area, macro EMG provides information of the entire cross-sectional area of the MU 
within the muscle, whereas other needle EMG methods record only from a portion of 
the MU.18 According to a model study simulating macro EMG, an increased MU size 
affects the peak-to-peak amplitude and area in a similar fashion.14 
Because not only MU size but also factors such as MU recruitment and firing behaviour 
are responsible for EMG characteristics, we also examined the characteristics of the raw 
HD-sEMG signal itself. Recruitment and firing behaviour also contain information about 
neurogenic changes, but these changes may interfere with, or even confound, MU size 
information. Indeed, the monopolar RMS amplitude of the raw EMG signal and the LOI 
differed significantly between PPS and control subjects. Amplitude differences were 
not observed above 60% MVC, whereas the LOI became significantly different between 
groups at the higher force levels. At maximum voluntary contraction, the difference 
between PPS and control subjects in monopolar RMS amplitude lost significance. There 
are two complementary explanations for this. First, in healthy subjects, according to 
Henneman’s size principle, larger high-threshold MUs also become activated, leading to 
higher values in controls. Second, PPS subjects have fewer MUs, which prevents further 
increase of the amplitude with increasing force. 
However, the differentiation between groups with either variable was less obvious than 
with MU size variables. This indicates that MU size is the most prominent abnormality 
in PPS subjects. No significant differences were found in the maximal force levels 
between PPS and control subjects. Reinnervation still seems to be effective even in this 
group with PPS symptoms.
More items specific to the technique have to be addressed. In the mean value of MUAP 
sizes for each person, only the MUs recruited at low force-levels are represented. This 
disadvantage is hard to circumvent and is present in virtually all (including needle) EMG 
techniques addressing single-MUAP analysis. To obtain a mean MU size for one subject, 
all detected MUAPs of that subject were included. If, as expected, an MU is active at 
more than one force level, this MU is likely to be detected more than once. Because 
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PPS subjects have fewer MUs than healthy subjects, the risk of determining the same 
MU more than once may be higher in PPS subjects. However, in isometric contractions 
of healthy subjects, the order in which the MUs are recruited is more or less constant 
according to Henneman’s size principle,10 also leading to repeated detection of MUAPs. 
Therefore, we do not expect these repetitive detections to be a confounding factor in 
terms of distinguishing control and PPS MU populations.
A principal disadvantage of sEMG and EMG in general is that the amplitude measured 
depends on the distance between the active MU and the electrode. Because we used 
HD-sEMG, which covered about 27 cm2, for most detected MUs we were able to select 
the largest MUAP amplitudes from electrode positions directly above the centre of the 
MU, expecting to give the best representation of the actual electrical MU size. In some 
cases, the maximal MUAP amplitude was located just on the edge row of the grid. The 
true maximum was then probably off the grid. In such cases we used the highest recorded 
value. This could have led to an underestimation of the mean MU size. Differences in 
the thickness of the subcutaneous fat layer, or the average distance between MUs and 
the skin surface in general, also might have influenced detected HD-sEMG amplitude 
differences. Although information about MU depth is, in principle, provided by the 
spatial distribution of the HD-sEMG signals,16 we did not compensate for MU depth. 
First, because MUs are extracted on the basis of the signal in a bipolar montage with 
a small interelectrode distance (5mm), only MUs with superficial fibres will show up in 
this montage, automatically selecting the most superficial MUs. Second, the influence 
of MU depth when comparing men and women (knowing that the subcutaneous layer 
for women is almost twice as thick in the region studied) appeared to be insignificant 
(unpublished data). 
 The RMS amplitude differences between the groups were mainly significant in the 
monopolarly recorded data (Figs. 4A and 4B). In general, monopolar EMG characteristics 
proved to be more suitable to detect neurogenic changes in HD-sEMG than variables in 
a bipolar recording. For the same reason, macro EMG uses a monopolar leadoff scheme 
and we also estimated MU size from the monopolar data. 
The LOI, a variable representing the density of the (bipolar) interference pattern, was 
significantly different in PPS than control subjects, especially at higher force levels. 
Normally, muscle force is increased by frequency modulation and recruitment of 
additional MUs. Therefore, the density of the EMG interference pattern is higher at 
higher force levels. The lower LOI in PPS subjects also reflects the fact that these subjects 
have fewer MUs available, which becomes especially evident at higher force levels, and 
leads to the poorer interference pattern. This is a common finding in concentric needle 
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EMG studies in these subjects as well.7, 8 The other frequently used variables in sEMG, 
the MFCV and the median frequency, showed no obvious differences between PPS 
subjects and controls. MFCV abnormalities are often correlated to fibre diameter.1 
Biopsies in patients with prior poliomyelitis have shown a spectrum of morphological 
changes. Besides hypertrophic fibres, Dalakas also found atrophic fibres in patients 
with symptoms of PPS.3 As a result, the mean muscle fibre diameter may be within 
the normal range (consisting of both hypertrophic and atrophic fibres), explaining an 
average MFCV within normal limits. The same reasoning also applies to the median 
frequency of the MUAPs, which is known to be strongly related to the MFCV value.
In a clinical setting the non-invasive character of HD-sEMG has considerable 
advantages over needle EMG. Because sEMG causes less pain and stress, the (near-) 
maximal contractions required to assess a muscle’s pattern of MU recruitment are 
easier to attain. Furthermore, HD-sEMG is relatively easy to apply. We conclude that 
with HD-sEMG it is possible to detect neurogenic MU changes both by analysis of the 
raw HD-sEMG signal itself and by analysis of extracted single MUAPs. Although time-
consuming, the diagnostic yield of the latter is clearly superior. 
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Summary
High density-surface EMG (HD-sEMG) is a non-invasive technique to measure electrical 
muscle activity with multiple (more than two) closely spaced electrodes overlying a 
restricted area of the skin. Besides temporal activity HD-sEMG also allows spatial 
EMG activity to be recorded, thus expanding the possibilities to detect new muscle 
characteristics. Especially muscle fibre conduction velocity (MFCV) measurements 
and the evaluation of single motor unit (MU) characteristics come into view. This 
systematic review of the literature evaluates the clinical applications of HD-sEMG. 
Although beyond the scope of the present review, the search yielded a large number of 
‘non-clinical’ papers demonstrating that a considerable amount of work has been done 
and that significant technical progress has been made concerning the feasibility and 
optimization of HD-sEMG techniques. Twenty-nine clinical studies and four reviews 
of clinical applications of HD-sEMG were considered. The clinical studies concerned 
muscle fatigue, motor neuron diseases (MND), neuropathies, myopathies (mainly in 
patients with channelopathies), spontaneous muscle activity and MU firing rates. 
In principle, HD-sEMG allows pathological changes at the MU level to be detected, 
especially changes in neurogenic disorders and channelopathies. We additionally 
discuss several bioengineering aspects and future clinical applications of the technique 
and provide recommendations for further development and implementation of HD-
sEMG as a clinical diagnostic tool.
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1.  Introduction
Surface EMG (sEMG) is a non-invasive technique to measure muscle activity where 
surface electrodes are placed on the skin overlying a muscle or group of muscles.73 In the 
context of routine motor-nerve conduction studies in clinical neurophysiology, the use of 
surface electrodes is widely used to record compound muscle action potentials. Outside 
electrodiagnostic medicine, in rehabilitation research, sport sciences, kinesiology and 
ergonomics,75 sEMG is used to record on-off switching of muscles and to estimate 
muscle force during voluntary dynamic contractions. Clinical neurophysiology uses 
EMG recordings during voluntary activity as a diagnostic tool especially in patients with 
neuromuscular disorders. Intramuscular needle EMG electrodes are predominantly 
used to evaluate motor unit (MU) function but since it is a painful procedure, sEMG 
constitutes a good alternative, particularly in the examination of children. 
1.1.  Clinical application: EMG as a diagnostic tool
In clinical practice, needle EMG evaluation, in combination with nerve conduction studies, 
is the standard method for assessing neurophysiological characteristics of neuromuscular 
diseases. Although considerable effort has been made to quantify needle EMG, most 
clinical neurophysiologists continue to base their diagnoses on subjective assessments 
of motor unit action potentials (MUAPs) by visual inspection of the on-screen signals 
and auditory evaluation of the discharging units. In contrast, sEMG can hardly be judged 
without proper data quantification, especially when simultaneous recordings from 
multiple electrodes need to be interpreted, which is the subject of this review. To facilitate 
the assessment of such large volumes of data, information needs to be compressed. 
Another difference between the two techniques is their scope (see Fig. 1). Insertional 
activity, for instance, cannot be evaluated with sEMG because of the absence of 
needle insertions.  Also spontaneous activity occurring at the single fibre level, such as 
fibrillations, positive spikes and myotonia, is too small to be recorded via the skin’s surface. 
Where in principle the two techniques meet is in the information at MU level. Single 
MU information can be recorded rather easily with needle EMG. Because the distance 
between the active muscle fibres and the needle electrode is small, and force levels are 
moderate, MUAPs can be recorded fairly selectively with needle electrodes. Conversely, 
conventional sEMG techniques comprising a single bipolar signal from two electrodes 
placed on one muscle do not allow a non-ambiguous extraction of single MU information, 
which is why the technique is of little or no use for clinical neurophysiological purposes. 
Two reports that assessed the clinical utility of conventional sEMG as a tool in the 
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diagnosis and treatment of neuromuscular diseases.69, 128  Both concluded that sEMG was 
unacceptable as a tool in clinical diagnosis. However, since their publication important 
technical advances have been made in sEMG recording techniques.
1.2.  Introduction of a new sEMG technique: high-density surface EMG
The development of sEMG equipment that records the input of multiple electrodes 
placed on one muscle has increased the possibility of detecting single MU 
characteristics.7, 109, 154 
The complex nature of this new multi-channel sEMG signal, to be henceforth 
referred to as ‘high-density surface EMG’ or HD-sEMG, places high demands on the 
instrumentation and signal analyses.7, 8, 41, 93 New spatiotemporal features at MU level 
have been introduced.26, 86, 130, 154, 171 Despite the technical possibility to obtain single MU 
information from sEMG, to date HD-sEMG has not yet been widely used as diagnostic 
tools in the clinical neurophysiological practice. 
Figure 1. The scope of the various EMG techniques. Conventional bipolar sEMG, with one bipolar 
electrode pair over each muscle, is mainly used in movement studies. It yields concurrent information 
of muscle activity in different muscles. With the development of HD-sEMG, a technique that used 
multiple electrodes on one muscle, it became possible to also subtract information at the single 
motor unit (MU) level. With HD-sEMG information on muscle-fibre conduction velocity (MFCV) can 
be used to supplement the information at the muscle-fibre level obtained with needle EMG. 
We have conducted the current systematic review to gain a more comprehensive insight 
into the current status of the clinical applications of HD-sEMG. With a proper inventory 
of the studies performed so far we aimed to derive suggestions and recommendations 
for future studies fostering the development of HD-sEMG as a clinical tool.
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Studies using HD-sEMG with either electrode arrays or matrix electrodes are discussed. 
Those that applied HD-sEMG in patients were included as clinical applications. We 
excluded HD-sEMG studies of the lumbar area. Although we by no means consider 
such studies less important and they frequently involve multiple electrodes at the back 
muscles, we deemed them unsuitable for the present review in that they were too far 
removed from routine clinical diagnostics.
2.  Methods
2.1.  Literature searches
The literature search was performed on May 24, 2006 and comprised two databases: 
PubMed and Web of Science. Table 1 lists the search terms used. Only full papers 
were included. Abstracts published as conference or workshop proceedings were not 
considered as the information provided was insufficient to allow in-depth analyses of 
the presented work. Reviews were analyzed separately. We also included two studies 
of clinical applications our group has recently conducted, one of which is in press, the 
other submitted.
2.2.  Classification of the relevant literature
In the PubMed search we confined ourselves to the system’s human studies category. 
Reports from both sources that were based on the data from one bipolar electrode 
pair over each examined muscle were excluded as were animal studies, non-English 
language studies, studies whose main topic was other than sEMG, sEMG studies in 
which activity was not evoked voluntarily (i.e. electrically stimulation), and studies of 
non-skeletal muscles. We classified the relevant literature as follows:
I.  Bioengineering in HD-sEMG, subdivided into (i) improvements or developments at 
an instrumentation level, (ii) physiological modelling of sEMG signals and (iii) signal 
acquisition and analysis procedures.
II. Physiological applications of HD-sEMG.
III. Clinical applications of HD-sEMG, subdivided into (i) fatigue studies in 
neuromuscular disorders and chronic fatigue syndrome (CFS), (ii) motor neuron 
diseases (MND) and neuropathies, (iii) combination studies of MND, neuropathies 
and myopathies (iv) myopathies (including channelopathies), (v) positive muscle 
phenomena and (vi) MU firing rate.
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As explained above, we focused on the clinical applications of HD-sEMG. All reports 
on studies on patients with neurological or neuromuscular diseases and the use of 
sEMG with more than one bipolar electrode pair on a single muscle were considered as 
such. Hence, all studies using a three-electrode linear electrode array up to large two-
dimensional matrixes of electrodes were included. The term neuromuscular disorder 
refers to isolated or associated primary or secondary disorders of the MU. We adopted 
the subdivision of the clinical application studies on the basis of the literature our 
searches yielded. 
Table 1. Overview of the search terms and strategy. 
PubMed:
(surface emg AND (mfcv OR muscle fibre conduction velocity) AND patients) OR (surface emg 
AND clinical applications) OR (channel surface emg AND neuromuscular disorders) OR hsr-
emg OR surface electrode-array EMG OR surface electrode-array electromyogram OR surface 
EMG multi-electrode) OR (multi-channel AND “surface electromyography”) OR multi-channel 
surface emg OR multi-channel semg OR multichannel semg OR multichannel surface emg 
OR (“surface electromyography” AND high-density) OR high-density semg OR high-density 
surface emg OR high density semg OR high-density semg OR high density surface emg OR 
“surface electrode array” OR “surface electrode arrays” OR (surface emg AND muscle cramp)
Web of Science:
multichannel surface-electromyography OR (multi-channel AND surface electromyography) 
OR multi-channel surface emg OR multi-channel semg OR multichannel semg OR multichannel 
surface emg OR (surface electromyography AND high-density) OR high-density semg OR high-
density surface emg OR high density semg OR high density surface emg OR surface electrode 
array OR surface electrode arrays OR surface electrode-array electromyogram OR surface 
electrode-array EMG OR Surface EMG multi-electrode OR MCSEMG OR hsr-emg OR multi-
electrode array emg OR multielectrode emg OR hsr-emg OR multi-electrode array emg OR 
(surface emg AND neuromuscular disorders) OR (surface emg AND clinical applications) OR 
(surface emg AND (mfcv OR muscle fibre conduction velocity) AND patients)
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3. Results
3.1.  Literature reviewed
The PubMed search initially generated a total of 205 articles and the Web of Science 
search 160 references. Eighty-three articles proved to have been mentioned twice. 
We successively excluded meeting abstracts (5), articles that were not in English 
(10), animal studies (6), articles not primarily dealing with surface EMG (21), reports 
on bipolar sEMG (67), studies on evoked MUAPs (4), paraspinal muscles (7) and non-
skeletal muscles (1). After assessing the full text of 160 articles we classified the articles 
(Table 2a). We took the liberty to include two recent articles of our own group one 
of which is in press and the other has recently been submitted, concerning clinical 
applications of HD-sEMG. Table 2b shows the references concerning bioengineering 
and physiological applications of HD-sEMG. Only the 29 articles regarding HD-sEMG 
and clinical applications are discussed. 
Table 2a. Classification of the HD-sEMG studies included for review and the number of reports 
per category. 
HD-sEMG No. of articles (N=162) Reviews
I Bioengineering in HD-sEMG
• Instrumentation level  8  1
 Facial muscles   1
 Anal sphincter muscle  2
• Physiological modelling of sEMG signals  18  2
• Signal acquisition and analysis procedures   48  4
II Physiological applications of HD-sEMG  31  2
 Facial muscles  8
 Anal sphincter muscle  1  2
III Clinical applications of HD-sEMG  29  4
3.2.  Clinical applications of HD-sEMG 
Our search yielded four review articles of clinical applications of HD-sEMG.75, 154, 
170, 171 Zwarts and Stegeman focused on the new possibilities HD-sEMG offers for 
clinical studies. Hogrel published a systematic review of the literature describing the 
application of sEMG within the framework of neuromuscular disorders. 
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Next, we will discuss the various clinical HD-sEMG studies categorized as:
1. Fatigue in neuromuscular disorders and CFS: five studies (Table 3).
2. MND and neuropathies: seven studies (Table 4).
3. Combination studies of MND, neuropathies and myopathies: four studies (Table 5).
4. Myopathies (including channelopathies): eight studies of which six concerned 
channelopathies (Tables 6a and 6b).
5. Positive muscle phenomena: two studies.29, 30
6. MU firing rate: three studies.15, 85, 155
Table 2b. All references concerning bioengineering in HD-sEMG and physiological applications 
of HD-sEMG
I Bioengineering in HD-sEMG
• Instrumentation7, 37, 92, 101, 111, 126, 127, 139, 144, 157, 163 Review109
• Modelling6, 18-20, 22, 38, 41, 50-52, 59, 60, 108, 113-115, 116, 145 Review107, 153
• Signal acquisition and signal analysis5, 8, 12, 14, 21, 23, 34, 36, 39, 40, 42-46, 48, 53, 54, 61, 62, 65-68, 71, 72, 76, 81-83, 87, 88, 
102, 104, 112, 117-119, 122, 124, 125, 133-135, 147, 148, 151, 152 Review1, 24, 49, 130
II Physiological applications of HD-sEMG
2, 13, 16, 35, 47, 55-58, 64, 70, 77, 78, 84, 98-100, 103, 105, 106, 120, 121, 123, 140-142, 146, 149, 150, 137, 169 
Review132, 138
HD-sEMG applied to anal sphincter muscle33 Review3, 32
HD-sEMG applied to facial muscles10, 11, 63, 80, 89, 93, 158, 159
3.2.1  Fatigue in neuromuscular disorders and chronic fatigue syndrome
Five studies examined fatigue (see Table 3 for an overview). The four publications 
by Linssen and his team94-97 all concern fatigue studies into different myopathies. 
Two studies95, 96 describe fatigue at high ischemic levels in congenital myopathy 
characterized by type-I predominance. The patients showed an almost complete lack 
of decline in muscle-fibre conduction velocity (MFCV) during the fatiguing exercise. 
In their 1990 and 1996 studies, Linssen et al. found an unimpaired muscle membrane 
excitability during high-level fatiguing exercises, indicating a dominant role for the 
intramuscular lactic acid formation in the normal decline of muscle fibre conduction 
in healthy subjects. Schillings and colleagues143 compared patients with CFS to healthy 
subjects during maximal voluntary contraction and reported that MFCV declined less in 
the patients and that their peripheral-muscle- fatigue at the end of the contraction was 
less pronounced than it was in the healthy controls. A diminished central activation of 
the muscle was thought to be responsible for this phenomenon.
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Table 3. Overview of the HD-sEMG studies on muscle fatigue in patients with neuromuscular 
disorders and chronic fatigue syndrome (CFS)
Authors
EMG variables
(No. of electrodes) Controls Patients Muscles
Linssen et al (1990) MFCV 26 5 McA BB
Frequency spectra
Amplitude
(5)
Linssen et al (1991) Amplitude 26 3 CCD BB
MFCV 1 NRM
(5)
Linssen et al (1991) Amplitude 6 CCD VM
MFCV 1 NRM
Frequency spectra 1 EM
(5)
Linssen et al (1996) Amplitude 7 3 McA BB
MFCV
Frequency spectra
(5)
Schillings et al (2004) MFCV 14 14 CFS BB
CAF
Abbreviations: MFCV, muscle-fibre conduction velocity; McA, McArdle’s disease; BB, biceps 
brachii muscle; CCD, Central core disease; NRM, nemaline rod myopathy; EM, exertional myalgia 
patient with 80% type-I dominance in muscle biopsy; VM, vastus medialis muscle; CAF, central 
activation failure; CFS, chronic fatigue syndrome 
3.2.2.  MND and neuropathies
Table 4 lists the six HD-sEMG studies of MND and neuropathies.4, 26, 31, 136, 161, 164. The case 
report of Lanzetta et al.,91 who evaluated recovery of a transplanted hand, is not listed in 
Table 4. They recorded HD-sEMG signals with a linear electrode array of 16 electrodes 
and an interelectrode distance of 2.5 mm, from intrinsic muscles of the transplanted 
hand to assess their degree of reinnervation. First signs of reinnervation of single MUs 
were reported as reflected by the voluntary modulation of discharge rates of the MUs 
measured.
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Van der Hoeven et al.161 studied MFCV in patients with amyotrophic lateral sclerosis (ALS) 
and in patients with traumatic lesions of the plexus brachialis using both needle and 
surface EMG. With the needle EMG potentials were evoked with a stimulation needle 
electrode and mean MFCV as well as fastest and slowest MFCV ratios were calculated. For 
the sEMG measurements they used a rigid array with three silver electrodes (diameter 2 
mm) with a common centre electrode and interelectrode distances of 10 mm. The mean 
MFCV and the mean median frequency (Fmed) were calculated from the bipolarly derived 
data at different force levels. The sEMG signals in the ALS patients revealed increased 
MFCV values in combination with a decrease of the Fmed. The authors attributed the 
elevated MFCV to muscle-fibre hypertrophy in the surviving, voluntarily recruited MUs 
and the Fmed decrease to the broadening of MUAP wave shapes. 
Roeleveld et al.136 also compared the results of the two EMG techniques. They obtained 
MUAPs during voluntary contractions of the biceps muscle of patients with enlarged 
MUs resulting from prior poliomyelitis using macroEMG, a needle technique in which a 
substantial part of the electrode shaft is used as a recording electrode, and a HD-sEMG 
technique with 58 electrodes with a diameter of 1.2 mm. Averaged surface MUAPs 
were obtained by needle EMG and sEMG triggered averaging. The MUAPs area and 
peak amplitudes in the HD-sEMG recordings showed similar correlations as found in 
the needle EMG data. HD-sEMG MUAPs obtained both by needle triggering and by 
HD-sEMG triggering were equally sensitive to pathology as the macro MUAPs. The 
most sensitive difference between the polio patients and the healthy controls was the 
final positive peak amplitude. The authors hence suggested to use the late wave as a 
measure of MU size and concluded that sEMG is largely equivalent to macro EMG in 
detecting enlarged MUs. 
In their attempt to detect changes in MU architecture through an increased 
understanding of the volume conductor effect Wood et al.164 utilized simple surface 
waveform variables. A 16 x 2 electrode array (overall dimension 5x 45 mm) with an 
electrode diameter of 1mm was placed transversely to the muscle fibres of the flexor 
digitorum superficialis muscle. To identify repeated firings of single, large amplitude 
MUAPs the authors devised a pattern-recognition algorithm, the resultant spatial 
information facilitating the decomposition process. To estimate the size of a MU, they 
used the transversal width of the potential distribution from that MU to correct for MU 
depth. Using this model the differences in MU size estimate between the patients with 
MND and the healthy subjects became statistically significant. 
El Dassouki and Lefaucheur31 studied the correlation between the MFCV in the thenar 
muscle in patients with moderate carpal tunnel syndrome (CTS). In healthy subjects 
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they established a correlation between MFCV and distal motor latency or mean nerve-
conduction velocity (MNCV) but found no such correlation in patients, due to the nerve 
pathology and normal MFCV values. 
Bahm et al.4 examined 51 children with obstetric brachial plexus lesions with an 
electrode grid with an electrode diameter of 0.5 mm and a small interelectrode distance 
of 2.5 mm. HD-sEMG was recorded from the abductor pollicis brevis muscle, the biceps 
muscle and the infraspinatus muscle of the affected side. Recordings for the abductor 
pollicis brevis muscle were possible for all children but the biceps muscle recordings 
demanded more cooperation of the patients. Although follow-up studies after 
reconstructive surgery were performed for a limited number of patients the authors 
failed to present quantification of variables or group results.
Drost et al.26 studied MU characteristics in nine healthy subjects and nine patients with 
postpoliomyelitis syndrome to look for variables that would most clearly discriminate 
between the two groups. A grid with 126 electrodes with a diameter of 1.5 mm and an 
interelectrode distance of 5 mm was used and both the single MUAPs extracted from 
the HD-sEMG signals and the raw signal itself were analyzed. Force and HD-sEMG were 
recorded simultaneously at different force levels. Extraction of single averaged MUAPs 
was performed in accordance with the method described by Kleine and co-workers 
83 and proved possible at force levels of 5 and 20% of the MVC only. The estimated 
MUAP size, determined as the highest area under the curve of these extracted 
MUAPs, perfectly separated the patients from the controls. Raw signal analysis showed 
significant between-group differences for the monopolarly recorded amplitude at force 
levels up to 60% MVC. At high force levels the level-of-interference (LOI), a variable 
closely related to the so-called turns-and-amplitude analysis in needle EMG, differed 
significantly between patients and healthy controls. 
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Table 4. Overview of HD-sEMG studies in patients with neurogenic disorders
Authors EMG variables Controls Patients  
(No. of electrodes) (Age in yrs) (Age in yrs) Muscles
van der Hoeven et al (1993) MFCV 28 16 PBL BB
Frequency spectra (34-74 y) (16-32 y)
(3) 22 ALS
(33-78 y)
Roeleveld et al (1998) MU size 7 10 PPP BB
(58) (20-36 y) (51-72 y)
Wood et al (2001) MU size 10 12 MND FDS
(16) (30-59 y) (28-75 y)
El Dassouki and Lefaucher MFCV 20 20 CTS APB
(2002) (16) (24-78 y) (30-76 y)
Bahm et al (2003) visual inspection 51 PBL APB
(1.5-16 y) BB
ISM
Drost et al, (2004) Amplitude 9 9 PPS VL
MFCV (38-68 y) (37-68 y)
Frequency spectra
LOI
MU size
(126)
Abbreviations: MFCV, muscle-fibre conduction velocity; BB, biceps brachii muscle; PBL, plexus 
brachialis lesion; ALS, amyotrophic lateral sclerosis; MU size, motor unit size; PPP, prior polio patients; 
MND, motor neuron disease; FDS, flexor digitorum superficialis muscle; PPS, postpoliomyelitis 
syndrome; VL, vastus lateralis muscle; LOI, level of interference (representing the density of the 
interference pattern); APB, abductor pollicis brevis muscle; ISM, infraspinatus muscle.
 3.2.3. Combination studies of MND, neuropathies and myopathies
Four studies examined both patients with myopathic and patients with neurogenic 
disorders (for an overview, see Table 5).79, 90, 129, 166 Kumagai and Yamada studied various 
patient samples with a ‘matrix’ type of surface electrode with a diameter of 5 mm and an 
interelectrode distance of 7 mm. In the normal subjects they found MFCV values in both 
the tibial anterior and the biceps brachii muscles to be higher at moderate contractions 
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than those during weak contractions. No significant changes were found for age or 
sex. Furthermore, MFCV was significantly related to the amplitude of the MUAPs. Both 
groups of researchers concluded that the MFCV cut-off point between healthy subjects 
and patients with myopathy was about 3.0 m/s. The mean MFCV was significantly 
reduced in patients with Duchenne muscular dystrophy (DMD) and patients with 
myotubular myopathy. In the myopathic patients the MFCV in both muscles did not 
increase with muscle force as it did in the healthy subjects. In an asymptomatic DMD 
carrier, the MFCV proved reduced during weak and moderate isometric contractions.
In neurogenic patients the mean MFCV values were within the normal range. In two 
patients with Guillain-Barré syndrome (GBS) high-amplitude potentials are described 
that were similar to those in a patient with spinal muscular atrophy (SMA).90 
Ramaekers et al.129 studied the clinical application of HD-sEMG for the recording of 
single MU activity in children with DMD and SMA whose data were compared with 
those from 63 healthy children ranging from the neonatal period to the age of 24 
years. They concluded that in healthy neonates the MFCV was lowest at 1 - 2 m/s and 
gradually reached a plateau of 2.9 - 4 m/s from the age of 4 years onwards. MUAPs in 
DMD patients had a more blunted waveform and an abnormal pattern with significantly 
lower amplitude MUAPs in 30 of the 31 patients. In 10 SMA patients the sEMG showed 
abnormally high MUAP amplitudes and a reduced recruitment of firing MUs. The MFCV 
remained within the normal range. 
Huppertz et al. retrospectively determined the diagnostic accuracy of the HD-sEMG 
method.79 The best result was achieved by calculating a set of three more advanced 
signal characteristics and MFCV. Using a special evaluation procedure they were able 
to assign the subject to the correct group in about 81% of the cases. The sensitivity for 
the detection of abnormal vs. normal was reported to be 82%, specificity 97%, and PPV 
97%. Myopathic and neuropathic disorders were recognized with a sensitivity of 85% 
and 68%, specificity 97% and 98%, and PPV 92% and 91%, respectively. The authors 
accordingly claimed to have obtained a specificity and sensitivity to distinguish patients 
from controls that was within the same range as the results obtained with needle 
EMG. 
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Tabel 5. Overview of HD-sEMG studies combining patients with neurogenic and patients with 
myopathic disorders.
Authors EMG variables Controls  Patients 
(No. of electrodes) (Age in yrs) (Age in yrs) Muscles
Yamada et al (1991) MFCV 28 2 DMD BB
(6 x 10) (5-40 y) 1 MM TA
1 MD
1 SMA (KW)
2 GBS
(5 -28 y)
Kumagai et al (1991) MFCV 28 4 DMD BB
Amplitude (5-40 y) 1carrier DMD TA
(6 x 10) 1 MD
2 MM
1 SMA (K-W)
(5 -28 y)
Raemackers et al (1993) 7 variables + 63 35 DMD APB
(17 electrodes) (0-25 y) 21 SMA
 2 GBS
(0 -24 y)
Huppertz et al (1997) 9 variables++ 61 35 DMD APB
(32 electrodes) (0-25y)  6 BMD
21 SMA*
10 HMSN
Abbreviations: MFCV, muscle-fibre conduction velocity; DMD, Duchenne muscular dystrophy; MM, 
Myotubular myopathy; MD , Myotonic dystrophy; MD, Myotonic dystrophy; BMD , Becker muscular 
dystrophy; SMA, Spinal muscular atrophy; (KW, Kugelberg-Welander type); GBS, Guillain-Barré 
syndrome; * 1 Werdnig-Hofmann disease, 6 intermediate, 3 SMA type-III, 11 not classified 
+ Raemakers: 1. MFCV in single MUAPs; 2. Signal entropy; 3. First zero crossing of ACF; 4. Dwell-
time over RMS; 5. Chi-value of amplitude distribution; 6. Gradient of peak edge; 7. Peak frequency 
distribution 
++ Huppertz: 1. MFCV of single MUAPs; 2. Signal entropy; 3. Gradient of peak edge; 4. Dwell 
time over RMS, 5. Chi-value of amplitude distribution; 6. Peak/gap energy; 7. Maximum peak 
amplitude; 8. RMS; 9. Autocorrelation function
182 Chapter 10  Clinical applications of high-density surface EMG: A systematic review 183
3.2.4.  Myopathies (including channelopathies)
Eight studies were found using HD-sEMG in patients with myopathies, from which six 
concerned channelopathies (see Tables 6a and 6b, respectively).25, 27, 74, 160, 162, 165, 167, 169 
Hilfiker and Meyer74 reported that MFCV could not be determined in some patients in 
a late stage of progressive muscular dystrophy, as there was no discernible time shift of 
the bipolar potentials. To explain the lack of propagation, they postulated the increased 
longitudinal spread of motor endplates, as can be observed in myopathic muscles. In 
DMD patients, the MFCV could be measured and was significantly reduced, with a mean 
value of 2.81 m/s. Based on the MFCV value each DMD patient could be clearly separated 
from the controls. Yamada et al. also found abnormal propagation patterns of MUAPs in 
de TA muscles of 2 DMD patients.165 In their biceps muscles a decreased mean MFCV to 
2.8 and 3.2 m/s was observed. Most of the HD-sEMG studies were performed in patients 
with channelopathies (as summarized in Table 6b), which are myopathies due to a genetic 
defect in the gene encoding for a voltage-gated channel in the muscle membrane. 
Hypokaliemic periodic paralysis (HOPP): The two studies performed on HOPP patients 
were based on the same extended family.162, 167 Eight of the nine HOPP patients had a 
reduced MFCV (2 SDs lower than controls) compared to their controls.167 The mean 
MFCV of the controls was 4.55 ± 0.33 m/s. In six of the asymptomatic relatives MFCV 
was also reduced. The Fmed of the patients and the relatives with a low MFCV proved 
to be significantly lower than the values of the healthy controls. The MFCV was more 
often abnormal than the Fmed in HOPP patients. Van der Hoeven et al.
162 observed a 
significantly lower mean MFCV in HOPP patients and in asymptomatic carriers, both 
with invasive MFCV measurements and with three surface electrodes. However, only 
the invasive method showed a lower MFCV in all proven carriers. Detecting HOPP 
carriers with the surface MFCV method had a sensitivity of 77%. 
The amplitude of the sEMG signal at maximum voluntary contraction was lower 
in the carrier group. There was a positive correlation between the MFCV and the 
neuromuscular efficiency (the quotient of force and EMG amplitude) in the controls but 
not in the HOPP carriers. Since type-II fibres have a higher neuromuscular efficiency, 
this suggested a preferential involvement of type-II fibres in HOPP. 
Recessive myotonia congenita (RMC): Zwarts and van Weerden169 studied transient 
paresis in myotonic syndromes. EMG was recorded during five maximal 10-s voluntary 
contractions followed by 13-s recovery. In the recessive myotonia congenita patients 
a decline of EMG amplitude was found during an initial loss of force. This transient 
paresis was accompanied by a dramatic fall in the MFCV concomitant with a shift of the 
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power spectrum to lower frequencies. During the decline in force, amplitude and MFCV 
lessened with each successive contraction (warm-up phenomenon). 
Using a 126 HD-sEMG grid Drost et al.25 showed that transient paresis was explained 
by a deteriorating membrane function, ending in conduction block and paresis. During 
the period of force decline in transient paresis, a decrease in amplitude of the MUAPs 
from endplate towards the tendon was observed. The disturbance increased with time 
and place, indicating a deteriorating membrane function, and ended in a complete 
blocking of propagation within seconds. Furthermore, it was shown that transient 
paresis was a force-dependent phenomenon in that at low force levels it remained 
absent in recessive myotonia congenita patients. In a later study Drost et al. tested the 
hypothesis that although muscle-membrane function is already disturbed at low force 
levels, abnormal MU recruitment acts as a compensatory mechanism to obtain normal 
force stability.27 The sEMG abnormalities included disturbed propagation of MUAPs 
over the muscle-fibre membrane and abnormal MU recruitment pointing to central 
adaptation mechanisms. Prolonged periods of low sEMG amplitudes were sometimes 
present despite normal force, indicating that mechanisms other than MU recruitment 
also contribute to force preservation. During the periods of low sEMG, the density of 
myotonic discharges, recorded simultaneously with needle EMG, was not increased. It 
was concluded that abnormal MU recruitment as a compensatory mechanism occurs in 
recessive myotonia congenita, but cannot fully explain constant force. 
Besides transient paresis and constant force, van Beekvelt et al.160 also examined the 
warm-up phenomenon (the diminishing of the initial temporary weakness that occurs in 
RMC patients with repetitive contractions) with HD-sEMG. The underlying hypothesis 
of their study was that the warm-up phenomenon is associated with the exercise-related 
activation of Na+- K+-ATPase. The contraction was preceded by an infusion of the Na+- 
K+-ATPase inhibitor ouabain into the brachial artery of the exercising arm. Transient 
paresis occurred after initiation of exercise, accompanied by electrophysiological 
changes indicating sarcolemmal conduction block. Ouabain infusion did not affect the 
recovery from transient paresis or the electromyographic changes, indicating that the 
warm-up phenomenon in RMC is not mediated by Na+- K+-ATPase. 
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Table 6a. Overview of HD-sEMG studies in myopathies (excluding channelopathies)
Authors EMG variables Controls Patients Muscles
(No. of electrodes) (Age in yrs) (Age in yrs)
Hilfiker and Meyer (1984) Mean MFCV 17 5 PMD (15-46 y) BB
(30) (6-68 y) 5 DMD (6-8 y)
Yamada et al (1987) Mean MFCV 14 2 DMD (7-8 y) BB
Amplitude distribution (4-50 y) TA
(60)
Abbreviations: MFCV, muscle-fibre conduction velocity; BB, Biceps brachii muscle; TA, Tibialis 
anterior muscle; PMD, progressive muscular dystrophy
3.2.5.  Positive muscle phenomena in patients and HD-sEMG
In two studies of our group we examined positive involuntary muscle phenomena, 
fasciculation potentials30 and involuntary contractions in Satoyoshi syndrome.29 
Fasciculations can easily be observed with sEMG as Kumagai and Yamada demonstrated 
with their measurements of the forearm flexor muscles of a patient with SMA.90 We 
showed that HD-sEMG is suitable to examine fasciculations because of its non-invasive 
character allowing long, stable recording times and because of the spatiotemporal 
information.30 The unique characteristics of fasciculation potentials across all channels 
facilitate extensive fasciculation potential characterization. 
In the second study, we examined involuntary painful muscle contractions in the legs of 
a patient with Satoyoshi syndrome using two non-invasive EMG techniques: HD-sEMG 
(with 126-channels) of the vastus lateralis muscle and polymyographic sEMG recordings 
on various muscles.29 During the involuntary contractions, HD-sEMG showed a fourfold 
increase in amplitude relative to the MVCs. These high potentials were distributed 
across the entire muscle and showed a pronounced oscillatory behaviour with a 
frequency around 45 Hz. Together with polymyographic sEMG that had revealed that 
the involuntary contractions often occur simultaneously in various muscles, these 
findings point to hyperactivity or a desinhibition at the alpha motor neuron level, 
probably originating at that level, although a central origin cannot be excluded. 
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Table 6b. Overview of HD-sEMG studies in channelopathies. 
Authors EMG variables Controls Patients Muscles
(No. of electrodes) (Age in yrs) (Age in yrs)
Zwarts et al (1988) MFCV 15 15 asymptomatic 
relatives
 BB
Frequency spectra (32 – 52 y) (15 –47y)
(3) 10 HOPP
(19 –71 y)
Van der Hoeven et al MFCV 46 33 HOPP carriers BB
 (1994) Frequency spectra (19-74 y) (16-57 y)
EMG amplitude 56++
(3) (16-76 y)
Zwarts and van Weerden EMG amplitude 3 3 RMC BB
 (1989) MFCV (29 –35 y) (23 – 40 y) BR
Frequency spectra 8 MD ADM
(3) (23 –64 y)
Drost et al (2001) MFCV 5 7 RMC BB
PPA (22-64 y) (22-57 y)
(126)
Drost et al, (2004) Amplitude 7 RMC BB
Visual analysis (22 –57 y)
(126)
Van Beekvelt et al (2006) Amplitude 9 3 RMC BR
MFCV (32-48 y)
(32)
Abbreviations: HOPP, hypokalemic periodic paralysis; RMC, recessive myotonia congenita; BR, 
brachioradialis muscle; ADM, abductor digiti minimi muscle; ++ asymptomatic first degree 
carriers; PPA, peak-peak amplitude
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3.2.6.  Motor unit firing rate and HD-sEMG
Three articles primarily used HD-sEMG to measure firing patterns of single MUs. In fact, 
our earlier study 27 also focused on central mechanisms besides membrane disturbances 
to explain constant force. 
Kleine et al.85 compared 126-channel HD-sEMG recordings from the biceps muscles of 
seven patients with Parkinson’s disease with those of five healthy controls to explore 
whether reduced inhibition in the motor cortex of the patients was accompanied by 
similar changes in their MU firing modulation by transcranial magnetic stimulation as 
was found in ALS. They applied a HD-sEMG decomposition technique to extract the 
firing pattern of up to five simultaneously active MUs. The peristimulus time histograms 
indicated a longer duration of the evoked excitatory postsynaptic potential. The authors 
attributed the results to prolonged corticospinal volleys resulting from impaired 
intracortical inhibition. 
Chen et al.15 also exploited HD-sEMG signals to analyze the temporal changes and 
spatial distribution of the dominant MU firing rate. They applied seven electrodes on 
the biceps muscle and seven electrodes on the triceps muscle from lateral to medial, 
with an interelectrode distance about 20 mm, to compare five healthy subjects, 
five Parkinson patients and five patients with cerebrovascular accidents (CVA). To 
estimate the dominant firing rate they used autoregressive spectrum analysis of the 
sEMG because the EMG spectrogram was expected to allow examination of the time-
varying characteristics of the firing rates and the recruitment of MUs from the sEMG 
signals. The authors found abnormalities of the mean MU firing rates and spatial 
patterns in both patient groups and suggest that via this new representation HD-sEMG 
spatiotemporal firing patterns were of clinical use in the electrophysiological detection 
and characterization of motor control disorders. Sun et al. also conducted a study 
of single MU firings involving a computer simulation and a clinical study with HD-
sEMG recordings of the interosseous muscle in patients with stroke, myopathies and 
neuropathies and in healthy controls (n = 16 for each group).155 The HD-sEMG consisted 
of a 2 x 2 matrix with a 0.2 mm diameter for each electrode and an interelectrode 
distance of 2.5 mm. The authors proposed a singular value decomposition method to 
study the MU firing patterns. The firing variability was found to be increased in the 
stroke patients and in the myopathy and neuropathy groups the mean firing rates 
were elevated. Relative to the healthy controls, the firing variation index, i.e. the firing 
standard deviation (SD) normalized by the firing mean, was elevated in every patient 
group. 
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4.  Discussion
The current overview of HD-sEMG application research clearly demonstrates that as 
a tool in clinical practice the technique is still in its infancy although the large number 
of ‘non-clinical’ papers our search generated shows that the technique is being probed 
extensively and progress has been made in its technical and practicable aspects. It 
proved difficult to find studies that used HD-sEMG in clinical applications, which was 
largely due to the lack of uniformity in the designations for this surface EMG technique 
involving multiple electrodes on one muscle. As the overview of our search strategy in 
Table 1 illustrated, a wide range of names was used, among which multi-channel sEMG, 
high-resolution sEMG and multi-array sEMG. Because the term multi-channel sEMG 
is also used in kinesiology studies to denote an EMG comprising bipolar electrodes 
on different muscles, we advise against the use of this term. There is a clear need for 
consensus regarding the technique’s name.
Another salient detail was the great variability in electrodes, electrode-positions, 
interelectrode distances and configuration of electrodes. This caused a similar 
variability in the results in the various pathologies, impeding their reproducibility 
and a sound interpretation. Especially for clinical applications, uniformity in electrode 
configuration and electrode grids will become increasingly essential. This is also the 
case for the recording systems and possibly also for the key features of the analysis 
software. Diversity in equipment complicates the clinical application of the technique 
unnecessarily. 
In sum, further improvements of HD-sEMG as well as future applications of the 
technique in the clinical practice warrant uniformity in various aspects. As Hogrel75 
already stated, a lack of standards for electrodes, configurations, electrode placement 
and recording protocols have adversely affected the possibility of the technique’s 
integration into routine clinical use. Accordingly, it is recommended to establish a 
consortium of leading investigators in this field to devise technical guidelines for 
clinical applications as was done by Hermens for kinesiology studies.73 
4.1  HD-sEMG and bioengineering 
As mentioned above, needle EMG is the standard to compare HD-sEMG signals with 
as it is virtually the only EMG technique that is used as diagnostic tool in clinical 
neurophysiology. However, diagnoses are mostly based on a subjective assessment 
of the signals. In contrast, for HD-sEMG interpretations quantitative variables are 
essential. Because of the magnitude of the data, automatic quantification and analysis 
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of the signals is indispensable, which poses a challenge for the introduction of HD-
sEMG in the clinical practice. Since we chose to restrict our review to the clinical 
applications of HD-sEMG, the discussion of studies concerning the biophysics and 
bioengineering of HD-sEMG was not exhaustive. For a more comprehensive overview 
of the state of the art on these topics in sEMG applications we refer to the review by 
Merletti and Parker.111 
4.2  Clinical applications to date
4.2.1.  HD-sEMG and fatigue studies
The scope of HD-sEMG applications is different from that of needle EMG. Because of 
spatial information allowing MFCV measurements and because of the longer recording 
times the technique affords, the greater majority of fatigue studies exploit the domain 
of sEMG. In most clinical studies using HD-sEMG MFCV, which is inaccessible to 
conventional needle EMG, proved an important variable providing useful information 
about the symptom in neuromuscular disorders. Because fatigue is such a pronounced 
symptom in nearly all neuromuscular disorders, this new EMG variable may prove a 
valuable addition for use in the clinical practice. 
4.2.2.  HD-sEMG and neurogenic changes 
The studies investigating neurogenic changes (see Table 3) showed that HD-sEMG can 
identify these changes relatively easily. Variables from ‘raw’ HD-sEMG data such as 
MFCV and Fmed were studied,
161 and also amplitude measurements and variables that 
provide information about the MUAPs’ interference patterns were used in an attempt 
to differentiate between subjects with neurogenic diseases and healthy controls.26 No 
uniform pattern was found: in ALS patients MFCV was increased and Fmed decreased, 
and no differences were found in the MFCVs of patients with postpolio syndrome and 
healthy subjects. 
Some studies additionally performed MU size estimations with good results,26, 135, 164 
demonstrating that the extraction of single MUAPs from HD-sEMG data to estimate 
MU size facilitates the differentiation between neurogenic MUAPs and MUAPs of 
healthy subjects. It needs to be noted that the technique is still very time-consuming. 
The study by El Dassouki and Lefaucheur31 did not provide useful information about the 
diagnostic role of HD-sEMG and neither did Bahm et al.4 methodological observation. 
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4.2.3.  HD-sEMG and myopathies 
In muscular dystrophy several studies report a slowed MFCV, which is probably based on 
muscle fibre atrophy.90, 166 Disturbed MFCVs seem to be a hallmark in channelopathies. In 
the transient paresis phase of recessive myotonia our group found a unique conduction 
block along the muscle fibre.25
It was found that the disorder in the HOPP family described earlier was caused by 
a mutation (Arg528His) in the dihydropyridine receptor CACNL1A3. These findings 
underscore that HD-sEMG seems especially valuable and yields novel pathophysiological 
insights into disorders characterized by sarcolemmal disturbances. 
4.2.4.  HD-sEMG and positive muscle phenomena
Spontaneous muscle-fibre activity cannot be recorded via sEMG as fibrillation potentials, 
positive sharp waves and myotonic discharges, being single muscle fibre discharges, are 
beyond its scope. Indeed, researchers who applied HD-sEMG to examine patients with 
myotonic syndromes were unable to detect myotonic discharges.25, 27, 90, 160, 169 
Rather, and better than needle EMG, HD-sEMG is intrinsically suited to detect 
spontaneous MU activity like fasciculation potentials.30 Future studies in clinical 
settings will exploit this property further. To illustrate the technique’s potential, 
the HD-sEMG study of spontaneous MU activity in a child with Satoyoshi syndrome 
revealed new pathophysiological information about the involuntary contractions.28, 29
4.2.5.  HD-sEMG and the central nervous system 
Decomposition of HD-sEMG signals not only yields information about the MUs 
themselves, but also about how MUs are controlled by the central nervous system 
(CNS) in generating force.17 In patients with Parkinson’s disease, ALS, CVA and other 
disorders, studies of MU firings provide a non-invasive access to central processes and 
their pathophysiology. Decomposing the HD-sEMG signals and identifying single MUs 
will not only further our understanding of the pathophysiology of these diseases, but 
also our understanding of the raw EMG signal. Because of the recording stability of HD-
sEMG, MU information that can only be derived from long recording session with many 
thousands of discharges of the same MU come into view.86
4.3.  How to review a diagnostic tool
Frequently, due to their potential clinical values, expectations with respect to new, 
innovative diagnostic tests are high and sometimes even overheated. Because of the 
rapid advances in technology there is an increasing need for adequate evaluation 
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techniques to test new diagnostic tools and several systematic methods have been 
developed.9, 156 To improve the accuracy and comprehensiveness of reports on diagnostic 
accuracy a group of scientists and editors has drawn up the Standard for Reporting of 
Diagnostic Accuracy or STARD.9 It comprises a 25-item checklist and a flow diagram 
to help authors secure well performed studies. Unfortunately, as HD-sEMG is not yet 
utilized as a clinical application, its diagnostic accuracy cannot yet be evaluated in 
keeping with these new conventions.
Tatsioni et al.156 state that, as opposed to the quality of studies of therapeutic 
interventions, little is known about the methodological quality of studies of diagnostic 
tests and that outcomes often still have an ‘anecdotal’ character. They distinguish six 
levels in their proposed review of diagnostic technologies: (1) technical feasibility and 
optimization, (2) diagnostic accuracy, (3) diagnostic thinking impact, (4) therapeutic 
thinking impact, (5) patient outcome impact and (6) social impact. Evidently, these levels 
are not only applicable for evaluation purposes but can also serve as guidelines in the 
refinement of novel diagnostic tools like HD-sEMG. The present review has shown that 
the research into the clinical applications of HD-sEMG is almost entirely restricted to 
testing the first level. The only level-two study that examined the diagnostic accuracy of 
the HD-sEMG method is the study by Huppertz et al.79 Although the results they report 
look promising, prospective studies using blinded observers are needed to corroborate 
the outcomes. 
4.4.  HD-sEMG and future perspectives
For proper diagnostics in the clinical neurophysiological practice it is important to 
examine at MU level. However, a decomposition problem HD-sEMG shares with that of 
needle EMG is that the analysis of single MU firing patterns and MU characteristics is 
still too complicated and time-consuming, rendering it less viable for use in the clinical 
practice. To overcome this problem, more and better-validated automated analyses are 
crucial. A first, promising step in that direction has recently been taken by De Luca 
et al.17 For HD-sEMG to become a sophisticated, clinically accepted diagnostic tool it 
requires a more systematic evaluation process that should also be exploited to guide 
its refinement. 
A large body of research has been dedicated to engineering and physiology, which has 
yielded valuable insights and new methods. In effect, there is a ‘mismatch’ between the 
number of practical application studies and the number of supporting bioengineering 
reports. A similar tendency can be found for studies on special needle EMG techniques 
and advanced data quantification techniques, e.g. in MU decomposition studies: the 
development in clinical applications lags behind. This may in part be explained by the 
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intrinsic attraction of EMG-related signal analysis problems to the (bio)engineering 
world. Physiologically relatively well-understood signal sources, the firing motor 
units, occur in an intermingled and blurred signal, a typical problem for the signal 
processing sciences and a challenging aspect for modelling. It also explains why ‘signal’ 
processing is the largest discipline within bioengineering, larger than, for instance, 
instrumentation. 
Such rather negative conclusion can be turned into a positive prospect, as many building 
blocks for a successful journey of HD-sEMG possibilities into the clinical practice are 
available already. 
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In addition to an introductory chapter and an explanatory chapter on the development 
of the high density-surface EMG (HD-sEMG) technique that features in all studies 
presented, the thesis comprises three distinctive parts, each illuminating different 
aspects of the use of HD-sEMG. This non-invasive and sophisticated sEMG technique 
measures electrical muscle activity with multiple closely spaced electrodes overlying a 
restricted area of the skin. Besides temporal activity, HD-sEMG also allows the spatial 
aspects of EMG activity to be recorded, thus expanding the possibilities to detect new 
neuromuscular characteristics. In the general introduction of Chapter 1 influential 
research that substantially fostered the knowledge of electrical activity of muscles is 
summarized and the thesis is placed in a historical perspective. Furthermore, in order 
to understand EMG activity, it is important to take not only the anatomical, but also the 
physiological basis of such activity into account, which is why relevant physiological 
principles on muscle function are explained. Special attention is paid to the function 
of the sarcolemma, the muscle’s surface membrane that is the source of the electrical 
activity in striated muscles and therefore the source of the EMG activity measured. In 
the chapter’s final section the aim of the studies reported in the present thesis is briefly 
introduced. Chapter 2 describes the evolution and state of the art of HD-sEMG with an 
emphasis on the clinician’s perspective. The application of surface EMG in neurological 
disease is hampered by numerous inherent problems and, most specifically, the 
difficulties in extracting features of single motor units (MUs). From single bipolar 
arrangements and subsequent linear arrays of multiple electrodes, today’s high-density 
technique allows recordings of a matrix of densely packed electrodes, hence solving, 
in principle, this latter problem. At least for some muscles it is now possible to extract 
information from the surface EMG recordings, which was conventionally restricted to 
the domain of needle EMG.
Part I. Sarcolemmal dysfunction
Part I of the thesis deals with electrical properties of the outer muscle-fibre membrane 
(sarcolemma) and force production in patients with an ion-channel disease. Patients 
with autosomal recessive generalized myotonia (GM) suffer from both muscle stiffness 
(myotonia) and muscle weakness. The transient muscle weakness or transient paresis 
occurs after a period of rest and within seconds of the initiation of activity. Both 
transient paresis and myotonia diminish with repetitive contractions, which is known 
as the ‘warm-up’ phenomenon. Although the genetic defect that is responsible for the 
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disease has been identified, the pathophysiological processes that link genotype to the 
typical phenotype of GM remained unexplained. 
GM is caused by a defect in the gene encoding a voltage-gated skeletal-muscle chloride-
channel protein. Skeletal-muscle chloride channels play an important role in regulating 
muscle excitability, as the chloride conductance is essential for the repolarization 
phase of the sarcolemma after propagation of the action potential. To gain a better 
understanding of the electrophysiological reactions of the muscle fibre membrane in 
these patients, we performed several studies using HD-sEMG. 
In Chapter 3, we studied transient paresis in GM patients by simultaneously measuring 
force and HD-sEMG. Transient paresis proved to be explained by a deteriorating 
sarcolemmal function, resulting in conduction block and paresis. During the force 
decline in the episode of transient paresis the HD-sEMG recordings showed a decrease 
in peak-peak amplitude of the motor unit action potentials (MUAPs) from endplate 
towards tendon. The disturbance increased with time and over place, indicating a 
deteriorating membrane function, and ends in a complete blocking of propagation 
within seconds. Spatiotemporally, this led to a specific V-shaped sEMG pattern. The 
study demonstrated that GM patients were unable to exert normal force at medium- 
and high-force levels due to their transient paresis. At low-force levels, however, their 
force production was normal. Intrigued by these normal force profiles during low force, 
we tested in Chapter 4 the hypothesis that also during low force sarcolemmal function 
is disturbed, but that abnormal MU recruitment acts as a compensatory mechanism 
to obtain normal force stability. During normal force, the HD-sEMG abnormalities 
included disturbed propagation of MUAPs over the sarcolemma, but also abnormal 
MU-recruitment patterns, pointing to central adaptation mechanisms. Although we 
found evidence of a compensatory mechanism involving abnormal MU recruitment, 
this could not fully explain constant force. 
In Chapter 5, we tested the premise that the warm-up phenomenon was attributable to 
the exercise-related activation of Na+-K+-ATPase. Patients performed sustained isometric 
contractions of the brachioradialis muscle on two separate days. Randomly, on one of 
these days, isometric contraction was preceded by an infusion of the Na+-K+-ATPase 
inhibitor ouabain into the brachial artery of the relevant arm. Force was measured 
simultaneously with electric muscle activity using HD-sEMG. Transient paresis occurred 
after initiation of the exercise and was accompanied by electrophysiological changes 
indicating sarcolemmal conduction block. Ouabain infusion did not affect the recovery 
of transient paresis, nor the associated electromyographic changes, indicating that the 
warming-up phenomenon in GM is not mediated by Na+-K+-ATPase. 
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In a more general sense, we concluded that spatiotemporal information as made 
available through non-invasive HD-sEMG indeed provides novel insights into 
electrophysiological aspects of membrane dysfunction and strongly contributed to 
bridging the gap between genotype and the typical phenotype in GM.
Part II. Positive phenomena: Involuntary muscle activity
In Part II spontaneous muscle activity is examined. In our study reported in Chapter 
6 we demonstrate that HD-sEMG is a suitable instrument to study fasciculations in 
patients as it is a non-invasive technique that allows long, stable recordings providing 
quantitative information that includes both temporal and spatial characteristics of the 
fasciculation potentials. Examples of the fasciculation potentials of a patient diagnosed 
with definite ALS are presented, which are shown in different electrode montages, as 
well as the unique spatial characteristics of different fasciculation potentials. During 
a 30-second recording, 137 of these potentials were detected. Via a decomposition 
algorithm these fasiculation potentials could be assigned to 11 different underlying 
sources. 
In Chapter 7 we sought to gain a better understanding of the electrophysiological 
characteristics of the painful, involuntary contractions in a patient with the rare 
Satoyoshi syndrome. We investigated the muscle contractions in the legs by means of 
two non-invasive techniques: HD-sEMG of a single muscle and polymyographic sEMG 
using bipolar recordings from various muscles. During the involuntary contractions, 
HD-sEMG showed a four-fold increase in amplitude compared to maximal, voluntary 
contractions. The high potentials were widely distributed across the entire muscle and 
showed a pronounced oscillatory behaviour. The polymyographic sEMG recordings 
revealed that the involuntary contractions often occurred simultaneously in various 
muscles or showed a switch of activity from one muscle to another. These findings point 
to hyperactivity or desinhibition, most likely originating at the alpha motor-neuron 
level although a central origin cannot be excluded. These new electrophysiological 
insights spawned an additional study described in Chapter 8, which led to the discovery 
of antibodies against glutamic acid decarboxylase in the serum of a child with Satoyoshi 
syndrome, confirming the autoimmune origin of the disease. These findings in turn 
prompted the supposition that Satoyoshi syndrome in childhood could be a variant of 
another rare disease, stiff-person syndrome. 
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Part III. Clinical applications
Part III of this thesis comprises our endeavours to assess the applicability of HD-sEMG 
as a diagnostic tool in a clinical setting. The purpose of the study presented in Chapter 
9 was to identify ways to detect neurogenic changes with HD-sEMG. We analyzed the 
raw HD-sEMG signal itself as well as the properties of single MUAPs extracted from 
the signal in patients with postpoliomyelitis and in healthy subjects. Both analysis 
techniques indeed allowed us to non-invasively detect neurogenic MU changes, with 
the diagnostic yield of the single MUAP analysis clearly being higher. These findings 
show the technique’s potential for application in the clinical practice and invite further 
studies exploring its diagnostic value. 
In view of these promising findings on its clinical potential, the ongoing refinements 
of the HD-sEMG apparatus and related software and our widening knowledge about its 
possibilities, we felt a comprehensive and systematic review of the use of HD-sEMG in 
the clinical practice was in place. Our review, which we present in Chapter 10, the final 
chapter of Part III, revealed that, notwithstanding the notable technical progress that 
has been made, the practical implementation of HD-sEMG is still in its infancy. 
In future research a famous question of Erik Stålberg in 2001 concerning surface EMG 
will be remembered: “Surface EMG, will it stay forever promising?” Despite its patient-
friendliness, it is clear that for HD-sEMG to become an applicable diagnostic tool in 
clinical settings will require further ample and well-designed research for which the 
recommendations formulated in Chapter 10 may be of help. 
Chapter 12
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Dit proefschrift bestaat - naast een introductie en een samenvatting - uit drie 
delen. Hierin wordt ‘high-density’ oppervlakte EMG (HD-sEMG) gebruikt, enerzijds 
om pathofysiologische inzichten te verwerven, anderzijds om mogelijke klinische 
toepassingen te verkennen. HD-sEMG is een non-invasieve techniek die gebruikt wordt 
om elektrische spieractiviteit te meten. Dit gebeurt met meerdere elektroden, die dicht 
bij elkaar op de huid geplaatst worden. Door middel van HD-sEMG kan elektrische 
activiteit gemeten worden zowel in tijd als op verschillende plaatsen boven de spier. De 
op deze manier verkregen spatiotemporele informatie maakt het mogelijk om nieuwe 
karakteristieken van het neuromusculaire systeem te onderzoeken.
De algemene inleiding, hoofdstuk 1, bevat een samenvatting van een aantal weten-
schappelijke bevindingen van invloedrijke wetenschappers. Deze bijdragen zijn 
bepalend geweest voor het huidige kennisniveau op het gebied van elektrische activiteit 
in spieren. Het onderhavige onderzoek wordt eerst kort in historisch perspectief 
geplaatst. Daarna zal de aandacht vanuit meer fysiologisch perspectief vooral uitgaan 
naar de spiervezelmembraanfunctie. Die vormt de bron van elektrische activiteit in 
dwarsgestreepte spieren en is daarmee dus ook de bron van gemeten EMG-activiteit. 
Daarnaast wordt in hoofdstuk 1 het doel van dit proefschrift beschreven. 
In hoofdstuk 2 staat de ontwikkeling die de HD-sEMG techniek doorgemaakt heeft 
centraal. We behandelen de toenmalige status van deze techniek vanuit een klinisch 
perspectief. Er zijn een aantal problemen die de toepassing van oppervlakte-EMG (sEMG) 
beperken. Allereerst zijn er problemen die inherent zijn aan de techniek zelf. Daarnaast 
is er sprake van problemen bij het verkrijgen van specifieke kenmerken van afzonderlijke 
motorische eenheden (motor units) uit het EMG-signaal. De ontwikkeling uitgaande van 
een enkelvoudige bipolaire meting, via een rij elektroden naar meerdere dicht bij elkaar 
geplaatste HD-sEMG elektroden maakt het momenteel mogelijk om voor sommige 
spieren informatie uit het HD-sEMG te onttrekken die oorspronkelijk alleen tot het 
domein van het naald-EMG behoorden, bijvoorbeeld de grootte van motor units.
Deel I. Sarcolemma disfunctie
Deel I behandelt de elektrische eigenschappen van het buitenste spiervezelmembraan 
(sarcolemma) en de spierkracht bij patiënten met een ziekte die een specifiek ionkanaal 
betreft. Deze patiënten met autosomaal recessieve myotonia congenita (GM) hebben 
zowel last van spierstijfheid (myotonie) als van spierzwakte. De voorbijgaande 
spierzwakte, of transiënte parese, treedt op na een periode van rust en ook enkele 
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seconden na het begin van een beweging. Zowel transiënte parese als myotonie 
verdwijnen na herhaalde contracties, dit wordt het ‘warm-up fenomeen’ genoemd. 
Ondanks het feit dat het genetische defect dat verantwoordelijk is voor deze ziekte 
bekend is, zijn de pathofysiologische processen die genotype en fenotype correleren 
en tot het typische fenotype van GM leiden, nog steeds niet opgehelderd. GM wordt 
veroorzaakt door een defect in het gen dat codeert voor een voltage afhankelijk eiwit in 
het chloorkanaal van het sarcolemma. Chloorkanalen spelen een belangrijke rol bij het 
reguleren van de prikkelbaarheid van het sarcolemma. De doorlaatbaarheid voor chloor 
is essentieel voor de repolarisatie-fase van de spiervezelmembraan na het optreden van 
een actiepotentiaal. 
Om een beter begrip te verkrijgen van de elektrofysiologische eigenschappen van de 
spiervezelmembraan bij deze patiënten, verrichtten we verschillende studies met HD-
sEMG. In hoofdstuk 3 bestudeerden we de transiënte parese in GM-patiënten, waarbij 
zowel kracht als HD-sEMG activiteit gelijktijdig gemeten werden. We ontdekten 
dat transiënte parese verklaard kan worden door een gestoorde membraanfunctie 
die eindigt in een geleidingsblokkering en parese. HD-sEMG toont tijdens het 
krachtsverlies een afname in de piek-piek amplitude van de motorunit-actiepotentialen 
van de eindplaat naar de pees. Deze stoornis neemt toe zowel in tijd als in plaats en 
duidt op een gestoorde membraanfunctie die binnen enkele seconden eindigt in een 
complete blokkering in de geleiding van potentialen. Dit leidt tot een karakteristiek V-
vormig spatiotemporeel HD-sEMG-patroon. 
In dit onderzoek werd duidelijk dat patiënten door de transiënte parese geen normale 
kracht kunnen leveren op gemiddelde en hoge krachtniveaus. Op een laag krachtniveau 
kunnen zij dit echter wel. In hoofdstuk 4 staat dat laatste centraal: het normale 
krachtprofiel tijdens lage kracht. We testten de hypothese dat de spiermembraanfunctie 
bij lage kracht al wel gestoord is, maar dat er abnormale motor unit rekrutering als 
compenserend mechanisme optreedt om de kracht te handhaven. Inderdaad lieten 
tijdens ongestoorde lage kracht, de HD-sEMG-metingen een abnormale geleiding van 
motorunit-actiepotentialen over de spiervezelmembraan zien, maar ook een abnormale 
motor unit rekrutering. Dit wijst op het optreden van een aanpassingsmechanisme in 
het centrale zenuwstelsel. We moesten echter concluderen dat de abnormale motorunit 
rekrutering als compenserend mechanisme toch geen volledig verklaring kan zijn voor 
de normale constante kracht.
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In hoofdstuk 5 testten we de hypothese dat het warm-up fenomeen mogelijk 
verklaard kan worden door de activering van de zogenaamde natrium-kalium pomp 
in het membraan (Na+-K+-ATPase), die gerelateerd is aan inspanning. Hierbij voerden 
patiënten aanhoudende isometrische contracties uit van de brachioradialis-spier in 
de onderarm op twee verschillende dagen. Willekeurig verdeeld werd op een van 
deze dagen de isometrische contractie voorafgegaan door een infuus van de Na+-K+-
ATPaseremmer ouabaïne in de brachialis arterie van de actieve arm (0.4 µg·min-1·dl-1). 
Gelijktijdig met de elektrische activiteit van de spier met behulp van HD-sEMG werd 
de kracht gemeten. In het begin van de oefening trad transiënte parese op samen met 
de elektrofysiologische veranderingen die wijzen op een geleidingsblokkering van 
actiepotentialen over het sarcolemma. Het infuus met ouabaïne had geen invloed 
op het herstel van de transiënte parese en ook niet op de bijbehorende HD-sEMG-
veranderingen. Deze bevindingen duiden erop dat het herstel van de transiënte parese, 
en het warm-upfenomeen in GM-patiënten niet beïnvloed worden door Na+-K+-ATPase. 
In meer algemene zin concluderen we dat spatiotemporele informatie verkregen via het 
non-invasieve HD-sEMG nieuwe inzichten kan geven in elektrofysiologische aspecten 
van sarcolemma disfunctie en sterk bijgedragen heeft aan het dichten van de kloof 
tussen genotype en fenotype in GM-patiënten.
Deel II. Positieve spierfenomenen: onwillekeurige spieractiviteit
In Deel II onderzochten we spontane spieractiviteit. In hoofdstuk 6 laten we zien 
dat HD-sEMG een geschikt instrument is om fasciculaties te bestuderen. De 
techniek geeft zowel temporele als spatiële informatie over fasciculatiepotentialen. 
We geven voorbeelden van fasciculatiepotentialen van een patiënt met ‘definite’ 
amyotrofe lateraal sclerose (ALS). Fasciculatiepotentialen worden in verschillende 
elektrodeafleidingen getoond en de unieke spatiële karakteristieken van verschillende 
fasciculatie potentialen worden weergegeven. Gedurende een registratie van 30 
seconden werden 137 potentialen gemeten, die via een algoritme konden worden 
herleid tot 11 verschillende onderliggende bronnen. Hieruit kan geconcludeerd 
worden dat HD-sEMG door haar non-invasieve karakter, en de unieke spatiotemporele 
informatie, zeer geschikt is om fasciculaties te onderzoeken. Er kan langdurig en stabiel 
worden gemeten, en de metingen leveren kwantitatieve informatie op. 
In hoofdstuk 7 proberen we meer inzicht te krijgen in de elektrofysiologische 
eigenschappen van de zeer pijnlijke onwillekeurige contracties van een patiëntje met 
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een zeldzame ziekte, het Satoyoshi syndroom. We onderzochten spiercontracties in haar 
benen en gebruikten daarbij twee non-invasieve technieken: HD-sEMG op een spier, en 
polymyografische registraties met bipolaire afleidingen op meerdere spieren. Tijdens 
de onwillekeurige contracties liet de HD-sEMG activiteit een viervoudige toename 
van de amplitude zien, dit vergeleken met de amplitude tijdens maximale vrijwillige 
aanspanning. Deze hoge potentialen waren over de gehele spier aanwezig en lieten een 
uitgesproken oscillerend karakter zien. De polymyografische registratie liet zien dat de 
onwillekeurige contracties vaak simultaan in verschillende spieren optreden. Daarnaast 
liet dezelfde registratie een overgang van de activiteit zien van de ene spier naar de 
andere. Deze bevindingen duiden op een desinhibitie die waarschijnlijk optreedt op het 
niveau van het alfa-motorneuron, alhoewel een oorzaak in het centrale zenuwstelsel 
niet uitgesloten kan worden. De elektrofysiologische inzichten gaven aanleiding tot 
een aanvullende studie. We toonden antilichamen aan tegen glutaminezuur in het 
bloed van het patiëntje met Satoyoshi syndroom. Dit bevestigt de auto-immuunoorzaak 
van de ziekte. We beschrijven dit in hoofdstuk 8. Deze bevinding gaf aanleiding te 
veronderstellen dat de ziekte een variant kan zijn van een andere zeldzame ziekte: het 
stiff-personsyndroom. 
Deel III. Klinische toepassing
Deel drie van dit proefschrift betreft de toepassing van HD-sEMG als diagnostische 
techniek in de klinische praktijk. Het doel van het onderzoek in hoofdstuk 9 was om 
manieren te vinden om neurogene veranderingen van motorunits vast te stellen middels 
HD-sEMG. Hiervoor werden postpoliomyelitis patiënten en gezonde proefpersonen 
onderzocht. Afzonderlijke motor unit-actiepotentialen (MUAPs), geëxtraheerd uit het 
HD-sEMG signaal, en ook het ‘ruwe’ signaal zelf werden geanalyseerd. Onze conclusie is 
dat het mogelijk is om met behulp van HD-sEMG non-invasief neurogene veranderingen 
vast te stellen, zowel door middel van analyse van de gemiddelde afzonderlijke MUAPs 
als door middel van analyse van het ruwe signaal zelf. De diagnostische opbrengst 
van de analyse van afzonderlijke MUAPs is duidelijk hoger. Deze bevindingen tonen 
een mogelijke klinische toepassing aan en nodigen uit tot verder onderzoek om 
de diagnostische waarde van HD-sEMG te verkennen. De verdere ontwikkeling en 
verfijning van HD-sEMG-systemen in de wereld en van de bijbehorende software en 
ons toenemend begrip van de mogelijkheden, leidden tot een systematische review van 
de klinische toepassing aan het eind van dit proefschrift in hoofdstuk 10. Deze review 
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laat zien dat, ondanks de belangrijke technische vooruitgang die er gemaakt is, de 
klinische toepassing van HD-sEMG nog in de kinderschoenen staat.
Er zal nog een aanzienlijke inspanning nodig zijn om HD-sEMG verder te ontwikkelen 
tot een bruikbaar diagnostisch instrument voor klinische toepassing. Goed opgezet 
onderzoek om de diagnostische waarde van deze patiëntvriendelijke techniek te 
evalueren is nodig. In hoofdstuk 10 zijn praktische aanbevelingen gegeven die daarbij 
een leidraad kunnen vormen. 
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jullie mij geschonken hebben. 
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wat het nu is. Mireille van Beekvelt, jou dank ik speciaal voor je enorme bijdrage aan 
het Na+-K+-ATPase artikel, het was veel werk en niet eenvoudig. Gerard Rongen, bij 
diezelfde bijdrage gaf jij als vanzelfsprekend de praktische hulp. Bert Kleine, jou bedank 
ik graag voor je belangrijke bijdrage over HD-sEMG en fasciculaties. Aad Verrips, dank 
voor de waardevolle en uiterst plezierige wijze waarop we ons hebben verdiept in het 
Satoyoshi syndroom. Frans Nollet, Herwin Horemans, en vooral ook Maartje Schillings, 
dank voor jullie bijdrage aan het postpolio-artikel. 
De wellicht meest tastbare bijdrage aan dit onderzoek hebben de medewerkers van 
de fysisch technische groep geleverd. Ik denk hierbij bijzonder aan Karin Roeleveld en 
Joleen Blok, Bernd Lapatki en Hans van Dijk, jullie hebben het HD-sEMG ontwikkeld 
tot een bruikbaar instrument. Hans, jij was mijn grote ‘technische achtervang’. Je bent 
echt bij alles betrokken geweest. En daarbij was je steeds de brug tussen praktijk en 
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wetenschap, tussen techniek en kliniek. Klinische toepasbaarheid staat hoog in jouw 
vaandel en dat is een bijzonder waardevolle kwaliteit. Mark Massa, dank voor het 
schrijven van Matlabprogramma’s, maar zeker ook voor een ander, niet onbelangrijk 
samenwerkingsaspect: gezellige kamergenoot zijn. En voor de computerproblemen had 
ik gelukkig jullie, Leo Haegens en Norbert Janssen. 
Onderzoek doe je niet ineens. Ik wil twee personen bedanken die op de weg naar 
onderzoek doen toe, veel voor mij betekend hebben. Dick Vingerhoets, je gaf mij een 
gedegen EMG-opleiding, waar ik je tot op de dag van vandaag dankbaar voor ben. Je was 
een uitstekend leraar en bent daarnaast een bijzonder aardig mens. Prof. dr. Servaas 
Notermans u was degene die mij aannam als arts-assistent neurologie, ‘ondanks’ het 
feit dat ik kinderen had. Mijn oprechte dank voor uw vertrouwen, tegen de stroom in. 
Onderzoek doe je dankzij de medewerkers van een afdeling, die je de gelegenheid 
geven om je onderzoek te doen. Ik ben dan ook heel veel dank verschuldigd aan de 
medewerkers van de afdeling klinische neurofysiologie. Jaco Pasman en Nens van Alfen, 
dank voor jullie collegialiteit. De laboranten, in het bijzonder Yvonne van den Bogaard, 
dank ik voor de flexibiliteit en de prettige werkomgeving, en de secretaresses voor hun 
praktische ondersteuning. Dank mede-promovendi voor de gezelligheid: Paul Blijkam, 
Sigrid Pillen, Caroline Houtman en Robert Oostenveld.
George Padberg, opleider Neurologie, jou wil ik danken voor de ruimte die je mensen 
geeft om zich te ontwikkelen, je bent altijd bereid om creatief mee te denken en 
oplossingen te zoeken. Jouw verdienste is dat je zoveel geïnspireerde neurologen om 
je heen weet te verzamelen: wat hebben we een enthousiaste, leuke club waarin we 
werken! Mijn collega neurologen in het UMCN, dank ik voor de prettige werksfeer 
en vaak welgemeende interesse en bemoedigende schouderklopjes. De snelle kopjes 
koffie aan het begin van de dag zijn een teken van onze collegiale band. Speciale dank 
aan Jurgen Schelhaas, neuromusculair collega en sparringpartner en aan Frank-Erik 
de Leeuw. Miranda Heijser en Elke Pastoors, dank voor jullie zichtbare, maar veelal 
onzichtbare werk om een onderzoek goed te laten verlopen. 
Alle medewerkers van het Neuromusculair Expertise en Consultatie Centrum in het 
UMC wil ik danken voor hun support. Met name dank ik Henk Hendricks voor het 
overnemen van taken en de plezierige samenwerking.
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de klinische neurofysiologie en jullie collegialiteit. Rob Ackerstaff, je leverde een 
belangrijke bijdrage aan mijn opleiding en je was steeds geïnteresseerd in mijn 
onderzoek. Hessel Franssen en Gert van Dijk, naast onze interesse in EMG deelden we 
veel andere interesses! Michel van Putten, het waren inspirerende en gezellige uren 
achter onze pc’s, toen ik mijn laatste hoofdstukken schreef: oprechte dank.
Net zoals neurofysiologie soms abracadabra is voor anderen, is schrijven voor mij 
soms een vak apart. Anke Tigchelaar en Hanneke Meulenbroek, ik dank jullie voor de 
vakkundige en fijnzinnige taalcorrecties. Ans Wilders wil ik danken voor het efficiënt en 
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Rianne Esselink en Elly van der Kooi, als moeder-neuroloog-promovenda konden we 
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Henny Janssen, als laborante was je van meet af aan betrokken bij het meten met HD-
sEMG. Mijn oprechte dank voor het meten met een nieuw instrument en voor de vele 
praktische tips. Eveneens voor het terzijde staan bij alle ups-en-downs die het meten 
met een nieuw instrument met zich meebracht. Fijn dat je tijdens de promotie mijn 
paranimf wilt zijn.
Mijn andere paranimf Marlou Majoor, en eigenlijk ook direct daarbij Jan-Karel, ben ik 
zeer veel dank verschuldigd. Geleund en gehangen heb ik op jullie. En jullie waren er. 
Dank voor jullie vriendschap door dik en dun en voor jullie adviezen bij onder andere 
het vormgeven van dit proefschrift.
Heert, we hebben veel gedeeld. Dank voor je zorg voor onze kinderen.
226 Dankwoord
Mijn nieuwsgierigheid naar alles wat leeft, heb ik meegekregen van bijzondere 
opvoeders, die veel voor mij betekend hebben. Ik noem: Baltus Drost, Eef Drost, 
Johannes Drost en bovenal mijn ouders, Dit en Bertus Drost. Ik draag jullie allen in mijn 
hart. 
Als laatsten, en daarmee als eersten, wil ik mijn kinderen danken, Roos en Sybe. Jullie 
hebben heel erg af moeten zien met een moeder achter de pc. Jullie hebben enorm 
meegewerkt aan dit proefschrift! Altijd weer kreeg ik support. Jullie zijn de meest 
fantastische kinderen die een moeder zich kan wensen! Als wij een doel hebben? 
Moeten we ervoor gaan! 
Gea Drost
Curriculum vitae
228 Curriculum vitae  Curriculum vitae 229
228 Curriculum vitae  Curriculum vitae 229
Curriculum vitae
Gea Drost was born on August 25th, 1962 in Overberg, The Netherlands. She graduated 
from high school (Christelijk Lyceum, Veenendaal) in 1978. She obtained her BSc in 
physical therapy from the Academy of Physical Therapy in Arnhem, and worked as a 
physical therapist in a rehabilitation centre from 1982 to 1986. In this period she also 
finished her propaedeutics (cum laude) in Psychology at the University of Utrecht, The 
Netherlands (1986).
In 1987 she started her medical training at the Radboud University Nijmegen and 
obtained her medical degree in 1994. She then started as a resident in at the Institute of 
Neurology, Radboud University Nijmegen Medical Centre, The Netherlands. During her 
residency she started the research described in this thesis on high-density surface EMG 
under supervision of Prof. dr. M.J. Zwarts, Prof. dr. D.F. Stegeman and Prof. dr. B.G.M. 
van Engelen. In 2000 she completed her residency in Neurology (Prof. dr. G.W.A.M. 
Padberg) with an emphasis on Clinical Neurophysiology (Prof. dr. M.J. Zwarts). The 
work described in Chapter 3 was awarded with the Young Investigators Award of the 
International Federation of Clinical Neurophysiology (IFCN).
At the moment, she works as a neurologist (staff member), with an emphasis on clinical 
neurophysiology, at the Institute of Neurology, Radboud University Nijmegen Medical 
Centre. 
She teaches clinical neurophysiology in MSc courses in human movement sciences and 
medical sciences. In addition, she is one of the coordinators of the multidisciplinary 
neuromuscular expertise centre in her hospital. Her special interests in clinical care and 
research are EMG and neuromuscular disorders, in particular muscle channelopathies. 
She is the mother of two children: Roos (1991) and Sybe (1994).

List of publications
232 List of publications  List of publications 233
232 List of publications  List of publications 233
List of publications  
Peer reviewed
Drost G, Verrips A, Thijssen HOM, Gabreëls FJM. Cerebellar involvement as a rare 
complication of pneumococcal meningitis. Neuropediatrics 2000;31: 97-9
Zwarts MJ, Drost G, Stegeman DF. Recent progress in the diagnostic use of surface 
EMG for neurological diseases.  J Electromyogr and Kinesiol 2000;10: 287- 91 
Drost G, Blok JH, Stegeman DF, van Dijk  JP, van Engelen BGM, Zwarts MJ. Propagation 
disturbance of motor unit action potentials during transient paresis in generalized 
myotonia: A high density surface EMG study. Brain 2001; 124: 352- 60
Blok JH, Van Dijk JP, Drost G, Zwarts MJ, Stegeman DF.  A high-density multichannel 
surface electromyography system for the characterization of single motor units. Review 
of Scientific Instruments 2002; 73, 1887-97.
Grassme R, Stegeman DF, Drost G, Schumann NP, Scholle HCh. Selective spatial 
information from surface EMG after temporal filtering: the application to interference 
EMG using cross-covariance analysis. Clin Neurophysiol 2003;114:2338-2346
Horemans HL, Nollet F, Beelen A, Drost G, Stegeman DF, Zwarts MJ, Bussmann JB, De 
Visser M, Lankhorst GJ. Pyridostigmine in postpolio syndrome: no decline in fatigue and 
limited functional improvement. J Neurol Neurosurg Psych 2003;74:1655-61. 
Drost G, van Dijk JP, Stegeman DF, van Engelen BGM, Zwarts MJ. Maintaining constant 
voluntary force in generalized myotonia despite muscle membrane disturbances: 
Insights from a high-density surface EMG study. 
J Clin Neurophysiol 2004;21:114-23. 
Drost G, Verrips A , Hooijkaas H, Zwarts MJ. Glutamic acid decarboxylase antibodies in 
Satoyoshi syndrome. Ann Neurol 2004;55:450-1.
234 List of publications  List of publications 235
Drost G, Stegeman DF, Schillings ML, Horemans HLD, Janssen HMHA, Massa M, 
Nollet F, Zwarts MJ. Motor unit characteristics in healthy subjects and those with 
postpoliomyelitis syndrome: A high-density surface EMG study. Muscle Nerve 2004;30:
269-76. 
Trip J, Drost G, Ginjaar HB, van Engelen BGM, Faber CG. Het spectrum van de erfelijke 
skeletspierkanalopathieen. NTvG 2005;149:2093-8.
Voermans NC, Drost G, van Kampen A, Gabreels-Festen AA, Lammens M, Hamel BC,
Schalkwijk J, van Engelen BGM. Recurrent neuropathy associated with Ehlers-Danlos 
syndrome. J Neurol 2006;253:670-1. 
Trip J, Linssen WHJP, Krudde J, Drost G, van Engelen BGM, Faber CG. Twee families 
met stijve spieren; de niet-dystrofische myotonieen. Tijdschr Neurol Neurochir 2006;107:
54-61
Van Beekvelt MC, Drost G, Rongen G, Stegeman DF, Van Engelen BG, Zwarts MJ. Na+-
K+-ATPase is not involved in the warming-up phenomenon in generalized myotonia. 
Muscle Nerve 2006;33:514-23. 
Pillen S, van Engelen B, van den Hoogen F, Fiselier T, van der Vossen P, Drost G. 
Eosinophilic fasciitis in a child mimicking a myopathy. Neuromuscul Disord 2006;16:144-
8.
Trip J, Drost G, van Engelen BG, Faber CG. Drug treatment for myotonia. Cochrane 
Database Syst Rev 2006 Jan 25;(1):CD004762.
Hengstman GJ, Drost G, Wagenaar M, van Engelen BG. Persistent increased risk for 
thymoma in myasthenia gravis associated with myositis. Muscle Nerve 2006;34:251-2. 
Drost G, Verrips A, van Engelen BG, Stegeman DF, Zwarts MJ. Involuntary painful 
muscle contractions in Satoyoshi syndrome: A surface electromyographic study. Mov 
Disord 2006 Sep 13;21:2015-18 
 
Drost G, Stegeman DF, van Engelen BG, Zwarts MJ. Clinical applications of high-density 
surface EMG: A systematic review. J Electromyogr Kinesiol 2006;16:586-602. 
234 List of publications  List of publications 235
Trip J,  Faber CG, Ginjaar HB, van Engelen BGM, Drost G. Warm-up phenomenon in 
myotonia associated with the V445M sodium-channel mutation. J of Neurol (In press)
Drost G, Kleine BU, Stegeman DF, van Engelen BGM, Zwarts MJ. Fasciculation potentials 
in high-density surface EMG. J Clin Neurophysiol (in press)
Blijham PJ, Drost G, Stegeman DF, Zwarts MJ. Normal sarcolemmal changes after cold 
exposure in paramyotonia congenita. (submitted) 
Book chapters
Zwarts MJ, Stegeman DF, Drost G, van der Hoeven HJ. Surface EMG in the assessment 
of neuromuscular disease. In: Hermens HJ, Häggs G & Freriks B (eds.), Proceedings 
Second General Workshop European concerted action (BIOMED II) ‘Surface EMG for 
non-invasive assessment of muscles’, (SENIAM), ISBN 90-75452-06-3, 179-183 (1997).  
Roeleveld K, Drost G, Stegeman DF, Blok JH, Scholle HCh. Estimation of motor unit 
position from surface EMG topographical maps. In: Hermens HJ, Stegeman DF, Blok JH, 
Freriks B (eds.), ‘State of the Art on Modelling Methods for Surface ElectroMyoGraphy’, 
(SENIAM), ISBN 90-75452-11-X,  76-81 (1998)
Blok JH, Stegeman DF, Drost G. The use of spatiotemporal information in motor unit 
classification. In: Hermens HJ, Merletti R, Rix H, Freriks (eds.). ‘The state of the Art on 
Signal Processing Methods for Surface Electromyography’, (SENIAM), ISBN 90-75452-
17-9, 185 - 193 (1999). 
Zwarts, MJ, Stegeman, DF, Drost, G. The use of surface EMG in the assessment of 
disorders of nerve and muscle. In: Hermens HJ & Freriks B (Eds.), ‘Future applications 
of surface electromyography’ European concerted action (BIOMED II) “Surface EMG for 
non-invasive assessment of muscles” (SENIAM), (ISBN 90-75452-16-0), 149 – 152 (1999).
Drost G, Blok JH, Stegeman DF, van Dijk, JP, van Engelen BGM, Zwarts MJ, Stegeman 
DF: High density SEMG during transient paresis in Becker’s myotonia. In: Hermens HJ & 
Freriks B (Eds.), ‘Future applications of surface electromyography’ European concerted 
action (BIOMED II) “Surface EMG for non-invasive assessment of muscles” (SENIAM), 
ISBN 90-75452-16-0, 159 – 163 (1999).

